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CHAPTER 1. INTRODUCTION

1.1

Protein kinases

Intracellular phosphorylation catalyzed by protein kinases leads to the integration
of information from the extracellular environment to the cell nucleus. Phosphorylation
affects every basic cellular process including metabolism, growth and differentiation.
Protein kinases catalyze the transfer of the !-phosphate from adenosine triphosphate
(ATP) to the amino acid residues serine (Ser), threonine (Thr) and tyrosine (Tyr) in
eukaryotes. Kinases account for ~2% of the human genome and include at least 500
genes, which makes them one of the largest families of genes in eukaryotes. (1) Protein
kinases can be classified into two subfamilies based on their ability to phosphorylate Tyr
or Ser and Thr residues. These classifications can be further divided into receptor or
nonreceptor based on localization of the kinases. It has been estimated that 30% of all
proteins are phosphorylated on at least one residue and 100,000 phosphorylation sites
have been identified in the proteome to date. The number of sites phosphorylated by each
kinase varies greatly and this variation can be accounted for by the mechanisms
responsible for kinase substrate recognition.
1.2

Kinase substrate recognition

Deciphering the kinases that are responsible for phosphorylation of the various sites in
the proteome is a difficult task. Protein kinases contain structurally similar catalytic
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domains comprised of an N-terminal lobe composed of !-sheets and a C-terminal lobe
containing "-helices. Between the two lobes is a catalytic cleft which is responsible for
binding ATP and the substrate sequence as well as catalyzing phosphotransfer from ATP
to the hydroxyl group of the phosphorylatable residue. (2-4) While all kinases share these
similar structural folds, they differ in their recognition of the phosphorylation site
residues and surrounding sequence. The depth of the catalytic cleft promotes
discrimination between Ser/Thr and Tyr residues for their respective kinases. Tyr kinases
have a deeper cleft compared to Ser/Thr kinases to accommodate the longer and larger
side chain of tyrosine. The ability of the catalytic cleft to identify the phosphorylatable
residue makes a significant contribution to substrate recognition through its affect on the
binding energy of the substrate to the kinase through this residue. This has been observed
from the large difference in binding energy between substrate peptides and
pseudosubstrates, in which the phosphorylatable residue is replaced with an
unphosphorylatable structural mimic (i.e. substitution of tyrosine to phenylalanine, or
serine to alanine). The PKA substrate Kemptide (LRRASLG) has a Km = 16 µM, which
is a surrogate for binding affinity, Kd; whereas the pseudosubstrate LRRAALG has a Ki =
490 µM, which is the dissociation constant of the inhibitor (pseudosubstrate)-PKA
complex, a 30-fold decrease in affinity for the peptide. (5, 6) Likewise the Src substrate
YIYGSFK has a Km = 55 µM, while the tyrosine to phenylalanine substituted
pseudosubstrate YIFGSFK displays significantly weaker interaction (by an order of
magnitude) with a Ki = 575 µM. (7, 8) These results demonstrate that the
phosphorylatable residue (or phosphorylation site) contributes a substantial amount of
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binding energy to the kinase-substrate interaction, facilitating substrate recognition and
differentiation between Ser/Thr and Tyr kinases.
Kinase catalytic domains also differ based on the hydrophobicity and charge of
surface residues surrounding the catalytic cleft. These residues interact with the amino
acids in the immediate vicinity of the phosphorylation site through electrostatic
interactions, hydrogen bonding, and van der Waal’s interactions contributing
significantly to the kinase-substrate recognition. The effects of these interactions on
kinase substrate recognition have been demonstrated by examining the effect of varying
substrate sequence lengths on kinase recognition. A peptide library containing a range of
sequences from dipeptides to hexapeptides was used to examine the effects of varying the
number of flanking residues as well as the charge and hydrophobicity using glutamic acid
and alanine. The Km values of the majority of these peptides were rather large (1-16 mM)
demonstrating a weak interaction between the substrate and the kinase. However, the
sequences containing five acidic flanking residues on either side of the phosphorylation
site (EEEEEY or YEEEEE) exhibited significantly reduced Km = 130 µM. (9) These
observations suggest that a sufficient amount of interaction through an appropriate
number of contacts is required between the kinase and substrate to promote
phosphorylation of the sequence.
Additionally, the results described above suggest that the chemical properties of
the substrate cooperate with the residues in the kinase surrounding the catalytic cleft to
affect substrate recognition. The effects of the residues residing in the catalytic cleft on
substrate recognition have been demonstrated using a structural homology model of the
catalytic domains of Abl and Src, based on the crystal structure of insulin receptor
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tyrosine kinase (IRK) bound to a peptide substrate. (10, 11) Substitutions of residues in
the kinase and the substrate were made based on IRK substrate interaction, and peptide
substrates and mutant kinases tested resulted in distinct changes in substrate kinetics. For
Abl, the optimal substrate sequences contain the motif Ile-Tyr-Ala-X-Pro; substitutions
of the substrate sequence at the critical positions -1, +1 and +3 resulted in significant
changes in the Km and Vmax of the substrates. However, substitutions made to the
catalytic domain residues did not change substrate residue preference and resulted in only
modest changes in the Km values for the substrate. Significant changes were observed in
the catalytic efficiency (Vmax/Km) of the mutant kinases due to elevated Vmax values.
These changes could arise due to several factors, including the possibility of substituted
residues not being directly involved in the interaction with the substrate. Recognition
could involve multiple residues and it may be that a single substitution is not sufficient to
alter the interaction. Another possibility is that the conformation of the catalytic domain
is altered due to the substitution. Without a crystal structure of the kinase-substrate
complex, it is difficult to fully assess and define the kinase domain residues involved in
recognition of a substrate. Nevertheless, these models demonstrate the importance of
kinase-substrate recognition determinants in both the catalytic domain and the substrate
itself for maintaining kinase substrate specificity.
Another example of the contribution of the substrate sequence to kinase specifity
was shown by substrate substitution effects on the autophosphorylation site in the A-loop
of anaplastic lymphoma kinase (ALK). (12) Isoleucine at the -1 position was found to be
an important determinant for ALK substrate recognition, as a substitution at this position
resulted in a 10-fold decrease in phosphorylation compared to the wild-type sequence.
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More importantly, the basic residues at the +6 and +7 positions resulting in 33-fold and
5-fold decrease in substrate phosphorylation, respectively. Substitutions at the -3, -2 and
+1 did not have the same marked effect, resulting in just 2-fold decreases in
phosphorylation. These distal interactions were demonstrated to facilitate substrate
release rather than promoting other behaviors that could reduce phosphorylation, such as
substrate inhibition. The substrate specificity of ALK found in this study exhibited that
substrate specificity through kinase-substrate interactions can also occur with portions of
the kinase outside of the catalytic cleft and substrate residues distal to the
phosphorylation site.
Distal kinase-substrate interactions are able to increase the affinity of the substrate
for the kinase, thus increasing the specificity of the substrate for the kinase. One of the
most well studied examples is the control of mitogen activated pathway kinase (MAPK)
substrate specificity through binding to the D and DEF domains (Figure 1-1). The Ddomain with the consensus sequence (Arg/Lys)2-3-(X)1-6-!-X-! is 50-100 residues away
from the phosphorylation site, and increases the affinity of the substrate by binding to a
complementary docking site on the opposite side of the kinase relative to the catalytic
site. This docking site is composed of a highly acidic patch and a hydrophobic pocket that
are complementary to the consensus sequence. (13) Many MAPK substrates also contain
the DEF domain, which is characterized by the consensus sequence Phe-X-Phe-Pro. This
sequence facilitates binding to a region adjacent to the catalytic cleft. (14) The
application of these motifs individually and together has been shown to significantly
enhance the specificity of peptide substrates not just for MAP kinases but also between
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family members Erk, p38 and JNK by facilitating lower KM values, higher Vmax values
and overall greater catalytic efficiency. (15, 16)
D domain motif
R/K2-3-X1-6-!-X-!
D domain

Catalytic
Cleft

DEF
domain

kinase
recognition
sequence

DEF motif
F-X-F-P

Figure 1-1 Representative schematic of MAPK substrate recognition through distal
catalytic domain interactions. The kinase recognition sequence within the substrate
interacts with the MAPK through the catalytic cleft.
The contribution of distal interactions between substrates and kinases has also
been shown to extend beyond the kinase domain to noncatalytic domains of the kinase.
For Src-family kinases (SFKs) the SH2 and SH3 domains facilitate important proteinprotein interactions and have been demonstrated to assist in kinase recognition of
substrates. This concept was demonstrated in vitro by examining the effect of adding SH3
or SH2 domain ligands to an Hck peptide substrate. (17, 18) The addition of the proteinprotein interaction domain ligands resulted in significantly lower Km values (10-fold) and
increased the efficiency of phosphorylation of the substrate. This organization of kinase
specificity through noncatalytic domains has been observed in vivo as a mechanism to
allowed highly related kinases have distinct functional roles. The mitogen activated
pathway kinase kinases (MAPKKs) share closely related kinase domains, yet have very
distinct functions in yeast. (19) By introducing the required interaction motif of the
MAPKK Ste7 into other MAPKK family members, these other MAPKKs could be made
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to perform the same functions (Figure 1-2). These results demonstrate the importance of
protein-protein interacts in governing kinase substrate specificity.
A

B

C

Ste11

Ste11

Ste11

Mkk2
Pbs2

Mkk2
Pbs2

Ste7

Fus3

Ste5

Fus3

Ste5

Fus3

Ste5

Figure 1-2 Protein-protein interactions determine yeast MAPKK function. A) MAPK
signaling cascade in yeast is facilitated through protein-protein interaction resulting in
Fus3 phosphorylation by Ste7 B) Localization of other MAPKKs to the scaffold protein
is not sufficient to recapitulate Ste7 function C) The Ste7-Fus3 interaction motif is
necessary and sufficient for Mkk2 and Pbs2 to recapitulate the same function of Ste7.
The recombination of noncatalytic domains to alter kinase specificity and function
is not limited to the same family or even closely related families of kinases. The
exchange of SFK Hck’s SH2 domain with acidic motif recognition PDZ domain, not
found in tyrosine kinases, results in redirecting the kinase specificity, observed by
alterations in proteome wide phosphotyrosine. (20) This manipulation of the Hck
modular structure resulted in rewiring of the Cas migratory pathway. Without the SH2
domain Hck could no longer interact with or phosphorylate Cas. Only when a PDZ
domain ligand was engineered into Cas were the Hck interaction and phosphorylation of
Cas reconstituted. This serves as a key demonstration that the noncatalytic domain
interaction can redefine substrate specificity and rewire signaling pathways.
The rewiring of signaling networks through noncatalytic domain interaction has
extended beyond substitution of protein-protein interaction domains to the use of scaffold
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proteins. In one example, an artificial synthetic adaptor protein was used to facilitate a
novel protein-protein interaction between the SH3 domain of SFK Hck and the !–helix
of the hDM2 protein, resulting in phosphorylation of hDM2. (21) This further
demonstrates the importance of protein-protein interaction in kinase substrate
recognition. Together with the results described above for SH2 and SH3 domains, these
results show that protein-protein interactions can play a dominant role in defining kinase
substrate specificity, and new kinase functions can arise from recombining catalytic
domains with interaction domains or facilitating novel interactions.
To summarize, kinase substrate specificity is determined by a number of factors,
including the structure of the catalytic domain, the residues of the substrate sequence,
distal interaction of the substrate sequence within the kinase domain, and noncatalytic
domain interactions with other proteins. The ability to define the specificity of the
catalytic domains as well as noncatalytic domains would provide insight as to how each
kinase recognizes substrate proteins and the substrate sequence within the protein. These
insights could then be applied to decipherthe vast number of phosphorylation sites
identified to date and in the future.
1.3

Methods for determining kinase substrate sequence specificity

The determination of the favorable residues in the substrate for each kinase at
each position has proven to be a daunting task, as the sizes of combinatorial peptide
libraries considering the key residues in the immediate vicinity of the phosphorylation
site (-4 to +4 positions) comprise more than 2.5 billion sequences. Several approaches
have been developed to use peptide libraries to empirically determine the substrate
sequence features responsible for kinase specificity. These libraries can broadly be
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categorized as encoded libraries, such as phage displays, or synthetic libraries, including
oriented peptide libraries and one-bead-one-peptide libraries. Both of these categories of
methods are based on generating large sequence libraries for kinase substrates, subjecting
them to kinase reactions, selecting and identifying the phosphorylated library members,
and then determining the features responsible for kinase recognition based on the patterns
within sequences observed to be phosphorylated.
1.3.1

Genetically encoded peptide libraries

Nature is able to generate vastly diverse collections of functional biomolecules,
including peptides, proteins and antibodies, by subjecting libraries of nucleic acids
(genomes) to cycles of translation, selection, amplification and diversification.
Genetically encoded peptide libraries mimic this biological process in vitro by exploiting
the link between the properties of the library such as binding affinity or substrate
specificity (the phenotype) and the genetic information encoded (the genotype).
Translation of the encoded genetic constructs under appropriate conditions produces a
library of peptides fused to a protein, RNA, or DNA. The library can be subjected to in
vitro selection for desired properties, such as binding affinity or substrate specificity. The
library members that contain the desired properties are enriched, the genetic information
is amplified using PCR, and hits are identified using (for example) high-throughput
sequencing (Figure 1-3). The use of genetic material to encode the library offers several
key advantages for screening. The information content of DNA is sufficiently high that a
21-mer nucleotide could encode 1.28 x 109 sequences. Also the ability to amplify subfemtomole quantities of DNA by PCR provides extremely sensitive and specific
quantitative detection. As opposed to other screening methods such as small molecule
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inhibitor screening libraries where each library member is examined individually, an
entire encoded library can be screened simultaneously in a single experiment. This
concept has been applied to examine protein-ligand interactions, antibody epitope
binding, and protease substrate specificity. (22-24) In the next section, the application of
genetically encoded libraries of peptide sequences and selection for the determination of
kinase substrate specificity is reviewed.

identification

cDNA library

translation

substrate sequences

peptide library

selection

screening

kinase assay

Figure 1-3 In vitro screening and selection of genetically encoded peptide libraries

1.3.1.1 Phage display libraries
Phage display libraries are constructed by using bacteriophages to translate the
encoded peptide library as peptide sequences fused to minor or major coat proteins to be
displayed on the outer coat of a filamentous phage with the encapsulated DNA within.
The peptides can be fused to the most abundant coat protein pVIII, which allows for
multiple copies to be displayed; however, instability of the phage coat is a concern with
this approach. The use of the single copy pIII coat protein located at the tip of the phage
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has been shown to more amenable, since it does not cause as much instability in the
phage coat. Once the library is expressed it can be incubated with a purified kinase.
Selection of substrate peptides can be achieved using affinity enrichment by
immunoprecipitation or metal affinity. Identification of substrate peptides can also be
performed using radioactive labeling with 32P-ATP during the kinase assay. Following
selection, phages can be genetically sequenced to identify their displayed peptide
substrate sequence. (25)
The use of phage display suffers from some limitations as a result of the library
expression and display. Phage display libraries require an in vivo step to facilitate
expression; the DNA library must be transformed into the bacteria resulting in limitation
of the library sizes to 109-1010 sequences. Additional concerns arise from the need for the
in vivo step with the use of phage display, including poor expression in the host, failure to
process peptide-protein fusion to the phage surface, toxicity of the gene product, and
maintenance of phage coat integrity. Together these issues make it difficult to ensure the
entire sequence library is expressed. Nevertheless, this approach has been productive; for
example, phage display was applied for the identification of substrate motifs for tyrosine
kinases Syk, Src, Lyn and Blk. The following concensus motifs were identified for the
kinases: Src, EXLYWXFX; Blk, XXIYDXLP; Lyn, DXIYEXLP; Syk, XXDYEXXX.
(26)
1.3.1.2 mRNA fusion peptide libraries
mRNA display is an alternative cell free technique that eliminates the limitations
associated with the in vivo step of phage display libraries. In mRNA display, the encoded
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peptide library is fused directly to the mRNA by the formation of a covalent linkage
between the mRNA template and the expressed peptide through 3’-puromycin.
Puromycin mimics an amino-acyl tRNA, resulting in covalent binding to the nascent
peptide following the peptidyl transferase activity of the ribosome. The coupling
efficiency through is puromycin is low (10-40%), reducing the number of expressed
sequence that can be identified. Despite this low efficiency the sequence complexity
achieved is greater than phage display by 10,000 fold. (27)
A mRNA-peptide fusion library designed to display a tyrosine residue surrounded
by five random amino acids was applied to interrogate v-Abl tyrosine kinase specificity.
Following exposure to v-Abl, phosphorylated peptides were isolated through rounds of
immunoprecipitation with the phosphotyrosine-specific antibody 4G10. Amplification of
the mRNA by PCR allowed for DNA microarray identification of sequences. (28) v-Abl
was found to select substrates with the motif I/L/V-Y-X3-4–P/F which was in agreement
with the results obtained by several other methods. Despite the success of this approach,
the application of mRNA display is limited due to the instability of mRNA. This
constrains the types of assays and selection conditions available to probe the library. The
stability of the mRNA template can be improved by reverse transcription to form a
RNA/DNA hybrid; however, this only provides a modest improvement.
1.3.1.3 cDNA display libraries
Using DNA fused to the peptide rather than mRNA provides greater stability for
the library, allowing for the use of a variety of selection conditions in which RNA would
otherwise degrade. The increased stability also allows for selection assays that require

!

13
longer experimental times, such as off-rate selections for affinity reagents such as
antibodies and aptamers, as well as enzyme inhibitors. Also, the use of DNA allows for
directed evolution of the selected sequences from the library due to the compatibility with
PCR-based mutagenesis, which can’t be performed with mRNA display libraries. The
construction of a cDNA display library is accomplished by first expressing the library as
mRNA-peptide fusions as described above using a covalent puromycin linkage. Next, a
DNA primer is crosslinked to the RNA by psoralen and the RNA is reverse transcribed to
produce a single stranded DNA (ssDNA)/single strand RNA (ssRNA) hybrid. The RNA
is removed from the ssDNA/ssRNA by RNase treatment and the single stranded cDNApeptide fusion is transcribed to form a double stranded DNA (dsDNA)-peptide fusion.
The dsDNA has been shown to be stable in cell lysates for over two hours making them
ideal for cell-based selections, which provide more biologically-relevant systems than
purified kinases. (29)
The substrate specificity of Abl was assessed using cDNA fusion by encoding a
combinatorial mutation library of the previously identified optimal Abl substrate, Abltide,
EGEAIYAAPFA. (30) This approach allowed for the entire sequence space to be
examined through all iterations of this sequence to access single substitutions
quantitatively. It was ultimately determined that Abltide was the optimal substrate for
Abl, but a more detailed analysis of Abl specificity was also performed. This analysis
revealed that Abl substrate sequence preference also included the motif E-A/L/P/G-I-YA/W/S/E/Q-X-P, where X is any amino acid.
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1.3.1.4 DNA/PNA programmed synthetic libraries
The translation of the biosynthetic approaches of encoded peptide libraries to
organic synthesis of peptide using DNA has many advantages over traditional peptide
chemistry. The use of DNA encoded peptide libraries is an attractive synthetic approach
for the development of a combinatorial library because the DNA not only facilitates
construction of the library but also tags the sequence. Several distinct synthetic
approaches have been developed to produce peptide libraries including DNA-templated,
DNA-routed and YocotReactor syntheses. (31-33) In each of these methods, each unique
DNA/PNA triplet contained in the genetic tag encodes a specific amino acid monomer.
The synthesized libraries can be subjected to in vitro selection to identify individual
compounds possessing the desired property through amplification and sequencing of the
DNA template.
This approach was used to examine the substrate specificity of Abl, VEGFR2, and
ErbB2/Her2 with a PNA encoded library containing 10,000 fluorescently labeled
peptides with four variable positions in the sequence Phe-Gln-AA4-AA3-Tyr-AA2-AA1Ile- Lys. (34) The library was exposed to the kinases and then hybridized to a DNA
microarray. The array was probed for phosphorylation using the antiphosphotyrosine
antibody 4G10 followed by a Cy3 conjugated secondary antibody (Figure 1-4). The
substrate specificity profiles determined for Abl, VEGFR2 and ErbB2/Her2 were F-ES/E-E-Y-E/S, K-E/K/S-Y-E/K/S-D-Pro and K/E/S-S/K/D-Ala-Y-D-Pro/S/D-Val-D-Pro/S
respectively.
This approach provides several advantages for determination of kinase substrate
specificity. This assay allows for radioactive isotope-free detection and rapid
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identification of individual sequences with high sensitivity and accurate profiling, and
also gives relative quantification of phosphorylation. Relative quantification is
accomplished through normalization of the fluorescent phosphorylation signal to the
fluorescent peptide signal, allowing for variation in hybridization and synthesis yields to
be taken into account. The use of the DNA array permits rapid identification of the
peptide sequences due to the hybridization to specific locations on the microarray. PNA
encoded libraries also provide the additional advantage of allowing for the incorporation
of non-natural amino acids, such as the D-isomers, into the peptide sequences.

Total
peptide

pTyr

translation
PNA library

peptide library

selection
and identification

Abl

screening

Figure 1-4 Workflow of PNA-encoded peptide library for the determination of Abl kinase
substrate specificity. The PNA library is translated through peptide synthesis. The library
is then exposed to Abl kinase in an in vitro kinase assay. The library is hybridized to a
DNA microarray and probed for phosphorylation.
1.3.2

Synthetic peptide libraries

Synthetic peptide libraries provide the most robust way to have absolute control
over the sequence space available in the kinase screen. However, challenges arise due to
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the time and cost required to synthesize large peptide libraries that are capable of
exhaustively examining the entire sequence space. Also, without the genetically encoded
tag present for identification, determining the individual sequences is a technical
challenge. Several approaches have successfully used synthetic peptide libraries and
sufficiently addressed the technical challenges of sequence identification to determine
kinase substrate specificity.
1.3.2.1 Oriented Peptide libraries
Oriented peptide libraries are typically designed to cover the entire combinatorial
sequence space (more than 2.5 billion sequences) The library of peptides is synthesized
exhausting all possible combinations of amino acids, in which each residue is screened at
each position. The entire library is exposed to the kinase of interest and the
phosphorylated peptides are enriched using antibody-based or metal affinity
chromatography. Due to the large number of sequences selected as substrates (~1%, 25
million sequences) it is usually impossible to identify each sequence individually;
however, since each sequence is the same length, Edman sequencing can determine the
abundance of each amino acid at each position in selected pools of sequences. This
approach allows for universal determination of kinase substrate specificity and has been
applied to 13 Tyr kinases and 18 Ser/Thr kinases. (35, 36) However, due to the selection
of only phosphorylated sequences and the population-based determination of specificity,
any potential information concerning interpositional dependence (in which certain amino
acids at a given position influence the interactions of those at other positions) and/or nonpermissive residues (residues that actively decrease phosphorylation as opposed to either
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promoting or being neutral for phosphorylation) is lost. Additionally, these libraries are
unable to determine substrate interactions outside of the -5 and +4 (which may influence
specificity) without resulting in an exponential increase in the library size. Finally, the
time and cost to synthesize this type of library and determine amino acid abundance can
make this approach somewhat cumbersome for determination of kinase substrate
specificity.
1.3.2.2 Positional scanning peptide libraries
To improve on the limitations of oriented peptide libraries, the synthetic library
approach was modified by partitioning the entire sequence space into 198 sublibraries.
Each library contains a fixed amino acid at one position and random residues at all other
positions. Each sublibrary is exposed individually to the kinase in solution with 32Plabeled ATP, and then captured on streptavidin-coated nitrocellulose paper by a Cterminal biotin tag. The level of phosphorylation is typically assessed based on
incorporation of radioactive phosphate. Rather than simply determining the abundance of
each amino acid at each position represented overall, this method enables the effect of an
individual amino acid at each position to be empirically determined. This approach also
increases the throughput by eliminating Edman’s sequencing. This method has been
successfully applied to determine the substrate specificity of 61 yeast kinases as well as at
least 179 human kinases. (37-39). Like OPL, since only one amino acid is fixed and
known at a given position, PSPL do not provide information about the individual
sequences that were phosphorylated; therefore, any potential contextual information,
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including the possibility of nonpremissive residues, cooperativity, and/or interdependent
positions, is lost.
1.3.2.3 One-bead-one-peptide (OBOP) libraries
Solid supported synthetic combinatorial peptide libraries have also been applied
for the determination of kinase substrate specificity. These peptide libraries are
synthesized using solid-phase split-and-pool peptide synthesis such that in principle, only
a single peptide sequence is conjugated to each individual bead of the solid support. The
on-bead library of peptides is then exposed to the kinase of interest and substrate
sequences can be detected by a variety of methods including radioactive labeling with
32

P-labeled ATP followed by autoradiography. The identities of the phosphopeptides then

must be determined by Edman sequencing. (7) The universal application of this method
has been limited due to the requirement for Edman sequencing for determination of
substrates.
An alternative approach to allow for higher throughput identification of individual
peptide sequences is to apply mass spectrometry (MS) analysis following selection of the
phosphorylated peptides. To facilitate MS sequence identification the OBOP library is
synthesized to contain a sequence ladder by terminating the peptide during each amino
acid coupling using competitive acetylation. (Figure 1-5A) (40) The ladder provides a
mass fingerprint in the MS spectra facilitating analyses of matrix-assisted laser
desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) data and
increasing the throughput of the sequence identification compared to Edman sequencing.
(Figure 1-5B) Following selection of phosphorylated sequences using alkaline
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phosphatase-conjugated antiphosphotyrosine antibody, the mass ladder can be liberated
from the solid support via a UV-cleavable linker and analyzed by MALDI-TOF MS. This
method has been applied for determination of Src, Zap-70 and Brk substrate specificity.
A

Ac-AA1-BEBE-PLL
Ac-AA2-AA1-Ala-BEBE-PLL

AA1-BEBE-PLL

......

BEBE-PLL

Ac-BEBE-PLL
Ac-BEBE-PLL

Ac-AAn-...-AA2-AA1-Ala-BEBE-PLL

B
Kinase assay
Detection

UV
MALDI-TOF

m/z

Figure 1-5 Synthesis of one-bead-one peptide ladder library. The library is synthesized
with a photolabile linker (PLL) and spacer group (BEBE). The peptide sequence is
synthesized with the Fmoc-amino acid and 10% (mol/mol) acetic acid resulting in
acetylation and termination of the peptide sequence. This process is repeated until the
peptide sequence is completed. B) Experimental workflow using one-bead-one-peptide
ladder library for determination of kinase substrate specificity. The library is exposed to
the kinase of interest and phosphorylated sequences are identified based on alkaline
phosphate fluorescent. The positive beads are isolated and the peptide ladder is liberated
from the bead by UV irradiation. The substrate sequence is then determined by MALDITOF analysis of the peptide ladder.
This method can be adapted for the identification of Ser/Thr kinase substrate
specificity using chemical modifications of the phosphorylated Ser/Thr resiudes. Specific
detection of Ser/Thr kinase substrates leverages the availability of !-protons and the
presence of a good leaving group, phosphate. Under alkaline conditions phosphoserine
and threonine undergo !-elimination resulting in the formation of dehydroalanine and !methyldehydroalanine. (41) These residues provide an ", !-unsaturated system that can
be chemically modified by the addition of a nucleophile-linked probe, such as an organic
dye or affinity tag such as biotin, via a Michael addition. However, a notable limitation of
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this approach is the !-elimination reaction can give rise to false positive selection of
sequences, which could alter the interpretations of the specificity profile.
Recently, an alternative approach for the determination of kinase specificity that
overcomes the limitations of the OBOP methods discussed has been developed using
thiophosphorylation to label substrate sequences. The kinase reactions are performed in
the presence of adenosine 5’-O-(3-thio)triphosphate, which resulted in the labeling the
substrate sequences with a thiophosphate. (42) Phosphorylated peptides are selected
using a pyridyldithio-containing fluorescent probe that results in a disulfide exchange
covalently attaching the organic dye to the peptide. The identify of the positive sequences
was determined by partial Edman degradation mass spectrometry (PED/MS), where the
sequences are converted to a sequence ladder of progressively shorter fragment peptides
by performing multiple cycles of partial Edman degradation similar to the acetylation
terminated peptide ladder synthesis. The series of peptides can then be analyzed by
MALDI-TOF MS to give the amino acid series for the sequence. This approach has
successfully been applied to identify the substrate specificities of the Ser/Thr kinases
Pim1 and MKK6 and the Tyr kinase Csk demonstrating the potential for universal
application of the method to all types of kinases.
While the OBOP library methods described here are successful, they each still
suffer from some limitations. The synthesis of the library requires a complicated method
to produce the sequence fragment ladder, which must be optimized. If the whole
sequence is synthesized the method still relies on the costly and time-consuming Edman’s
degradation. While promising, the use of thiophosphorylation significantly reduces
catalytic efficiency of some kinases unless conditions such as metal cofactor are
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optimized resulting in lower sensitivity, as well as altering the kinetics of the substrates.
(43)
1.3.3

Computational methods for the prediction of kinase specificity

In the past, short sequence motifs have been used to attempt to describe the
pattern of kinase substrate recognition. These motifs are generally insensitive and
unspecific. For example, the motif [S/T]-[Q] has been used in the past to describe DNA
protein kinase (DNA-PK) kinase substrate recognition. This motif is expected to occur
often in the proteome and be recognized by many other Ser/Thr kinases including ataxia
telangiectasia muatated (ATM) kinase. This means that without further elaboration,
“traditional” substrate motifs to describe kinase substrate specificity offer little
information. The identification of more complex and subtle patterns is required to
accurately predict kinase substrate specificity with the necessary specificity and
sensitivity.
The use of computational approaches provide an alternative method to probe
deeper into the information obtained from experimental biology to predict and identify
kinase substrates. Prediction of kinase substrate specificity is a binary classification
problem as each sequence included in a training set could be classified as phosphorylated
(substrate) or non-phosphorylated (non-substrate). The establishment of a method for the
prediction of kinase substrate specificity requires 1) having a well-collected and curated
data set of positive and negative sequences 2) identification of features to characterize the
sequences as one of the two classes and 3) the development of a classifier trained from
the known sequences that is capable of making the prediction for new sequences. Over
the past decade more than 40 methods have been developed to predict phosphorylation
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sites. These methods differ in their approaches based on a number of attributes associated
with them including the algorithm or machine learning technique used, the number of
residues considered in a sequence, the incorporation of kinase sequence and/or structural
information, focusing the prediction for individual kinases or families, and the training
and testing data.
1.3.3.1 Position-specific scoring matrices (PSSM)
Position-specific scoring matrices represent the simplest of the machine learning
methods for kinase substrate prediction. PSSMs are matrices that represent each amino
acid at every position within the sequence. Each element in the matrix can represent a
variety of features describing each amino acid depending the construction of the matrix.
The elements can represent the frequency of a given amino acid at a particular position.
The values can also represent the weighted contribution of each amino acid to the overall
ability to be a substrate. (44) In any case, PSSMs are ideal for expressing the value of a
residue at a particular position for promoting or impeding phosphorylation by a particular
kinase. However, more complex patterns in the substrate motif such as cooperativity or
interdependence of positions are overlooked. Additional features could provide insight
into kinase substrate recognition such as secondary and tertiary structural information.
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Figure 1-6 Representations of higher order machine-learning models A) Artificial neural
networks and B) support vector machines.
1.3.3.2 High order machine learning models
Artificial neural networks (ANNs) are computational approaches that attempt to
mimic the processing that occurs in the human brain. These methods aim at having highly
parallel, distributive computation learning to achieve a generalized understanding of the
classification. The algorithm accomplishes this task by receiving inputs from a number of
features, weighing each input and adding them together. If the total sum of the inputs is
above an arbitrary threshold, the output will classify that sequence as a substrate. Weights
of the inputs and the definition of the threshold can be determined in an iterative manner
by training the algorithm with examples of both classifications (positive and negative).
(Figure 1-6A) The application of this method for prediction of kinase substrates can take
into account many features of kinase substrate interactions including the peptide
sequence and any structural elements associated with the potential substrate and/or the
kinase for the prediction. One of the inherent problems with ANNs is that it is difficult to
determine why the algorithm makes a particular decision while weighting the features for
classification; this leaves the algorithm as a “black box”, which makes it difficult to
examine and understand the learning and classification process.
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Another higher order model is Support Vector Machines (SVMs), which are
kernel methods build on two concepts first to map the feature vectors in a nonlinear way
to a high dimensional space, then utilize linear classifiers in the new space. This means
that the algorithm manages the inputs and translates them into processed data that can be
represented in a high dimensional space (for example, three features produces data
represented in a 3-dimensional plot) and then separates the data sets into classes based on
a linear function (plane). (Figure 1-6B) This method has been applied to kinase substrate
specificity in the cell by using known information about the kinase recognition
sequences, protein-protein interactions, and subcellular localization as input features to
build the classification model.
One of the shortcomings of machine learning techniques for prediction of kinase
substrates is that the model is only as good as the data used to develop the model. While
some kinases are extremely well studied (Abl, Src and Erk had 710, 1,047 and 2,512
articles published studying each of them, respectively, in 2012 alone), other kinases are
poorly studied (Ack, GRK4 and PRP4 had 4, 11 and 1 articles published studying each of
them, respectively, in 2012 and only 64, 116 and 27 articles, respectively, total in
Pubmed). These results are also reflected in the number of phosphorylation sites
identified for each kinase. Examining the Phosphosite Plus database
(www.phosphosite.org), which consists of over 13,000 phosphorylation sites (many from
proteomics datasets), 220 of the 518 kinases in the kinome do not have a single identified
and verified substrate. (Figure 1-7) This limited or even complete lack of data makes it
difficult, and in some cases impossible, to generate an accurate model of kinase substrate
specificity regardless of the machine learning approach applied.
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Figure 1-7 Number of identified phosphorylation sites for each kinase annotated in the
Phosphosite Plus data set.
1.4

The role of protein kinases in disease

As demonstrated above, kinase function is governed by substrate specificity
through sequence recognition and protein-protein interactions. Other regulatory
mechanisms, including regulation of the on/off state of the kinase by phosphatases
(which remove phosphates), subcellular localization, and alterations in expression level
or proteasomal targeting for degradation through ubiquitination, also contribute to the
control of kinase activity. The synchronization of these processes is critical for
maintaining normal cellular function, and deregulation of one these processes can
drastically affect the dynamics of a kinase’s activity often leading to overactivation of the
kinase. Given the importance phosphorylation plays in most cellular processes, it is not
surprising that dysfunction in kinase activity results in numerous disease states including
neurological diseases such as Alzheimers disease, metabolic disorders including type 2
diabetes and cancer.
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A recent review examining 915 kinase mutations that underlie 67 single-gene
diseases identified that more than 80% of mutations identified in kinases directly affected
the catalytic domain. (45) These mutations result in gain- and/or loss-of-function in the
kinase. Gain-of function mutations increase the activity of the kinase through an
additional function; whereas loss of function mutations that lead to increases in kinase
activity occur through mutational loss of inhibitory regulatory elements. Specific kinases
have been seen to be mutated in a variety of diseases states, such as Btk in X-linked
agammaglobulinaemia, and Akt2 in type 2 diabetes and lipodystrophy, resulting in
overactivation of kinase activity. (46, 47) Somatic mutations can also arise due to large
chromosomal rearrangements such as translocations. The most well studied example of
this occurs in chronic myeloid leukemia (CML), which is characteristically caused by the
reciprocal translocation of chromosomes 9q and 22p forming the Philadelphia
chromosome. This genetic aberration results in the fusion of the Breakpoint cluster region
(BCR) gene and Abl tyrosine kinase gene (Abl) into the BCR/ABL gene. This gene
product produces the oncogenic fusion protein Bcr-Abl, which possesses constitutive Abl
tyrosine kinase activity. Constitutive activation is conferred through the loss of function
of a normal Abl intramolecular inhibition mechanism due to the presence of Bcr on the
N-terminus of Abl. Additionally, there is also a gain of function facilitated by the coilcoiled domain of Bcr, which results in trans-autophosphorylation and activation of the
Abl kinase domain. (48)
Given the role protein kinases play in these diseases, and the direct link between
the genotype of certain disease states and aberrant kinase activity, the development of
therapeutic treatments targeting kinases has been a major focus of the pharmaceutical
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industry over the past two decades. Despite this effort by the pharmaceutical industry,
only 24 small molecule inhibitors have been FDA approved since the approval of the first
kinase inhibitor imatinib in 2001. These inhibitors target only 18 different kinases (~5 %
of the kinome) and are only approved for the treatment of various cancers for which
constitutive kinase activity is involved. (49) One of the rate limiting factors in the
discovery of new small molecule inhibitors is the lack of specific probes that provide
sensitive detection of kinase activity. Therefore there is a need for tools that provide
sensitive, selective and high throughput monitoring of kinase activity.
1.5

Peptide biosensors for monitoring kinase activity

The use of peptide substrates for detection of kinase activity is attractive for a
number of reasons including the specificity and sensitivity of kinase substrate recognition
and interactions (as reviewed above), the compatibility of peptides with multiple
chemistries and multiple detection platforms ranging from traditional biochemistry
techniques such as radioactivity and ELISA to emerging techniques such as surface
enhanced Raman spectroscopy (SERS) and fluorescence lifetime imaging. (50, 51) The
following is a review of the current methods used for monitoring kinase activity using
peptide substrates.
1.5.1

Traditional molecular biology techniques

The use of traditional molecular biology techniques such as Western blotting and
radioactive labeling have been applied for the detection of kinase activity using peptide
substrates. Radioactive detection using 32P-ATP has long been the traditional strategy for
detecting peptide phosphorylation, but is unattractive for large scale implementation due
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to the waste generated during detection and the specific considerations for disposal as
well as the safety concerns.
Antibody-based detection has also been applied for monitoring the
phosphorylation status of peptide substrates using traditional Western blotting. The
development of new multiwell read-out platform technologies using fluorescence
polarization, time-resolved lanthanide-based resonance energy transfer, and
chemifluorescent solid-phase kinase assays has drastically increased the throughput for
monitoring kinase activity in vitro. (52, 53) (Figure 1-8) However, detection in these
formats requires phosphospecific antibodies or generic phosphoantibodies such as 4G10
for phosphotyrosine. Such an antibody does not exist for phosphoserine or threonine;
however, recently introduced small molecule and nanoparticle-based phosphate affinity
reagents including Phos-tag and pIMAGO show promise in providing more universal
phosphate probes. (54, 55) Regardless, the use of generic phosphate affinity reagents also
reduces the number of phosphorylation events that can be monitored without
confounding the results. This prevents the detection of more than one phosphorylation
event (i.e. multiplex detection). Additionally, the number of handling, wash, and labeling
steps required with some antibody–based methods reduces the throughput as well as
increases the cost per data point.

!

29

HRP

P
Re

P
Re

po

Neutravidin

rte
r

P

po

B

Neutravidin

HRP

Re
r

P

po

rte

B

Neutravidin

Re

po

rte

r

B

Neutravidin

rte

r

B

Neutravidin

Figure 1-8 ELISA-based detection of peptide biosensor phosphorylation. Following
exposure of the peptide biosensor to the cells, the cells are lysed and added to a
Neutravidin™-coated 96-well plate. The substrate is captured from the lysate by the high
affinity interaction of biotin and Neutravidin™. Phosphorylated substrates are labeled
with the anti-phosphotyrosine antibody, 4G10. The primary antibody is labeled with a
horseradish peroxidase-conjugated secondary antibody. Finally, Amplex Red™ is added
to the well and oxidized to a fluorescent reporter in the presence of horseradish
peroxidase.
1.5.2 Mass Spectrometry detection
Post-translation modifications of proteins have long been studied using mass
spectrometry due to the unique mass changes associated with each modification, which
enables label-free detection. Peptide phosphorylation can be detected by the shift 80 Da
mass shift, and the peptide sequence and phosphorylation site can also be identified
simultaneously through its mass fragmentation spectra. The ability to determine
individual sequences based on the fragmentation patterns provides robust identification of
peptides and allows for multiplexed detection of thousands of peptides in a single assay.
Mass spectrometry also provides high sensitivity of detection, which allows for small
amounts of biological material (cell lysate or number of cells) to be used. Additionally,
MS detection is compatible with online and offline enrichment strategies such as metal
chromatography for phosphopeptides, which can further increase the sensitivity of
detection. Finally, MS detection can also provide quantitative detection through a number
of techniques including the incorporation of isotopically labeled standards. (56) All of
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these features make mass spectrometry an attractive detection platform for monitoring
kinase activity using peptide biosensors.
A recently developed technique named “Kinase ActivitY Assay for Kinome
profiling” (KAYAK) has enabled quantitative, simultaneous detection of phosphorylation
rates for 90 different peptides from proteins representing selected signal transduction
pathways from cell lysates in a single in vitro reaction. (57) Following quenching of the
kinase reaction, a set of the identical stable isotope-labeled phosphopeptides are added to
provide a quantitative internal standard. The phosphopeptides are enriched and detected
using Orbitrap MS to allow for high sensitivity and mass resolution. This approach
allows for phosphorylation signatures to be generated that can be associated with a
particular cellular stimulus or inhibitor. A setback of this approach is that it has limited
utility to study biology de novo. The peptides used to generate the signature via KAYAK
are not specific enough to provide information about which kinases are active, and
without a previously well-studied inhibitor or stimulus signature to compare against, it is
difficult to discern the significance of the biology. Additionally, using cell lysate to
perform the kinase reaction can result in drastic changes in the organization of signaling
networks due to removal of the compartmentalization of the cell. This can result in
alterations in the kinase activity, since changes in protein-protein interaction can occur.
Therefore, measuring kinase activity in intact, live cells is desirable for achieving the
most biologically relevant detection.
Recent work in our lab has aimed at circumventing these issues by delivering
kinase-specific peptide biosensors into live cells to directly monitor kinase activity. (58)
The design of these sensors leverages two degrees of kinase specificity by using both an
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artificial kinase specific substrate and a specific protein-protein interaction domain
ligand. The application of artificial substrates with multiple reaction monitoring mass
spectrometry (MRM-MS) has the advantage that the tryptic fragment is an unnatural
sequence providing a unique mass fingerprint that is unconfounded by the background of
tryptic peptides from native proteins in the cell lysate. MRM-MS allows for greater
sensitivity for detection in the fmol-amol range depending on the specific analytes and
instrumentation. MRM detection can achieve this sensitivity because it uses targeted
mass analysis, in which the mass analyzer focuses on detection of specific parent and
fragment masses (termed “transitions”) while filtering out all other ions. Monitoring two
transitions for an Abl-specific substrate provided confident identification of the peptide
and quantificative detection with limits of detection (LOD) and limits of quantification
(LOQ) of 0.5 fmol from a whole cell lysate.
1.5.3

Fluorescence detection techniques

Fluorescent techniques have become widespread in biological research.
Fluorescent proteins, small molecule organic dyes, semiconductor nanoparticles and
organometallic chelators have been developed and applied to monitor a wide array of
cellular events including protein localization, protein-protein interactions and cation
signaling. The application of these strategies has provided continuous real-time detection
with high sensitivity and selectivity as well as high spatial and temporal resolution in the
cell. The use of peptides for detection of kinase activity has been applied with a number
of fluorescent techniques including lifetime measurements and anisotropy. The following
is a review of peptide biosensor technologies using steady-state fluorescence and timeresolved measurements for detection of kinase activity.
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1.5.3.1 Genetically encoded FRET-based biosensors
The discovery and development of fluorescent proteins including GFP and its
engineered variants has led to the development of numerous cellular probes for
monitoring virtually every cellular process. Perhaps the most widely used and extensively
developed sensors for detection of cellular kinase activity are genetically encoded Förster
resonance energy transfer (FRET) biosensors. These biosensors are designed to contain a
FRET pair of two terminal fluorescent proteins with a kinase-dependent molecular switch
that induces a conformation change upon phosphorylation. (59) The molecular switch is
designed to contain a polypeptide substrate recognized by the kinase of interest and an
appropriate phospho-recognition domain (i.e. SH2, 14-3-3, WD40 domains). Upon
phosphorylation, the phospho-recognition domain binds the kinase substrate, altering the
distance between the fluorescent proteins and resulting in detectable FRET signal (Figure
1-9). These sensors allow for real-time continuous monitoring of cellular kinase activity
with high spatial and temporal resolution at the single cell level. Recently FRET sensors
were applied to monitor the temporal regulation of Erk kinase activity at the single cell
level following steady-state EGF stimulation. The ability to continuously monitor Erk
activity revealed that Erk is activated in discrete pulses and the duration of the pulse
controls S-phase entry.
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Figure 1-9 Genetically encoded FRET-based biosensor. The biosensor is composed of a
FRET pair of, for example, cyan fluorescent protein and yellow fluorescent protein, as
well as a kinase substrate and a phosphopeptide binding domain.
The development of genetically encoded FRET biosensor suffers from a severe
bottleneck due to a number of factors. The identification of sensitive and specific kinase
recognition sequences that are simultaneously compatible with phosphobinding domains
is a laborious process that has not yet been optimized to provide high throughput
development. The sensitivity and amplitude of response of these sensors varies based on
FRET pair, phosphobinding domain and conformation change induced by the
phosphobinding domain and kinase recognition sequence. This requires time and effort to
develop iterations of the sensor to achieve optimal detection. Even with optimization,
these sensors display small dynamic ranges due to modest changes in signal (10-60%)
making them only moderately quantitative and not ideal for detection of kinase activity
compared to other fluorescent methods.

1.5.3.2 Nanoparticle-conjugates
Quantum dots (QDs) are nanometer-size luminescent semiconductors that possess
many unique optical properties, making them excellent fluorescent probes. QDs have
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high fluorescence quantum yield, robust photostability, broad absorption bands and
narrow emission bands, which reduces spectral bleed through. These properties can be
tuned by controlling the size, shape and composition of the QD. Also, the surface
chemistry of QDs can be modified to allow for number of conjugation chemistries that
are compatible with peptides. These conjugation chemistries include Michael-addition
reactions, coupling through carbodiimide reactions, and succinimide ester activation.
Additionally, traditional metal surface chemistries are also available for conjugation by
self-assembly through chemisorption and electrostatic interactions. (61) These properties
of QDs have been exploited for the detection of kinase activity through the use of QDpeptide substrate conjugates.
QD-peptide substrate conjugates have been applied for sensitive detection of the
activity of the Ser/Thr kinase casein kinase 2 (CK2) using !-adenosine triphosphate-Atto590, which fluorescently labels the peptide substrate upon phosphorylation. (62) FRET
and electron transfer quenching processes between the QD and the Atto-590 labeled
peptide were used to monitor CK2 activity. In this system the QD is the electron donor
and Atto-590 fluorophore is the electron acceptor; therefore, phosphorylation of the
peptide results in decreasing QD fluorescence and increasing Atto-590 fluorescence.
(Figure 1-10A) Quantification of phosphorylation was determined by the percent
decrease in the fluorescence of the QD. A similar strategy was used to monitor Abl and
Src kinase activity using a CdSe/ZnS QD-peptide conjugate and an AlexaFluor 647
conjugated anti-phosphotyrosine antibody for fluorescent labeling. (63) While these
applications demonstrate the potential of QDs for kinase activity detection, the use of
ATP-analogs and fluorophore labeled antibody increases the handling steps and prevents
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these platforms from being applied for real-time detection or to in vivo models, which
would require a label-free approach.
A label-free approach for the detection of kinase activity using QD-peptide
conjugates exploits effect of surface charge on QD dispersion in solution. QDs are
monodisperse in solution due to electrostatic repulsion; however, neutralizing the surface
charge abolishes the electrostatic effects resulting in aggregation of the semiconductors.
(Figure 1-10B) A cationic substrate for PKA when unphosphorylated was capable of
neutralizing the surface charge of the QD leading to aggregation and diminished redshifted fluorescence. (64) Phosphorylation of the substrate results in the addition of a
negative charge to the peptide neutralizing the cationic charge and eliminating
aggregation leading to an increase in blue-shift fluorescence emission.

Figure 1-10 Quantum dot detection of kinase activity using A) phosphorylationdependent fluorescent labeling and FRET and B) surface charge aggregation.
1.5.3.3 Environmentally-sensitive Fluorescence
Environmentally-sensitive fluorophores (ESFs) display differences in their
spectroscopic properties depending on the physiochemical conditions of their
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environment. These fluorophores include 7-nitrobenz-2-oxa-1,3-diazole (NBD), pyrene,
and dapoxyl. ESFs are characterized by large excited-state dipole moments and low
quantum yields in polar solvents such as water but become highly fluorescent with blueshifted emission in non-polar environments such as nonpolar solvents or hydrophobic
binding pockets of proteins. The properties of these fluorophores have been exploited for
the detection of kinase activity through the incorporation of ESFs into kinase peptide
substrates positioned one to five residues from the phosphorylation site. Protein kinasecatalyzed incorporation of phosphate into the sequence in the proximity of the ESF
should, in principle, result in a change in the local polarity of the fluorophore resulting in
enhanced fluorescence emission. (Figure 1-11A) This approach has been applied to the
detection of PKC activity. (65)
An alternative approach using ESFs combines kinase substrate recognition with
phosphopeptide recognition domains such as phosphotyrosine-binding SH2 domains,
phosphoserine/threonine-binding 14-3-3 and WD40 domains. Once the sequence is
phosphorylated the phosphopeptide product is recognized by the binding domain
introducing the ESF to the hydrophobic environment of the phosphorecognition domainbinding pocket resulting in a change in polarity and fluorescence. (Figure 1-11B) This
strategy has been applied for the detection of Src kinase activity using the Src SH2
domain with dapoxyl; however, this robust result was not obtained with other ESFs. (66)
The lack of universally robust detection with ESFs makes it difficult to design peptidebased sensors using this approach.
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Figure 1-11 Environmentally-sensitive fluorescent peptide biosensors. A)
Phosphorylation alters the local environment of the fluorophore leading to an increase in
fluorescence. B) Phosphorylation of the peptide substrate results in SH2 domain binding
and a change in the fluorophore environment leading to an increase in fluorescence.
1.5.3.4 Chelation-enhanced Fluorescence
Another approach for fluorescent detection of kinase activity using peptide
substrates uses hard metal ions such as zinc, calcium, magnesium or lanthanide ions
including terbium and europium to mediate fluorescence or luminescence detection.
These sensors display low affinity for the metal ions in the unphosphorylated state and as
a result have little to no fluorescence. Introduction of the hard phosphate di-anion
increases the binding affinity of the sensors for the metal ions, causing enhanced
fluorescent or luminescent signal corresponding to kinase activity.
1.5.3.5 Biologically available metal chealation
One strategy is the use of chelation-sensitive fluorophores containing heteroatoms
that can coordinate biologically available divalent metal ions such as Zn2+, Mg2+ and Ca2+.
These fluorophores have different electronic structures when coordinated with a metal
ion than in the absence of the metal ion, which results in difference in the spectroscopic
properties. These changes can be attributed to a lone electron pair of the fluorophore,
which quenches fluorescence by an electron transfer mechanism in the absence of the
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metal ion; however, the involvement of the electron pair in metal coordination results in
increased fluorescence. These sensors are designed to leverage the ability of phosphate to
coordinate hard metal ions such as those mentioned above, so once incorporated in
proximity to the fluorophores, the phosphate group can aid in coordination to produce the
enhanced fluorescence signal.
1.5.3.6 Calcium-based chelation-enhanced fluorescence peptide biosensors
Detection of phosphorylation through calcium chelation has been facilitated by
the development of fluorophores that combine the eight coordination positions of
tetracarboxylate in 1,2-bis(2-amino-phenoxyethane-N,N,N’,N’)-tetracetic acid (BAPTA)
with a xanthene chromophore. These fluorophores displayed strong Ca2+ coordination
through the four carboxylic acids with binding constants in the range of 0.37-2.3 µM.
Calcium coordination changes the electronic configuration of the fluorophore resulting in
3-40 fold enhanced fluorescein fluorescence. (67) Placing the fluorophore next to the
phosphorylation site of a peptide allowed for one of the iminodiacetate arms of the
fluorophore to be replaced. (Figure 1-12A) This biosensor has been successfully applied
for the detection of cellular PKC activity by exploiting the Ca2+ dependent activation of
PKC. (68) However, the vast majority of protein kinases are not Ca2+ dependent making
this approached limited to detection of PKC and other Ca2+ dependent kinases.
1.5.3.7 Magnesium-based chelation enhanced fluorescence peptide biosensors
To circumvent the dependence on calcium activation, an alternative approach is to
achieve enhanced fluorescence through chelation of metals with consistently high
intracellular concentrations such as Mg2+, K+ and Na+. Mg2+ has steady-state intracellular
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concentration in the millimolar range making it an ideal metal for chelation-based
detection. The development of sulfonamide-oxime (Sox) fluorophores has utilized Mg for
enhanced fluorescence following phosphorylation for detection of kinase activity. The
Sox residue is separated from the phosphorylation site by a !-turn, which results in a
change in the directionality of the peptide and facilitates coordination between the
phosphorylation site and nonnatural fluorescent amino acids. (Figure 1-12B) Installation
of the !-turn is accomplished through a two amino acid sequence consisting of a proline
and glycine. Phosphorylation typically results in a 4-12 fold increase in fluorescence. (69)
However, the structural requirement for the !-turn hinders the ability of sensor design to
consider all aspects of kinase substrate recognition within the sequence. The development
of the next generation C-Sox, which consists of an alkylated cysteine containing the Sox
chromophore, allows for greater flexibility in sensor design by alleviating the
requirement for a !-turn. (70) The next generation design of Sox-containing biosensors
has focused on kinase recognition, resulting in sensors with comparable catalytic
parameters to those of the parent optimal kinase substrate. (Figure 1-12C) (71)

!

40
A

CO2- CO2N

CO2-

OH
O

O

F

N
H

HO

O

F
O

O

O
P
O

O

O

O

HO
F
O

Ca2+

CO2-

N

O
HN

F

O
O

O
S

B

O

NH2

NH2

S

O

O

HO

O
N

N

O
NH2

N
H

O

OH

O

P

O
O

O

Mg2+

N
H

NH2
O

O

O
S

C

O

NH2

S
O

HO

Mg2+

N

OH

NH2
O

O

O
S

P

O
O

O

N
S

Figure 1-12 Biologically available metal based CHEF biosensors A) CHEF-based Ca2+
dependent kinase biosensor; B) Sox; C) C-Sox

1.5.3.8 Lanathanide-based chelation-enhanced luminescence
The lanthanide metals (Ln3+), elements 57-71, also known as the “Rare Earth”
metals, display many unique photophysical properties due to the presence of electrons in
the 4f orbitals, which offers several advantages compared to biologically available hard
metals. The luminescence emission of lanthanides produces large Stokes shifts (~100-200
nm) between the absorption and the emission compared to organic fluorophores (~ 20-30
nm). The emission spectra produce very narrow bands (~20 nm wide) and are insensitive
to the chemical environment. The f-f electric dipole transitions that would lead to short
lifetimes are Laporte-forbidden by parity rules, therefore the Ln3+ ions have extremely
long luminescence lifetimes (millisecond for Tb3+ and Eu3+ and microseconds for Sm3+
and Dy3+). The long lifetimes make lanthanides well suited for time-resolved
measurements. Organic dyes and biological chromophores have fluorescence lifetimes in
the nanosecond ranges, therefore time-resolved measurements will allow for these short
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lived fluorophores to decay prior to collection of the longer-lived lanthanide-specific
signal. This is ideal for a detection method because it allows for highly specific and
sensitive signal from the sensor’s phosphorylation. (72)
Another direct result of Laporte-forbidden nature of the f-f transitions is that Ln3+
have extremely low molar extinction coefficients. This results in the need for a
chromophore to absorb the incident radiation and transfer it to the Ln3+ to facilitate
excitation. This has been accomplished by a variety of UV-absorbing chromophores
including coumarin derivatives, tryptophan, and tyrosine. Excitation of the chromophore
results in an excited singlet state. This singlet can either fluoresce or undergo
intersystem-crossing to an excited triplet state. The triplet state can emit a photon and
phosphoresce, or it can undergo energy transfer to and excitation of Tb3+. The excited
state of Tb3+ can be either quenched by nonradiative energy transfer or can emit
producing luminescence. Quenching can occur through nonradiative energy transfer to OH oscillators due to the similarity in the energy levels between the excited state of Tb3+
and the fourth overtone of water; therefore, water molecules coordinated to Tb3+ can
quench luminescence emission. This makes it important to consider the incorporation of
an appropriate chromophore as well as the coordination environment provided by the
sensor during the design of probes for the detection of kinase activity using lanthanides.
(72)
1.5.3.9 EF-hand based sensors
The Ln3+ are very similar to Ca2+, with Tb3+ and Eu3+ having only slight
differences in atomic radius and both elements are hard acids. The calcium-binding EF
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hand domains contain five hard base side chains and one main chain carbonyl to facilitate
coordination of Ca2+. Upon binding, these domains undergo drastic conformational
changes into well organized helix-loop-helix structures. In the past Tb3+ has been used as
a probe to determine Ca2+ binding affinity of these domains as well as to survey for
potential Ca2+ binding sites in proteins. Zondlo and coworkers have leveraged the
properties of the EF hand domains to develop kinase responsive sensors using Tb3+
luminescence for detection. (73) To accomplish this design, serine (Ser) was used as a
phosphorylation inducible mimic of glutamic acid (Glu) due to the similarities in
electrostatic and Lewis base properties. The Glu at position 12 of the EF hand domain is
critical for Ca2+ binding through its bidentate coordination, and thus is conserved amongst
EF hand domains. The replacement of this Glu with Ser generates a phosphorylation
responsive motif. Unphosphorylated Ser is a poor mimic of Glu and results in poor Tb3+
binding and minimal luminescence, while phosphorylated Ser provides the required
bidentate coordination through the phosphate group, and has the appropriate side chain
length to tightly bind Tb3+ and enhance luminescence. (Figure 1-13A) Additionally, the
residues on either side of this Glu are poorly conserved across EF hand domains,
allowing some elements of kinase substrate recognition to be incorporated at these
positions. This design has been applied to develop a sensor for Ser/Thr kinase PKA.
This approach has been modified to apply this sensor design to tyrosine kinases.
The size of phosphotyrosine prevents it from mimicking Glu, but length of side chain
allows for an alternative structure-based design by shifting the phosphorylation inducible
mimic motif by one position to replace Glu. (74) This strategy was applied to the
detection of Abl activity and inhibition. Similar to the first generation of Sox-based
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chemosensors, the requirements for the conformational change and Tb3+ binding
somewhat limits the ability of the sensor design to consider all the necessary kinase
substrate recognition features, ultimately limiting the catalytic efficiency and sensitivity
of the sensors.
1.5.3.10 Macrocyclic terbium chelate sensors
Another approach using lanthanides for detection of kinase activity has employed
binuclear Tb3+ complexes. Similar to the dinuclear zinc-pyridylmethlamine complex,
“phos-tag”, which binds the divalent phosphate anion selectively, Komiyama and
coworkers have developed a dual 1,4,7,10-tetrazacyclododecane-1,4,7,10-tetraacetic acid
(DOTA) chelator incorporated with Tb3+ for selective detection phosphotyrosine. This
design allows one water molecule to be coordinated at each Tb3+ ion and does not contain
a chromophore for sensitization. Once bound to pTyr the water molecules are displaced
and the aromatic ring of tyrosine can facilitate sensitization resulting in a 10-fold increase
in luminescence. (Figure 1-13B) (75) This approach was shown to be selective in the
presence of other phosphate contain molecules including ATP, ADP, GMP, GDP due to
the required appropriate chromophore for sensitization being absent or too far away for
energy transfer. The application of this technique for detection of Ser/Thr kinases is
limited due to the lack of an appropriate chromophore attached to the phosphate
containing Ser/Thr residue.
1.5.3.11 Chelator Based
Inspired by the design of the Ca2+ chelating BAPTA-xanthene peptide conjugate
described above, a similar design was applied for lanthanide-based detection of tyrosine
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kinases Src and Abl. The chemosensor was designed to contain an iminodiacetate
chelator, which would coordinate a lanthanide ion in the presence of phosphotyrosine
contained within the generic Tyr kinase substrate. (76) Sensitization of both Tb3+ and
Eu3+ was achieved through incorporation of the chromophore carbostyril 124 as an
“antenna”. (Figure 1-13C) Phosphorylation of the sensor resulted in binding of Tb3+ or
Eu3+ and a 10-fold increase in luminescence. This sensor design could also be applied to
Ser/Thr kinases due to the incorporation of the antenna into the sensor. However, the low
substrate efficiency resulting in the requirement for the kinase reaction to proceed for 20
hours and the lack of quantitative detection suggest that the sensors require further
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1.6

Dissertation Objective

As demonstrated above, previous work has successfully established a number of
techniques for the identification of optimal kinase specific substrates. These substrates
have been applied to develop various peptide biosensors for specific detection of kinase
activity through a wide range of methods. However, over the last decade there has been a
bottleneck in the identification of kinase specific substrates and thus also in the
development of peptide-based biosensors for novel kinases. Herein, strategies for the
development of various novel peptide biosensors as well as novel detection methods will
be presented.
Spleen tyrosine kinase (Syk) is critically important to B-cell function through the
B-cell receptor pathway, but there are few methods that provide direct detection of Syk
activity. Chapter 2 will describe the development of a novel modular peptide biosensor
for live cell detection of Syk activity. The design of this sensor was inspired by a
biosensor previously developed in the lab for detection of intracellular Abl activity. The
Syk artificial substrate peptide (SAStide) sequence was identified using a semi-empirical
bioinformatic analysis of Syk phosphorylation sites. The specificity of the biosensor will
be demonstrated using a small panel of purified kinases as well as control cell lines. The
application of this sensor for specific detection of Syk activity and inhibition in response
to physiologically relevant stimuli and inhibitors will be demonstrated. The development
of an enzyme-linked immunosorbent assay (ELISA)-based chemifluorescent method for
detection of SAStide phosphorylation will also be discussed.
Based on the similarity of SAStide with the !–synuclein sequence surrounding
Y125, which has been demonstrated to sensitize Tb3+ luminescence in a phosphorylation
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dependent manner, the use of Tb for detection of Syk activity using SAStide was
explored. Chapter 3 will report the use of SAStide to sensitize Tb in a phosphorylation
dependent manner as well as characterization of the mechanism of sensitization through
the photophysical properties of Tb3+. The characterization of this method for detection of
Syk activity and the application for monitor activity and inhibition in vitro will also be
reported.
Expanding on this initial work of SAStide for phosphorylation-dependent
enhanced Tb3+ luminescence detection, the development of a pipeline to identify peptide
substrates, but also substrates that are not only kinase specific, but that would also
sensitize Tb3+ in a phosphorylation-dependent manner will be presented in Chapter 4.
Although previous methods have successfully identified kinase specific substrates, these
methods require costly and laborious analysis and experimentation, which has lead to the
aforementioned bottleneck in the development of kinase peptide biosensors for new
kinases. New computational approaches have attempted to identify kinase substrate
specificity and predict phosphorylation networks de novo from phosphoproteomic data.
However, these approaches have yet to be applied to the development of new artificial
peptide substrates. Chapter 4 will detail the development of a new algorithm aimed at
identifying kinase substrate specificity and key determinants involved in determining
specificity. Biochemical validation of the key determinants for kinase specificity as well
as the predictive power of the algorithm will be examined. Additionally, the algorithm
will also predict the ability of the sequences to sensitize Tb3+ luminescence in a
phosphorylation-dependent manner. The generation of novel biosensors for Abl, Jak2,
and Src-family kinases and their application in kinase assays will also be detailed.
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The development of multiple kinase specific phosphorylation-dependent Tb3+
sensitizing biosensors inspired further engineering of the sensors to obtain simultaneous
detection of the activity of two kinases in a single assay. To achieve this goal, the
multiple emission bands of Tb3+ will be exploited to excite conjugated fluorophores using
the time-resolved lanthanide-based resonance energy transfer (TR-LRET) for multiplex
detection. Chapter 5 details the development of this approach using SAStide and the Srcfamily kinase artificial substrate peptide SFAStide to monitor Lyn and Syk activity
simultaneously.
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CHAPTER 2. A PEPTIDE-BASED BOSENSOR ASSAY TO DETECT
INTRACELLULAR SYK KINASE ACTIVATION AND INHIBITION

2.1

Abstract

Spleen Tyrosine Kinase (Syk) has been implicated in a number of pathologies including
cancer and rheumatoid arthritis and thus has been pursued as a novel therapeutic target.
Because of the complex relationship between Syk’s auto- and other internal
phosphorylation sites, scaffolding proteins, enzymatic activation state and sites of
phosphorylation on its known substrates, the role of Syk’s activity in these diseases has
not been completely clear. To approach such analyses, we developed a Syk-specific
artificial peptide biosensor (SAStide) to use in a cell-based assay for direct detection of
intracellular Syk activity and inhibition in response to physiologically relevant stimuli in
both laboratory cell lines and primary splenic B cells. This peptide contains a sequence
derived from known Syk substrate preference motifs linked to a cell permeable peptide,
resulting in a biosensor that is phosphorylated in live cells in a Syk-dependent manner,
thus serving as a reporter of Syk catalytic activity in intact cells. Because the assay is
compatible with live, primary cells and can report pharmacodynamics for drug action on
an intended target, this methodology could be used to facilitate a better understanding of
Syk’s function and the effect of its inhibition in disease.
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2.2

Introduction

Syk is a 72 kDa non-receptor tyrosine kinase originally isolated from bovine
thymus and porcine spleen1 best known for its role in B lymphocyte development and
activation. Loss of Syk expression results in perinatal lethality in mice and an arrest in
the development of B cells at the pro-B to pre-B cell and immature to mature B cell
transitions.2 Upon antigen binding to the B cell antigen receptor (BCR), the Src family
kinase, Lyn initiates the phosphorylation of immunoreceptor tyrosine-based activation
motifs (ITAMs) on components of the BCR. Phosphorylation of the ITAMs in turn
recruits and activates Syk, inducing its phosphorylation on multiple tyrosines including
Y525 and Y526 in its activation loop. Following this activation of Syk, numerous
signaling pathways are initiated leading to the activation of downstream transcription
factors including NFAT, NF!B and Elk1 and ultimately contributing to the induction of
cell proliferation and differentiation.
Dysregulation of the expression or the activity of Syk contributes to various
disease states, making it a potential therapeutic target.3 Syk has been implicated as a
factor in rheumatological disorders (such as rheumatoid arthritis) and malignant diseases
of myeloid, lymphocytic and even epithelial origin. For instance, Syk was found to be
constitutively active in primary blasts from a set of patients with acute myeloid leukemia
(AML).4 Inhibition of Syk decreased the viability of these AML blasts in vitro and
reduced the number of these cells infiltrating spleen and bone marrow in a mouse
xenograft model. In some chronic lymphocytic leukemia cells (B-CLL), Syk is
hyperactive despite exhibiting normal expression levels,5 and inhibition of Syk or
silencing of Syk expression via siRNA decreases cell viability.6 In another example,
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several peripheral T-cell lymphomas (PTCLs) exhibit aberrant expression of Syk.7 In
these cells, siRNA silencing of Syk translation or inhibition of its activity with a kinase
inhibitor (R406, Rigel Pharmaceuticals) induces apoptosis and blocks proliferation in
cells with elevated Syk Y525/Y526 phosphorylation.8 These results suggest that Syk
could be a novel therapeutic target for the treatment of PTCLs. Conversely, in breast
cancer, which has an epithelial origin, Syk appears to have tumor suppressor functions:
while Syk is expressed in normal breast epithelia, there is little to no Syk present in more
metastatic breast cancer cells.9 Expression of Syk negatively affects motility and invasion
in these carcinomas.9-10 Accordingly, to guide both the treatment of these cancers and the
development of novel therapeutics, it would be beneficial to selectively measure Syk
activity in patient samples.
There are three predominant methods currently in use to measure Syk activity: in
vitro kinase assays, luciferase reporter assays of downstream transcription factors and
phosphotyrosine antibody-based detection of Syk autophosphorylation or substrate sites.
Each of these methods has drawbacks that make them less than optimal for both
determination of Syk biology and translation to the clinical setting. In vitro kinase assays
measure Syk activity post lysis—however, Syk’s function is integrally dependent on its
binding partners. For example, in lysed cells proteins such as c-Cbl that normally
modulate the function of the kinase (and which are known to be critical for obtaining
biologically-relevant activation for Syk) can become separated from Syk; also, proteins
normally found in different subcellular compartments are able to artifactually interact
with Syk and alter its activity.11 Moreover, as a result of changes in Syk’s
phosphorylation state via phosphatase activity and autophosphorylation in vitro, Syk’s
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activity can change during in vitro kinase assays in ways that may not be relevant to its
intracellular activity in a disease context. Transcription factor-driven luciferase reporter
assays (another common read-out used for determining Syk activity) are performed in
whole cells and maintain the endogenous context of Syk—however, these represent an
indirect measure of Syk activity, with numerous proteins in the pathways between Syk
and the transcription factors allowing potential disruption of additional components of
these cascades. Phosphotyrosine antibody-based methods such as Western blots and
Phosphoflow cytometry12 use phosphorylation sites in endogenous proteins, such as
known Syk-targeted sites and/or Syk autophosphorylation sites, as surrogate reporters of
Syk activity. However, because of the complex relationship between Lyn and Syk
activation during B-cell receptor signaling, phosphorylation at endogenous sites (on Syk
and other proteins) has not been confirmed to be Syk-specific in all cases. Furthermore,
Syk is phosphorylated on multiple sites (by itself and other kinases including Lyn)
including some that negatively regulate the kinase,11a making it difficult to parse the
complex relationship between the phosphorylation state of these native sites and the
intrinsic activation of the enzyme. Besides these functional caveats, the fundamental
limitation exists that antibodies for every potentially meaningful site of Syk
phosphorylation are not available, and their development is subject to the uncertainties
inherent in epitope and antibody generation. Therefore, an ideal method to measure Syk
activity would be one that specifically monitors the ability of the kinase to catalyze a
phosphotransferase reaction in an intact cell.
Peptide-based approaches offer an alternative method that allows for direct
detection of kinase activity. Several peptide substrates for Syk have been previously
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reported, including some based on endogenous protein sequences and others derived
artificially from peptide libraries (through e.g. phage display).13 Peptides have been
applied to the detection of Syk activity in vitro using constrained tyrosine analogs and
artificial peptides containing fluorescent amino acids.13b, c, 14 Using these substrates, Syk
activity has been detected in stimulated cell lysates and from recombinant protein, but so
far they have not been used in live, intact cells that provide the necessary context for Syk
function. We were interested in developing a peptide biosensor substrate for Syk that
could be implemented to detect kinase activity in intact cells using a cell-penetrating
peptide approach. TAT-labeled peptide substrates have been used for specific and
sensitive detection of endogenous Akt activity in live single cells using capillary
electrophoresis.15 Our previous work applied a similar approach to detect intracellular
Abl activity in an over-expression model using a peptide biosensor and matrix-assisted
laser desorption/absorption ionization-time of flight mass spectrometry (MALDI-TOF) or
Western blotting.16 Here we present the development of a Syk specific artificial peptide
substrate capable of detecting physiologically relevant Syk activity in live, intact cells
following BCR engagement and oxidative stress using an ELISA-based assay.
2.3

Methods and Materials

Cell culture and biological reagents. The DG75 and DT40 B cell lines were
grown to a density of 0.4 x 106 cells/mL in RPMI-1640 medium containing 7.5% FBS, 1
mM sodium pyruvate, 100 IU/mL penicillin, 100 µg/mL streptomycin and 50 µM 2metcaptoethanol. Additionally, DT40 cell medium contained 1% chicken serum. Antichicken IgM and anti-mouse IgM F(ab’)2 fragments were purchased from Bethyl
Laboratories. Anti-human IgM was purchased from Rockland Immunochemicals.

!

65
Hydrogen peroxide was purchased from Mallinckrodt. Anti-Syk (N-19) was purchased
from Santa Cruz Biotechnology. Anti-tubulin and anti-phosphotyrosine (4G10) were
purchased from Millipore. Anti-phospho Syk (Y525/526) was purchased from Cell
Signaling Technology.
Peptide Synthesis and Purification. The Syk peptide biosensor was synthesized
using ‘Fast’ Fmoc solid-phase peptide chemistry with a Prelude Parallel Peptide
Synthesizer (Protein Technologies). The synthesized peptides were purified using a C18
reverse-phase column on an Agilent 1200 preparative HPLC system. The peptide was
characterized using liquid-chromatography mass spectrometry (LC/MS) on an
Accela/LTQ system (Thermo-Finnegan) and matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF/TOF) on a Voyager 4800 instrument
(Applied Biosystems).
In vitro kinase assay. Recombinant Abl, Src and Lyn enzymes were obtained
from a commercial source (Millipore). EGFP-conjugated Syk was isolated from DT40
chicken B cells stably expressing Syk-EGFP. Cells were lysed using a solution
containing 1% Nonidet P-40, 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM EDTA, 1
mM sodium orthovanadate, 2 mM NaF and 1X mammalian protease inhibitor cocktail
(Sigma). Syk-EGFP was immunoprecipitated using anti-GFP magnetic nanoparticle
beads (MBL, Japan). Lysates were incubated with the beads (40 µl per 1x107 cells) for 1
h at 4°C. The kinase-bound beads were washed and then used in the in vitro kinase assay.
Immobilized Syk-EGFP (55 nM per reaction, from 1.2 µg/µl stock, see supporting
information Fig. S1), recombinant Lyn, Abl or Src kinase (0.1 U each) was incubated
with kinase reaction buffer (500 !M ATP, 5 mM MnCl2, HEPES, pH 7.2) containing the
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peptide substrate at 25 µM. Aliquots (22 µL) were taken at designated time points and
quenched in 0.5 M EDTA, pH 8.5 (22 µL). The quenched sample (1 µL) was diluted into
ELISA wash buffer and analyzed as described below. For substrate comparison assays,
kinase reaction conditions were as described above except that substrate concentrations
were 4 µM, and concentration of enzyme used per reaction was 6 nM. The volume of
aliquots diluted in an equal volume of quench buffer was 4 µl (for 8 µl total quenched
volume), and the entire quenched amount was diluted into ELISA wash buffer and
analyzed as described below. For characterization of SAStide kinetic parameters,
substrate concentrations and reaction/quench volumes are given in Table S1.
ELISA-based fluorescence detection. Samples were incubated in a 96-well
Neutravidin™ coated plate (15 pmol biotin binding capacity per well, Thermo Scientific)
in Tris-buffered saline (TBS) containing 0.1% BSA and 0.05% Tween 20 for 1 h at room
temperature on a short-radius plate shaker (600 rpm). Following incubation, wells were
washed three times with wash buffer (TBS, 0.1% BSA, 0.05% Tween 20), then incubated
with mouse anti-phosphotyrosine monoclonal antibody 4G10 (1:5000 dilution in wash
buffer, 100 µL per well) for 1 h at room temperature with shaking. Wells were washed
three times with wash buffer and incubated with horseradish peroxidase-conjugated goat
anti-mouse immunoglobulin G (IgG) secondary antibody (Abcam) (1:1000 dilution in the
wash buffer, 100 µL per well) for 1 h at room temperature with shaking. Wells were then
washed three times with wash buffer and twice with sodium phosphate buffer (0.05 M,
pH 7.5). For chemifluorescence detection, Amplex Red™ reaction buffer (100 µL total
volume/well) consisting of Amplex Red™ reagent (50 µL) (Invitrogen), 20 mM H2O2
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(500 µL) and sodium phosphate buffer (4500 µL) and allowed to react for 30 min.
Fluorescence of Amplex Red™ was measure using a Synergy4 multiwell plate reader
(Biotek) with an excitation wavelength of 532 nm and emission wavelength of 590 nm.
Cell-based peptide biosensor assay. Cells were cultured as described above,
harvested and resuspended at a density of 8 x 106 cells/mL (8 mL), then treated with the
SAStide biosensor peptide (25 !M) for 15 min prior to stimulation with either anti-IgM
antibody (5 µg/mL), H2O2 (3.33 mM) or both. Concentrations of peptide lower than 25
µM resulted in low signal to noise in detection of phosphopeptide using the ELISA-based
read-out, and no toxicity was observed in the presence of the peptide at 25 µM (similar to
what was observed in our previously published work on Abl kinase16). Aliquots of the
cell suspension (1 mL) were harvested, lysed in PhosphoSafe Extraction Reagent (EMD
Millipore) containing 167 mM EDTA and freshly prepared protease inhibitor cocktail
(Roche) and flash frozen. Half the cell lysate from each sample was used for ELISAbased fluorescence detection and the other for immunoblotting. For dose-response
experiments, cells were stimulated with varying concentrations of anti-IgM (2.5-10
µg/mL) or hydrogen peroxide (1-7 mM), harvested at 5 min post-stimulation and
processed as described above. For immunoblotting, membranes were blocked in 5% goat
serum for 1 h. All primary antibodies were incubated at a dilution of 1:1,000 for 1 h at
room temperature and visualized using an HRP-conjugated secondary antibody (Pierce)
and ECL reagents (PerkinElmer). Uniformity of the amount of peptide taken up was
tested in a representative experiment using Syk-EGFP reconstituted Syk(-/-) DT40 cells,
and while there was a very slight (but not statistically significant) trend towards higher
peptide amounts over time, no significant difference was seen across conditions .
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Cell-based inhibition assay. Cells (4 x 106 cells/ml) were pre-treated with
varying concentrations of piceatannol or dasatinib for 30 min and with the SAStide
biosensor peptide (25 µM) for 15 min. Cells were then stimulated with anti-IgM antibody
(5 µg/mL) and H2O2 (1 mM) and harvested after 5 min as described above.
Isolation of primary mouse splenic B-cells and primary cell biosensor assay.
B cells were enriched from mouse spleens via “panning” as previously described.17 Cells
6 ml, 5 x 106 cells/mL) were treated with vehicle (DMSO), piceatannol (50 !M) or
dasatinib (100 nM) for 1 h and with the SAStide biosensor peptide (25 !M) for 15 min
prior to stimulation. The cells were stimulated with anti-IgM F(ab')2 (5 µg/mL). Cells
were harvested at 0, 5, 10 and 15 min following stimulation, lysed and analyzed as
described above.
2.4
2.4.1

Results

Development of a Syk biosensor

Using a Syk substrate consensus motif suggested recently by Geahlen
(EXXDEEDYEXPXEPX) and incorporating information on the preferences at the
variable sites of that motif gathered from phosphoproteomic studies,11a, 18 we designed a
putative Syk peptide substrate, DEEDYEEPDEP, which we named “Syk artificial
substrate” or SAStide. We incorporated SAStide along with several functional modules to
form a Syk biosensor peptide. These modules include a biotinylated lysine for affinity
capture of the substrate, a cell penetrating peptide for delivery of the biosensor into cells
and a photocleavable amino acid for release of the substrate from the rest of the biosensor
in case mass spectrometry-based analysis is desired for future applications (Figure 2-1).
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Figure 2-1 Syk peptide biosensor. The biosensor contains a biotinylated substrate reporter
that is phosphorylated by Syk, a photocleavable linker for release of the reporter from the
biosensor (for future mass spectrometry applications) and a cell penetrating peptide (TAT
peptide) for delivery into live cells. Upon delivery of the biosensor to cells and
stimulation of the B cell receptor, the substrate reporter is phosphorylated and can be
enriched via the biotin tag and analyzed using an antiphosphotyrosine antibody in an
ELISA-style multiwell plate format.
Phosphorylation of the biosensor by Syk was assessed using an in vitro kinase
assay, incubating the SAStide biosensor with immobilized GFP-tagged Syk kinase
(immunoprecipitated from DT40 chicken B cells) in the presence of ATP and MnCl2 for
varying times after which aliquots of the reaction mixtures were removed and kinase
activity quenched by adding an excess of EDTA. Phosphorylated biosensor peptide was
detected using a fluorescent ELISA-based assay in which the quenched reaction mixture
was incubated in a 96-well Neutravidin™ coated-plate to allow for affinity capture of the
biotinylated substrate. Each well had a biotin binding capacity of 15 pmol. The total
amount of peptide in the quenched reaction mixture applied to each well was 20 pmol,
which ensured that each well was saturated with peptide for analysis. The captured
peptide was then incubated with an anti-phosphotyrosine primary antibody (4G10)
followed by a horseradish peroxidase-conjugated secondary antibody. Chemifluorescent
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detection was accomplished by incubating each well with Amplex Red™ reagent and
hydrogen peroxide, which gives a fluorescence signal readout that is proportional to the
amount of horseradish peroxidase-conjugated antibody in each well, and thus reports the
degree of phosphotyrosine present (via the anti-phosphotyrosine antibody) (as described
by Wu et al. 19). Relative fluorescence units (RFU) were measured, which provided a
proportional representation of the amount of phosphorylated biosensor present. In control
experiments to generate a standard curve, phosphorylated SAStide was demonstrated to
bind reproducibly to the wells, and exhibited a linear increase in signal up to an amount
of phosphopeptide per well of 0.5 pmol (beyond which saturation of the ELISA signal
occurred). This validated that the amount of antiphosphotyrosine antibody-related signal
was proportionally related to the degree of peptide phosphorylation. A substantial
increase in signal over time was observed, demonstrating that SAStide was
phosphorylated by Syk in vitro (Figure 2-2A). To provide preliminary evidence for the
specificity of this substrate for Syk, SAStide was also assayed using Src, Abl and Lyn
kinases, none of which produced any significant signal for phosphopeptide (Fig. 2-2A).
We also compared the phosphorylation of SAStide over time with that of two
other known substrates of Syk kinase, the natural peptide parent of the previously
reported ‘Syktide’ (EDDEYEEV, which in the original work contained an unnatural
amino acid in place of the tyrosine that the authors demonstrated conferred specificity for
Syk over other kinases e.g. Lyn)13b and a Syk substrate discovered from a phage display
library (EDPDYEWPSA).13d Each was synthesized with glycine spacers on the C- and Nterminal sides of the substrate portion with a biotinylated lysine included at the Cterminus for capture and ELISA-based detection of phosphorylation signal (sequences are
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given in the caption for Fig 2-2). The kinase assay was performed using
immunoprecipitated Syk-EGFP (6 nM) with each substrate at 4 µM. We found that
SAStide was phosphorylated more rapidly than the previously reported Syktide sequence,
but not as rapidly as the phage display-derived sequence (Fig. 2-2B). Performing the
assay on SAStide at a range of concentrations (Fig. 2-2C) enabled the characterization of
its substrate kinetics with the immunoprecipitated Syk-EGFP enzyme as sigmoidal,
indicating some substrate activation through an as-yet unknown mechanism. The kinetic
parameters were characterized as Khalf = 86±10 µM (which represents the substrate
concentration at half of Vmax in a sigmoidal curve and is analogous to Km) and Vmax =
11±1 pmol/min, from which kcat = 216 min-1 and kcat/Khalf = 2.5 were derived (Fig. 2-2D).
Previously reported for Syktide13b were Km = 3 µM, kcat = 62.2 min-1 and catalytic
efficiency kcat/Km = 20.73 (the kinetic parameters for the Phage substrate have not been
reported). The SAStide catalytic efficiency is overall comparable to Syktide, with the
caveat that the assays were performed with different enzyme preparations and under
different substrate (ATP) concentrations. In the direct comparison shown in Fig. 2-2B
(under conditions that emphasize the effects of kcat rather than KM on substrate
phosphorylation), SAStide was phosphorylated more efficiently than the parent Syktide.
Compared to SAStide, the phage display peptide was more efficiently phosphorylated,
but exhibits substrate inhibition at higher concentrations (greater than 20 µM).13d SAStide
exhibited no substrate inhibition at concentrations up to 100 µM.
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Figure 2-2 Phosphorylation of the artificial peptide substrate for Syk (SAStide) in vitro.
A) The SAStide biosensor (25 µM) was incubated with Syk-EGFP (closed circles), Lyn,
Abl or Src in an in vitro kinase assay. Aliquots were removed at designated time points
and the amount of phosphorylated substrate was measured using ELISA-based detection
(given as relative fluorescence units, RFU). B) SAStide (GGDEEDYEEPDEPGGKbGG)
and two known Syk peptide substrates, ‘Syktide’13a (GGEDDEYEEVGGKbGG) and
‘Phage,’13d a peptide derived from a phage display library
(GGEDPDYEWPSAGGKbGG), were incubated with immobilized, immunoprecipitated
Syk-EGFP kinase (Syk-EGFP) as described in the Materials and Methods. Substrate
concentration for each was 4 µM. C) SAStide was assayed with Syk-EGFP at a range of
concentrations. D) Initial velocities were calculated from the data in (C) and plotted and
fitted to a sigmoidal curve to fit Khalf, Vmax, kcat and kcat/Khalf. For all panels, data points
represent the average of three replicate experiments and error bars indicate the standard
error of the mean.
2.4.2

Detection of Dose Dependent Activation and Inhibition of Syk in intact cells

We next examined the ability of the biosensor to detect dose-dependent activation of Syk
in the context of BCR activation and oxidative stress in intact, living Burkitt’s lymphoma
DG75 B-cells. DG75 cells incubated with the SAStide biosensor were stimulated by
cross-linking the BCR using polyclonal antibody specific for IgM11a or by treatment with
hydrogen peroxide to inhibit protein tyrosine phosphatases and activate Syk.20 The
stimulated cells were harvested and lysed in Phosphosafe extraction buffer with EDTA
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and protease inhibitors (to prevent further kinase activity, dephosphorylation by
phosphatases and proteolytic degradation in the sample), and the lysates were incubated
in Neutravidin™-coated wells to capture the biosensor peptide. The chemifluorescent
ELISA-based assay described above was used to detect phosphorylation of SAStide. Syk
activity was analyzed after 5 min and compared to unstimulated cells as a control. No
signal above the reagent background was observed in cells not treated with the peptide.
BCR stimulation resulted in increased phosphorylation of the biosensor in a dosedependent manner (Figure 2-3A). Induction of oxidative stress in the B cells via
hydrogen peroxide treatment also resulted in dose-dependent increases in
phosphorylation of the biosensor (Figure 2-3B). These results show the ability of the
peptide biosensor to detect dose-dependent changes in the Syk activity at endogenous
levels of expression in live cells.

Figure 2-3 Detection of stimulant dose-dependent intracellular Syk activity. (A) DG75
cells were treated with the SAStide biosensor (25 µM) 15 min prior to stimulation. The
cells were stimulated with varying concentrations of anti-IgM (A) or varying
concentrations of H2O2 (B). Cells were harvested 5 min following stimulation and the
amount of phosphorylated biosensor was measured. Experiments were performed in
triplicate and the data are reported as fold change compared to the unstimulated control
(which exhibited levels of signal similar to background observed in the in vitro assay
shown in Fig. 2, ~4000-8000 RFU). Data points represent the average of three
measurements and error bars indicate the standard error of the mean.
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We also examined the ability of the biosensor to monitor dose-dependent inhibition of
Syk using the Syk-specific natural product inhibitor piceatannol and the Src-family
kinase inhibitor, dasatinib (currently being explored as a therapeutic Syk inhibitor21). The
inhibitors were assayed in a dilution series from 1 mM – 100 pM (Figure 2-4A). We
found that dasatinib had greater potency than piceatannol for inhibiting Syk
phosphorylation of the biosensor. However, as expected from the literature22 and
observed from the loss of tubulin and Syk immunoblot signal (Fig. 2-4B, lanes 17 and
18), high concentrations of piceatannol in the presence of BCR activation and oxidative
stress were toxic to DG75 cells whereas dasatinib was not. The apparent IC50 values (the
concentration at which SAStide phosphorylation was decreased by 50% compared to the
control uninhibited cells) were calculated using the Hill function to be 10.8±9.3 nM and
1.2±1.5 !M for dasatinib and piceatannol, respectively. These results were also consistent
with the reduction in the level of Syk tyrosine phosphorylation as detected by Western
blot analysis (Figure 2-4B).
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Figure 2-4 Detection of Syk inhibitor dose-response. Burkitt’s lymphoma DG75 B cells
were treated with varying concentrations of dasatinib (closed squares) or piceatannol
(open circles) for 30 min and with the SAStide biosensor (25 µM) for 15 min prior to
stimulation. The cells were then stimulated with anti-IgM (5 µg/mL) and hydrogen
peroxide (1 mM) for 5 min and harvested. (A) The extent of biosensor phosphorylation
was analyzed by ELISA. Data indicate averages +/- SEM of experiments performed in
triplicate. (B) The level of total Syk, of Syk phosphorylated on Y525 and Y526 (Syk
pY525/526) and of tyrosine-phosphorylated proteins (pTyr) were analyzed by Western
blotting of lysates of cells not stimulated (NS), stimulated but not treated with inhibitor
(NI) or treated with increasing concentrations of the indicated inhibitor. Tubulin was
measured as an internal loading control.
2.4.3

Time-dependence of Syk activity following activation

To examine the time dependence of Syk activity following stimulation through the BCR
and/or oxidative stress, DG75 cells were treated as above and Syk biosensor
phosphorylation was analyzed every few minutes for the first 15 min following
stimulation. BCR stimulation gave a rapid increase followed by steadily maintained
phosphorylation of the biosensor (Figures 2-5A and B). As expected, the addition of
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hydrogen peroxide following BCR stimulation gave a very robust increase in
phosphorylation over the time course due to the amplified and extended BCR
signaling.11a, 12a, 20 Oxidative stress alone also resulted in increased phosphorylation of the
biosensor, peaking at 5 min and subsequently showing a slight decrease.20 The results of
this experiment demonstrate that the SAStide biosensor is able to monitor time-dependent
increases in Syk activity in live cells following stimulation.

Figure 2-5 Detection of time-dependent Syk activity following cell stimulation. DG75 B
cells were treated with the SAStide biosensor (25 µM) 15 min prior to stimulation. The
cells were stimulated with anti-IgM (5 µg/mL) (panel A and closed circles in panel D),
H2O2 (3 mM) (panel B and open squares in panel D) or both (5 µg/mL anti-IgM and 3
mM H2O2) (panel C and open triangles in panel D). (A-C), the expression of Syk, Syk
phosphorylated on Y525 and Y526 (Syk pY525/526) and GAPDH (loading control) in
cell lysates were analyzed by Western blotting. NS - no stimulation; NB - no biosensor
(15 min harvest). (D), cells were harvested at varying time points following stimulation
and analyzed for biosensor phosphorylation. Experiments were performed in triplicate.
Data are reported as normalized change compared to the unstimulated control; error bars
are shown either above or below data points for clarity. Data were analyzed using a
repeat measure one-way ANOVA test and a Dunnet post-test. Statistical significance is
indicated as follows: *P<0.05, **P<0.01 and ***P<0.001.
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2.4.4

Determination of the SAStide biosensor specificity in intact cells

While in vitro kinase assays (such as those described in Fig. 2-2) can provide useful
preliminary comparisons of the activity of a kinase for a given substrate, they cannot
necessarily be used to unequivocally demonstrate specificity or selectivity. In particular,
using classical Michaelis-Menten kinetic parameters such as kcat/Km as “specificity
constants” to compare the activity of different enzymes on a single substrate is not
relevant since it relies on assumptions that only apply to comparisons of the same enzyme
and its interaction with different substrates.23 Therefore, we sought to demonstrate the
selective phosphorylation of the SAStide biosensor in the context of the complex
intracellular environment. The specificity of the biosensor as a substrate for Syk and not
other tyrosine kinases in live cells was explored using DT40 chicken B-cells in which the
endogenous gene for Syk has been eliminated by homologous gene targeting.24 Sykdeficient DT40 cells were exposed to the biosensor and stimulated using a polyclonal
antibody specific for IgM. As a control, cells were treated with the biosensor but were
not stimulated. Phosphorylation of the biosensor was then monitored via quenched
aliquots every few minutes for a total of 15 min following stimulation (Fig. 2-6A). No
significant change in phosphorylation of the biosensor was detected over the time course
following stimulation when compared to unstimulated control cells. These results
indicated that the specificity of the biosensor was maintained in living cells in the context
of IgM engagement and BCR-activated signaling.
Since little tyrosine-phosphorylation was observed in anti-IgM-activated, Sykdeficient cells (Figure 2-6A), BCR-stimulated phosphorylation was amplified by the
addition of hydrogen peroxide. As seen with the anti-IgM stimulation alone, no
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significant change in the phosphorylation of the biosensor was detected over
unstimulated cells (Figures 2.6A). Western blot analysis of tyrosine-phosphorylated
proteins demonstrated amplified phosphotyrosine signaling compared to anti-IgM
treatment alone, indicating activation of multiple tyrosine kinases and inhibition of
tyrosine phosphatases (Figure 2-6E). Similarly, no significant change in the
phosphorylation of the biosensor was detected in cells treated only with hydrogen
peroxide (Figures 2-6D). This showed that even in the presence of amplified and
extended BCR-related and other H2O2-related signaling the SAStide biosensor was not
appreciably phosphorylated by other highly activated tyrosine kinases in Syk-deficient
cells. This experiment serves as a highly relevant specificity control in the intracellular
context, given that tyrosine kinase activity was clearly upregulated, yet none of these
activated kinases phosphorylated the biosensor peptide.
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Figure 2-6 Intracellular specificity of the artificial peptide substrate for Syk. Syk(-/-)
DT40 cells or Syk(-/-) DT40 cells reconstituted with stably expressed Syk-EGFP were
treated with the SAStide biosensor (25 µM) for 15 min prior to stimulation. The cells
were stimulated by treating with anti-IgM (5 µg/mL) (panels C and F, closed circles in
graphs A and B), H2O2 (3 mM) (panels D and G, open squares in graphs A and B) or both
(5 µg/mL anti-IgM and 3 mM H2O2) (panels E and H, open triangles in graphs A and B),
then harvested at varying time points. (C-H): the phosphorylation of proteins in cell
lysates was measured by Western blotting using anti-phosphotyrosine (4G10), anti-Syk,
antiphospho-Syk(Y525/526), antiphospho-BLNK(Y84) and anti-tubulin antibodies
(loading control). NS - no stimulation; NB - no biosensor (15 min harvest). (A, B):
chemifluorescence detection of Syk biosensor phosphorylation. The data are reported as
normalized change compared to the unstimulated control). Data were analyzed using a
repeat measure one-way ANOVA test and a Dunnet post-test; In graph A, no statistically
significant difference was seen for any time point or treatment relative to control.
Experiments were performed in triplicate.
To further support specificity, we performed the same set of experiments in Syk (-/-)
DT40 cells that had been reconstituted with Syk-EGFP. In the presence of BCR
stimulation by IgM, signal indicating phosphorylation of the biosensor peptide was
increased approximately 2-fold over control (unstimulated Syk-EGFP-expressing cells)
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and decreased slightly over time (Fig. 2-6B). When treated with H2O2 with or without
concurrent BCR stimulation, biosensor phosphorylation signal increased more
dramatically (to approximately 12-fold over control) (Fig. 6B). Phosphorylation of the
biosensor was consistent with that observed for the Syk autophosphorylation site and the
known Syk substrate BLNK (Fig. 2-6F-H).
2.4.5

Detection of Syk Activity and Inhibition in Primary Mouse Splenic B-cells

To examine the ability of the biosensor to monitor Syk activity and response to inhibitor
treatment in primary cells expressing endogenous levels of Syk, we isolated mouse
primary splenic B cells and treated these with the biosensor peptide in the presence of the
Syk inhibitors piceatannol or dasatinib. Primary B cells were treated with 10 nM
dasatinib, 1 !M piceatannol or vehicle (DMSO) for one h prior to stimulation. The
SAStide biosensor peptide was added 15 min prior to stimulation, and the cells were then
treated with anti-IgM F(ab')2 (5 µg/mL) and harvested at 0, 5, 10 and 15 min following
stimulation. As seen with the DG75 cells, stimulation of Syk activity following BCR
engagement resulted in a rapid increase in phosphorylation of the SAStide biosensor
(within approximately two minutes—the time required to handle and process an aliquot
of cells collected immediately after stimulation) followed by a maintenance of
phosphorylation over time as compared to control unstimulated cells, which showed only
background levels of phosphorylation-related signal (Fig. 2-7). In the presence of each
inhibitor the level of phosphorylation of the biosensor was decreased, giving a signal that
was close to background levels. These results showed that the biosensor peptide was
capable of detecting the activation and inhibition of endogenous Syk kinase expressed at
normal levels in primary cells that exhibit physiologically relevant B cell receptor
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signaling, and suggest that elevation of Syk activity is very rapid in response to B cell
receptor engagement in these primary cells.

Figure 2-7 Detection of Syk activity and inhibition in mouse primary splenic B-cells.
Mouse primary splenic B-cells were treated without (panel A and closed circles in panel
D) or with the tyrosine kinase inhibitors dasatinib (100 nM) (B), (D !) or piceatannol
(50 µM) (C), (D ") for 30 min prior to stimulation, then treated with the SAStide
biosensor (25 µM, 15 min) and stimulated with anti-IgM F(ab’)2 (5 µg/µL). Cells were
harvested at various time points following stimulation. (A-C) the expression of Syk and
of Syk phosphorylated on Y525 and Y526 (Syk pY525/526) were determined by Western
blotting. NS - no stimulation; NB - no biosensor (15 min harvest). (D) The data are
reported as normalized change in chemifluorescence signal compared to the unstimulated
control. N = 6; error bars indicate SEM.
2.5

Discussion

These studies present the development of a new versatile tool for direct and specific
monitoring of intracellular Syk kinase activity in physiological contexts. We showed that
we could develop a Syk-specific biosensor peptide by combining a peptide based on a
Syk substrate consensus sequence11a, 18a with other modular units including a biotinylated
lysine for affinity capture of the substrate and a cell penetrating peptide for delivery of
the biosensor into cells. Similar to the Abl kinase biosensor we previously reported,16 this
Syk kinase peptide biosensor (SAStide) did not cause toxicity at the concentration used in
these studies, and was able to detect dose-dependent and time-dependent activation and
inhibition of endogenous Syk using physiologically relevant stimuli in cultured cell lines
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as well as primary splenic mouse B cells. These results demonstrate the potential for this
strategy to be used in a multiwell plate ELISA assay to analyze Syk activity in contexts
that could include study of signaling processes in a basic research setting or even
potentially monitoring therapeutic response in translational applications.
Crucially, specificity of the SAStide biosensor for detecting Syk activation was
comprehensively demonstrated in a complex, biologically-relevant system using Sykdeficient DT40 chicken B cells. Syk plays a key role in B cell signaling, but is partly
dependent upon activation of Lyn through antigen binding to the BCR. Stimulation of
Syk-deficient cells by cross-linking the heavy chain of the BCR in the presence and
absence of H2O2 allowed for the specificity of the biosensor to be assessed in the context
of Lyn kinase activation. Phosphorylation of the biosensor was not increased above
background levels and did not change over time following BCR engagement in the
absence of Syk, even when overall tyrosine kinase signaling was amplified as a result of
H2O2 exposure. Syk also plays a major role in oxidative stress signaling, and its activation
during oxidative stress is the result of both its own activity (via autophosphorylation) as
well as other protein tyrosine kinases.20a, 25 Other kinases also become activated during
oxidative stress (as observed via antiphosphotyrosine blotting), yet there was no increase
in phosphorylation of the biosensor in the absence of Syk under these conditions.
Reconstitution of the Syk deficient cells with Syk-EGFP resulted in phosphorylation of
the biosensor peptide under B cell receptor-activating conditions and in the presence of
oxidative stress. This suggests that even in a complex cellular environment, our biosensor
is selectively phosphorylated by Syk and not by Lyn or other activated tyrosine kinases in
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these cells. Together these results demonstrate that our biosensor is specific for the
detection of Syk activity in B cells and B cell model systems.
Another advantage of this strategy is the ability to monitor kinase activation and
inhibition by compounds such as piceatannol and dasatinib in an intact cell. Isolation of a
kinase from the cellular environment can alter its function by removing regulatory
proteins, eliminating alternatively spliced variants, altering post-translational
modifications and/or disrupting subcellular compartmentalization. Additionally, isolation
of the kinase precludes evaluation of the contribution of off-target effects of the drug,
which could potentially affect efficacy (positively or negatively) via inhibition of
upstream signaling in addition to the direct inhibition of the target. While kinase
activation in intact cell contexts has been studied by detecting the phosphorylation of
known endogenous substrate sites, unambiguous detection of these sites requires highquality phospho-specific antibodies, and furthermore, not every endogenous site can
serve as a reliable generic ‘marker’ for the kinase activation state. For Syk, monitoring
phosphorylation of its tyrosines through surrogate sites (Y348, Y352, Y525/526) has
been the traditional strategy for determining its activation11a, 21—however, this does not
necessarily give an accurate report of Syk activity, since some of these sites are
phosphorylated by upstream kinases and some by Syk autophosphorylation, and
moreover, phosphorylation of some of these sites modifies the function of the kinase
while others do not. While Y525/526 is in the activation loop of Syk and is a major
autophosphorylation site in B cells26 and canonically phosphorylation of these sites would
suggest enhancement of kinase activity, the role of this phosphorylation in the functional
activation of Syk remains convoluted. Previous work using a Sox-based fluorogenic,
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generic tyrosine kinase substrate from Invitrogen has demonstrated that substrate
phosphorylation kinetics by activation loop-phosphorylated Syk kinase domain (i.e. the
phospho-Y525/526 form) are similar to those for the unphosphorylated and double
phenylalanine mutant (F525/F526) forms.14 This suggests that these residues are not
accurate markers of intrinsic kinase activation, and that a selective tool that can monitor
Syk’s activation state in complex cellular environments independently of these existing
markers would be useful for delineating the effects of specific phosphorylation sites and
kinase inhibitors on different components of the B cell receptor signaling cascade.
Using the SAStide biosensor, we also detected inhibition of endogenous
intracellular Syk activity in a dose-dependent manner by the Src-family kinase inhibitors,
dasatinib, and piceatannol. We found that the apparent IC50 values were 10 nM and 1 !M
for dasatinib and piceatannol, respectively. These values are lower than those reported in
the literature,21, 27 however the literature values were determined using assay formats that
were very different than the format employed here, and so cannot necessarily be directly
compared. When examining Syk activation in the mouse primary B cells in the presence
of these inhibitors, we observed levels of biosensor phosphorylation consistent with those
observed in EGFP-reconstituted DT40-Syk(-/-) cells—however, according to Western
blot analysis, Y525/526 remained phosphorylated under these conditions. Since these
cells were isolated from the spleen, this could be related to the role of kinases acting
upstream of Syk in signaling pathways.28 Along with the previous report that Y525/526 to
Phe mutations did not affect the kinase activity, these data also support the idea that
monitoring an endogenous phosphorylation site as a surrogate for Syk activity does not
necessarily correctly report the activity of the kinase or response to the inhibitor
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treatment—whereas phosphorylation of this SAStide biosensor may be used as a marker
for intrinsic activation of the kinase.
Aside from its potential utility in basic research on the function of Syk kinase, the
straightforward workflow and compatibility of this biosensor substrate with the multiwell
ELISA-style readout might be useful in a translational setting to determine Syk kinase
pharmacodynamics in patient B cell populations. Despite the observations from the basic
science research that Syk dysfunction plays a role in disease, the outcomes of clinical
studies and trials for Syk inhibitors indicate that the benefits of blocking Syk activity in
patients are less clear. A recent report of results from an ongoing clinical trial in nonHodgkins lymphomas (#NCT00446095) of the Syk inhibitor fostamatinib (R788, a
prodrug form of R406, Rigel Pharmaceuticals) described a range of effects depending on
lymphoma subtype, which included DLBCL, follicular lymphoma, mantle cell
lymphoma, MALT lymphoma, marginal zone lymphoma, CLL and SLL.29 The cohort
was very small, particularly when dissected by lymphoma subtype, and response rates
were low overall, with slightly better response in chronic lymphocytic leukemia than the
other types. Notably, in a recent study the R406 form of this drug was found to be one of
the least selective kinase inhibitors evaluated, in terms of binding affinity for kinases.30
This highlights the need for pharmacodynamically-relevant assays during the evaluation
and development of so-called “specific” kinase inhibitors.
On the immune side, another Syk inhibitor (R112, Rigel Pharmaceuticals), was
shown to be effective for relieving allergic rhinitis symptoms when delivered
intranasally, suggesting that there could be a therapeutic benefit to targeting Syk (which
is upstream of histamine release) for this purpose, and thus may provide an alternative to
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antihistamine drugs.31 For rheumatoid arthritis, an earlier trial found that Fostamatinib
provided a significant benefit (over placebo) for rheumatoid arthritis patients receiving
methotrexate;32 however, a more recent follow-up study by the same group found that this
inhibitor was not significantly beneficial in another subset of patients who had previously
failed biologic therapy (e.g. rituximab or abatacept).33 As the authors noted, their “study
was fraught with seemingly contradictory data.” Many other factors in these patients’
diseases (such as status of other inflammatory markers and ability to assess response
metrics in the presence of confounding factors) may have contributed to the overall
assessment of responses. Another intriguing possibility is that initial response to biologics
requires Syk involvement, and therefore this patient subset is inherently unlikely to
respond to an alternative Syk-targeting strategy. This is also consistent with evidence that
lower Syk expression in acute myelogenous leukemia is related to a lack of response to
another therapeutic antibody conjugated to a toxin (gemtuzumab ozogamicin).34 Either
way, this collection of paradoxical and weak responses indicates that monitoring Syk
kinase activity and function in the context of individual patients could aid the
interpretation of outcomes for trials of Syk-targeting agents, and maybe someday help
guide patient stratification for likelihood of benefit. This will be increasingly important as
new, more functionally selective Syk inhibitors (e.g. the recently reported compound
P505-153a) are brought into the market and through clinical trials.
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CHAPTER 3. TIME-RESOLVED LUMINESCENCE DETECTION OF SPLEEN
TYROSINE KINASE ACTIVITY THROUGH TERBIUM SENSITIZATION

3.1

Abstract

Disruption of regulatory protein phosphorylation can lead to disease, and is particularly
prevalent in cancers. Inhibitors that target deregulated kinases are therefore a major focus
of chemotherapeutic development. Achieving sensitivity and specificity in highthroughput compatible kinase assays is key to successful inhibitor development. Here we
describe the application of time-resolved luminescence detection to the direct sensing of
Syk kinase activity and inhibition using a novel peptide substrate. Chelation and
luminescence sensitization of Tb3+ allowed the direct detection of peptide
phosphorylation without any antibodies or other labeling reagents. Characterizing the
Tb3+ coordination properties of the phosphorylated vs. unphosphorylated form of the
peptide revealed that an inner-sphere water was displaced upon phosphorylation, which
likely was responsible for both enhancing the luminescence intensity and also extending
the lifetime, which enabled gating of the luminescence signal to improve the dynamic
range. Furthermore, a shift in the optimal absorbance maximum for excitation was
observed, from 275 nm (for the unphosphorylated tyrosine peptide) to 266 nm (for the
phosphorylated tyrosine peptide). Accordingly, time-resolved measurements with
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excitation at 266 nm via a monochromator enabled a 16-fold improvement in base signal
to noise for distinguishing phosphopeptide from unphosphorylated peptide. This led to a
high degree of sensitivity and quantitative reproducibility, demonstrating the amenability
of this method to both research laboratory and high-throughput applications.

3.2

Introduction

Protein kinases play a critical role in multiple cellular processes including growth,
proliferation and apoptosis. The deregulation of this mechanism can cause an imbalance
between proliferation and death leading to a number of disease states including cancer.
Kinase inhibitor drug development is often confounded by the complexity of protein
kinase signalling pathways, leading to advancement of inhibitors with substantial offtarget effects (which may or may not be beneficial to efficacy) into clinical trials. (1-2)
Spleen tyrosine kinase (Syk) has recently become an attractive therapeutic target due to
its role in multiple diseases, including rheumatoid arthritis, non-Hodgkin’s lymphomas
and chronic lymphocytic leukaemia. (3-5) However, the development of small molecule
inhibitors specifically and selectively targeting Syk has been challenging, (6-7) with the
inhibitor fostamatinib (previously described as ‘specific’ for Syk) found to bind to at least
100 other targets with affinity better than that for Syk. (6) Therefore, sensitive and specific
tools for monitoring Syk activity are needed to assist in the development of Syk specific
inhibitors through the rapid screening of therapeutic agents as well as for monitoring
therapeutic response as a companion diagnostic in the clinic.
Peptide-based approaches can be used for measuring kinase activity either in vitro
or in intact cells with a variety of detection strategies. (8-11) Because they enable the
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screening of many samples and conditions at once with high sensitivity using commonly
available instrumentation, multi-well plate-based detection methods using fluorescence or
luminescence are most compatible with drug discovery and clinical applications. (12-13)
Phosphorylation-sensitized lanthanide luminescence has been used as a high-throughputcompatible probe for kinase activity. Lanthanides have unique optical properties
including large stokes shifts, long luminescent life times and narrow emission bands. (14)
Additionally, lanthanides are hard acids giving them preferred coordination with
negatively charged species such as phosphate, carboxylate and carbonyl groups. (15-16)
However, lanthanides are poor absorbers and require a sensitizing chromophore to
achieve luminescence as well as a coordination environment that excludes water to
prevent solvent luminescence quenching. (17) Accordingly, highly acidic peptides that
contain appropriate chromophores can provide the necessary coordination environment
and sensitization for luminescence.
Several approaches have been developed for the detection of tyrosine
phosphorylation using terbium (Tb3+) based on these properties. Phosphorylation of a
peptide can dramatically increase the peptide’s affinity for terbium. (18-24) Sensitization of
luminescence is achieved either through a chromophore label or through the
phosphorylated tyrosine itself. (13, 18-20, 22, 25-26) Previously reported approaches provide
approximately a 2 to 10-fold increase in steady-state luminescence upon phosphorylation,
depending on the peptide sequence involved—however, since the unphosphorylated
forms of most acidic peptides also bind Tb3+ and exhibit luminescence to some degree,
signal to noise and background can be a challenge for distinguishing phosphorylated from
unphosphorylated peptide.
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Recently, we developed a Syk specific artificial substrate peptide (SAStide)
consisting of an acidic motif with a central tyrosine capable of detecting intracellular Syk
activity in response to physiologically relevant stimuli and pharmacological inhibition (27).
Based on the similarity of the arrangement of carboxylate groups and the central tyrosine
in this sequence with the motif found in the atypical phosphorylation dependent terbium
sensitizing peptide of !-synuclein (Fig. 3.2A), we chose to explore the use of this peptide
as a probe for the detection of Syk activity through terbium-sensitized luminescence.
Because (as with all fluorophores) lanthanide luminescent lifetimes are sensitive to the
chemical environment of the metal ion, (28) we also tested whether chelation of Tb3+ with
the phosphorylated vs. unphosphorylated peptide could be more easily distinguished
using time-resolved luminescence detection. In a time-resolved luminescence
measurement, the short-lived background luminescence is allowed to decay before
measuring the luminescence of the chelated Tb3+ (Figure 3.1). While the overall
sensitivity for a time-resolved vs. a steady state measurement is usually lower because of
the gating of the highest intensity initial signal, this can be mitigated to some degree by
optimizing the integration times. The long luminescent lifetime of terbium enables use of
longer integration times, and provides an opportunity to eliminate any interference from
autofluorescence and other background within the sample increasing the specificity and
signal to noise for detection. Here we describe the testing and characterization of this
strategy as a method for detecting Syk kinase activity and inhibition.

!

100

!
Figure 3-1 Time-resolved luminescence detection of Syk kinase activity using SAStide

3.3

Materials and Methods

Peptide Synthesis and Purification. Peptides were synthesized at a 50 µmol scale using
a Protein Technologies Prelude Parallel peptide synthesizer on CLEAR-amide resin
(Peptides International). Coupling of standard Fmoc (9-fluorenylmethoxy-carbonyl)protected amino acids (Peptides International) were achieved with HCTU in the presence
of NMM in DMF for two 10 min couplings. Fmoc deprotection was achieved in 20%
piperidine in DMF for two 2.5 min cycles. Side-chain deprotection and peptide cleavage
from the resin was performed in 5 ml cocktail of trifluoroacetic acid (TFA): water: ethane
dithiol (EDT): triisopropylsilane (TIS) (94:2.5:2.5:1). Peptides were precipitated and
washed three times with cold diethyl ether. The peptides were dissolved in acetonitrile:
water: TFA (50:50:0.1), flash frozen and lyophilized. The peptides were purified by
preparative reverse-phase HPLC (Agilent Technologies 1200 Series) a using C18
reverse-phase column.

!

101
Luminescence Emission Measurements. Emission spectra (both steady-state and timeresolved) were collected on a Biotek Synergy4 plate reader equipped with a
monochromator at 23°C in black 384-well plates (Greiner Fluortrac 200). For timeresolved measurements, spectra were collected after excitation at either 266 nm or 280
nm (as denoted in specific experiments) with a Xenon flash lamp followed by a delay of
50 µsec. A luminescence scan between 450-650 nm was collected in 1 nm increments
with 1 msec collection time and 10 readings per data point. Sensitivity (an instrument
parameter similar to gain) was adjusted as necessary and is reported where relevant.
Job’s Plot. The molar fraction of the pSAStide biosensor and Tb3+ were continuously
varied inversely of each other while maintaining a total molar concentration of 16 µM
(i.e. 1 µM pSAStide and 15 µM Tb3+, 2 µM pSAStide with 14 µM Tb3+, 15 µM pSAStide
and 1 µM Tb3+) for each data point. Luminescent emission spectra were collected as
described above and the area under the emission spectra was used as the parameter for
quantification of complex formation as luminescent increases with complex formation.
Binding Affinity. Tb3+ binding to SAStide and pSAStide was measured using Tb3+
luminescence sensitized by the central tyrosine or phosphotyrosine residue of SAStide
and pSAStide respectively. Tb3+ was added to 100 nM of either peptide at final
concentrations ranging from 0 to 20 µM. All experiments were carried out in 10 mM
HEPES and 100 mM NaCl (pH 7.5) at a volume of 100 µL. After excitation of the
samples at 266nm (pSAStide) or 280nm (SAStide), Tb3+ luminescence emission spectra
between 450 to 650 nm were collected for 1 ms following a 50 µs delay and 30 readings
per data point. Background luminescence emission was subtracted from the peptide in the
absence of terbium. The area under each spectrum was integrated and used as the metric

!

102
for quantification. The data were fit to Eq. 1 by using KaleidaGraph nonlinear curvefitting software, where I is the Tb3+ luminescence at a given concentration, Imax
corresponds to the maximum Tb3+ emission, [Tb3+]T is the total Tb3+ concentration, [P]T is
the total peptide concentration and Kd is the equilibrium dissociation constant.
I = Im * ([Tb3+]T + Kd + [P]T) - !(([Tb3+]T + Kd + [P]T)2 – 4([Tb3+]T * [P]T)) / (2 * [P]T) (1)
In vitro kinase assay. EGFP-conjugated Syk was isolated from DT40 chicken B cells
stably expressing Syk-EGFP. Cells were lysed using a solution containing 1% Nonidet P40, 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM EDTA, 1 mM sodium orthovanadate,
2mM NaF and 1X mammalian protease inhibitor cocktail (Sigma). Syk-EGFP was
immunoprecipitated using GFP-Trap_A beads (Chromotek). Lysates were incubated with
the beads for 1 h at 4°C. The kinase-bound beads were washed and then used in the in
vitro kinase assay (0.4 µg/µL). Syk-EGFP was incubated with the kinase reaction buffer
(3.4 µg Syk-EGFP, 100 µM ATP, 10mM MgCl2, 1µM Na3VO4, leupeptin, aprotinin, 125
ng/µL BSA and 25 mM HEPES pH 7.5, total volume 170 µL) containing SAStide at 37.5
µM at 30°C. Aliquots (20 µL) were taken at designated time points (0.5, 5, 10, 15, 30, 45,
60 and 90 min) and quenched in 6 M urea (20 µL). The quenched samples were then
treated with the luminescence buffer (500 µM Tb3+ and 500 mM NaCl, 10 µL) for a total
volume of 50 µL (final concentrations of sample components: 2.4 M urea, 40 µM ATP, 4
mM MgCl2, 0.4 µM Na3VO4, leupeptin, aprotinin, 50 ng/µL BSA and 10 mM HEPES pH
7.5). Luminescence emission spectra were collected as described above and the area
under each spectrum was integrated using GraphPad Prism. An additional aliquot (1 µL)
of the kinase reaction mixture was taken at each time point for validation of
phosphorylation using an ELISA-based chemifluorescent assay as previously
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described. (27) Briefly, each aliquot was quenched with 0.5 M EDTA and incubated in a
96-well Neutravidin coated plate (15 pmol biotin binding capacity per well, Thermo
Scientific) in Tris-buffer saline (TBS) containing 0.1% BSA and 0.05% Tween 20 for 1h.
Following incubation, each well was washed with the TBS buffer and the incubated with
mouse anti-phosphotyrosine monoclonal antibody 4G10 (Millipore, 1:10,000 dilution in
TBS buffer) for 1h. Following incubation, each well was washed with TBS buffer and
incubated with horseradish peroxidase-conjugated goat anti-mouse immunoglobulin G
(IgG) secondary antibody (Abcam) (1:1000 dilution) for 1h. Wells were then washed and
treated with Amplex Red reaction buffer (Amplex Red reagent, Invitrogen, 20 mM H2O2
and sodium phosphate buffer) for 30 min. Fluorescence was measured using a Synergy4
multiwell plate reader (Biotek) with an excitation wavelength of 532 nm and emission
wavelength of 590 nm.
Dose-Response Inhibition Assay. Syk-EGFP (0.4 µg/reaction) was incubated with the
kinase reaction buffer described above before adding SAStide in the presence of DMSO
(vehicle) or varying concentrations of piceatannol at 30°C for 10 min prior to the start of
the reaction. The reaction was started with the addition of SAStide (37.5 µM, total
reaction volume 20 µL). Each reaction was quenched after 30 min in 6 M urea (20 µL).
The samples were then treated with the luminescence buffer (500 µM Tb3+ and 500 mM
NaCl, 10 µL) for a total volume of 50 µL.
High-Throughput Screening Calculations. The Z’ factor was calculated according to
Eq. 2.
Z’ = (µpos - 3!pos/"n) – (µneg + 3!neg/"n) / (µpos - µneg)
And the signal window was calculated according to Eq. 3
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SW = (µpos - 3!pos/"n) – (µneg + 3!neg/"n) / (!pos/"n)

(3)

Where n is the number of replicates, µpos and µneg are the average luminescence of the
positive (pSAStide or uninhibited) and negative (SAStide or inhibitor treated EGFP-Syk)
controls respectively; !pos and !neg are the standard deviation of the positive and negative
controls.
3.4
3.4.1

Results

Time-resolved luminescence measurements increase signal to noise

Phosphorylated (pSAStide) and unphosphorylated (SAStide) forms of the peptide were
synthesized and steady-state luminescence of each 1:1 Tb3+ complex with excitation at
266 nm through a monochromator (for highly resolved excitation energy control) was
measured (Fig. 3-2B). The optimal excitation energy was determined to be 266 nm for
pSAStide and 275 nm for SAStide and were used for characterizing each species in
complex with terbium. At 266 nm excitation energy, pSAStide exhibited strong Tb3+
sensitization and SAStide displayed weaker luminescence. Based on this we used 266 nm
for all further analyses. While SAStide signal was somewhat mitigated by using 266 nm
excitation energy, there was still weak but significant luminescence from SAStide so the
signal to noise (comparing pSAStide and SAStide luminescence) was low (2:1).
However, time-resolved measurements significantly improved the signal to noise to 32:1
(Fig. 3-2C), demonstrating that taking advantage of the increase in Tb3+ luminescence
lifetime in the presence of phosphotyrosine vs. unphosphorylated tyrosine improved the
ability to detect phosphorylation of SAStide. The improvement in the signal to noise ratio
was accomplished by allowing the short-lived signal of the unphosphorylated peptide to
decay prior to collection.
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Figure 3-2 Detection of phosphorylation of SAStide through terbium luminescence. A)
Sequence alignment of a peptide from !-synuclein, an atypical terbium sensitizing
peptide, and SAStide. B) Steady-state luminescence and C) time-resolved luminescence
emission plots for SAStide and pSAStide. pSAStide (—) SAStide (---) and Tb (···).
Spectra were collected from 15 µM peptide in the presence of 100 µM Tb3+ in 10mM
HEPES, 100mM NaCl, pH 7.0, "ex=266nm, 1000ms collection time, 50 µsec delay time
and sensitivity 180. Data represent the average of experiments performed in triplicate.
3.4.2 Physical characterization of SAStide-lanthanide binding and luminescence
Binding studies were performed to determine the stoichiometry and affinity of pSAStideterbium complexation. The binding stoichiometry of the highest affinity complex was
established using the Jobs method of continuous variations. (29) The area under the
emission spectrum was used as the metric to quantify the pSAStide-Tb3+ binding ratios.
pSAStide and terbium individually displayed no detectable luminescence; therefore, any
changes in luminescence could then be attributed the formation of the pSAStide-Tb3+
complex. The Jobs plot displayed an increase in total area as the mole fraction of terbium
increased to 0.5 followed by a linear decrease with further increases in the mole fraction
(Fig. 3-3A). These data indicated that the preferred binding stoichiometry of pSAStideTb3+ binding is 1:1.

!

106

Figure 3-3 Characterization of the SAStide/Tb3+ physical interaction. A) Jobs Plot of
continuous variation. The mole fraction of Tb3+ and pSAStide were inversely varied
relative to each to maintain a total molar concentration of the two species at 16 !M.
Luminescence spectra were collected in 10mM HEPES, !ex = 266 nm, 1000ms collection
time, 50 µsec delay time and sensitivity 180. Data represent averages ± SEM of
experiment performed in triplicate. B) Binding affinity of SAStide-terbium complexation.
Spectra were collected using 1 µM pSAStide (!) or SAStide (") in the presence of
varying concentrations of Tb3+ in 10mM HEPES, 100mM NaCl, pH 7.5, !ex = 266 nm for
pSAStide and !ex = 275 nm for SAStide, 1000ms collection time, 50 µsec delay time and
sensitivity 180. Data represent averages ± SEM of experiment performed in triplicate.
Binding affinities were also determined using Tb3+ luminescence as a measure of
complexation. Terbium was titrated in the presence of 100 nM pSAStide or SAStide and
luminescence emission spectra were collected and integrated. The binding curves
displayed a hyperbolic increase in luminescence with increasing terbium concentrations
from 0-20 µM (representing a large excess of terbium), with saturation between at 20 µM
characteristic of one site binding (Fig. 3-3B). Additional increases in luminescence,
ranging up to three fold, were observed with increasing terbium concentrations, which
mass spectrometry analysis suggested were likely due to complexes containing multiple
terbium ions. However, for the remainder of this work detection of pSAStide was carried
out with 6.67 equivalents of terbium relative to peptide, thus the 1:1 binding mode
characterized by the initial hyperbolic increase was the most relevant to detection under
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conditions used subsequently for assays. The calculated Kd for the 1:1 pSAStide-terbium
complex represented by the hyperbolic curve was 1.51 ± 0.087 µM, which is comparable
to the affinities reported for other terbium binding peptides. (15, 20) The
unphosphorylated SAStide-terbium complexation displayed significantly weaker binding;
the 1:1 complex exhibited a Kd of 7.64 ± 0.32 µM (5-fold weaker than for the
phosphorylated peptide). These results demonstrate that phosphorylation increased the
affinity of SAStide for Tb3+. Also, since the greatest fold change in signal for pSAStideterbium vs. SAStide-terbium was observed for the 1:1 complex, this represented the best
ratio to maintain in subsequent kinase assays.
Measurements of the terbium luminescence lifetime were performed to
characterize the photophysical properties of pSAStide-terbium and SAStide-terbium
complexation. The hydration number (i.e. the number of water ligands (q) in the terbium
coordination sphere) can be determined via the luminescence lifetime of the complex in
H2O vs. D2O, since the terbium excited state is quenched by the –OH vibrational
overtones of H2O but not D2O. Luminescence spectra for the pSAStide:Tb3+ and
SAStide:Tb3+ complexes were collected in various ratios of H2O/D2O. The luminescence
lifetimes were fitted to a single exponential decay and were determined to be 2.02 ms and
2.48 ms in H2O and D2O respectively for pSAStide:Tb3. These lifetimes lead to a q value
of 0.12 for the phosphopeptide complex, indicating nearly an absence of H2O in the inner
coordination sphere of terbium at equilibrium. The unphosphorylated SAStide:Tb3+ had a
comparably shorter lifetime in H2O at 1.88 ms and a longer lifetime D2O of 2.92 ms
resulting in a q value of 0.66. These data suggest the SAStide:Tb3+ contain closer to one
H2O in the coordination sphere at equilibrium, resulting in more quenching of the terbium
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excited state, which manifested as a shorter lifetime. These differences are likely related
to the greater luminescence intensity observed for the phosphorylated vs.
unphosphorylated peptide, and also to the longer lifetime of the phosphopeptide that
enabled gating of the signal for better dynamic range for discriminating the
phosphorylated from unphosphorylated species using time-resolved signal collection.
(Table 3-1)
Table 3-1 Photophysical properties of the pSAStide-terbium and SAStide-terbium
complexes.
#
!Ex
"H2O
"D2O
Peptide
q
pSAStide

266

2.02

2.44

0.12

0.34

SAStide

275

1.88

2.92

0.66

N.D.

!Ex = maximum excitation wavelength; "H2O-1 = luminescence decay in the presence of
H2O; "D2O-1 = luminescence decay in the presence of D2O; q = number of H2O ligands in
inner coordination sphere at equilibrium; # = quantum yield.
The quantum yield for the pSAStide-terbium complex was determined using
diffusion-enhanced energy transfer from the complex to fluorescein isothiocyanate
(FITC). (30) Luminescence emission spectra were collected in the presence of varying
concentrations of FITC with increasing delay times. The time-resolved emission spectra
and corresponding lifetime plots display an increase in emission intensity and a
simultaneous decrease in the lifetime with increasing concentrations of FITC, and the
quantum yield calculated from these data was 0.34.
3.4.3

Quantitative detection of Syk kinase activity using Tb3+ sensitization

To demonstrate the use of SAStide:Tb3+ as a biosensor for quantitative detection of Syk
activity, a calibration curve was established using mixed ratios of SAStide and pSAStide
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in the presence of the kinase assay components and quenching buffer conditions (MgCl2,
BSA, ATP, NaVO4, protease inhibitors, piceatannol, DMSO, urea) at concentrations
sufficient to mimic an appropriate background matrix for a kinase assay measurement
(Fig. 3-4A). Luminescence emission spectra were collected for the various
SAStide/pSAStide ratios and the area under the curves were integrated. Controls showed
limited interference from the components of the kinase assay and quenching conditions.
The calibration curve demonstrated that the emission spectral area increased linearly and
was well correlated with increasing percent phosphorylation (Fig. 3-4B). However, there
was an increase in the basal signal in the absence of pSAStide (relative to mixtures of just
peptide and simple buffers) that was likely due to complexation of terbium with ATP.
The three phosphate groups of ATP can provide an appropriate coordination environment
and adenosine provides the appropriate chromophore for excitation (!ex=259 nm), giving
rise to some background even with time-resolved measurements. Compared to detection
of pSAStide vs. SAStide in HEPES buffer alone, this increase in background signal
reduced the signal to noise ratio (S/N) by half (Figure 3-2C compared to Figure 3-4B).
However, despite this decrease excellent S/N (15.3:1) was still achieved.
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Figure 3-4 Calibration and detection of phosphorylation of SAStide. A) pSAStide-Tb3+
luminescence emission spectra in the presence of the quenched Syk in vitro kinase assay
buffer (2.4 M urea, 40 µM ATP, 4 mM MgCl2, 0.4 µM Na3VO4, leupeptin, aprotinin, 50
ng/!L BSA and 10 mM HEPES pH 7.5). Spectra were collected from 15 µM peptide in
the presence of 100 µM Tb3+ (representing a ratio of 6.7 Tb3+:peptide, which corresponds
to the saturated range for 1:1 binding) in 10mM HEPES, 100mM NaCl, pH 7.0,
!ex=266nm, 1000ms collection time, 50 µsec delay time and sensitivity 180. B) Emission
spectral area calibration curve based on percent phosphorylation in vitro. C) in vitro Syk
kinase assay luminescence emission spectra. D) Interpolated percent phosphorylation
from Syk in vitro kinase assay. Data indicate averages ± SEM of experiments performed
in triplicate.
The limit of detection (LOD) for phosphorylation was 3.8 ± 0.51%, defined as the
percentage of pSAStide that gave a signal area corresponding to 3X the standard
deviation greater than the baseline for unphosphorylated SAStide in the quenched kinase
reaction buffer (the negative control). The limit of quantification (LOQ) for
phosphorylation was 7.4 ± 0.52 %, defined as the percentage of pSAStide that gave a
signal area 10X the standard deviation greater than the signal in the negative control. (31)
We also calculated the Z’ factor and the signal window (SW) to determine if this sensor
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would be appropriate for use in a high throughput screening (HTS) assay. The Z’ factor
should be between 0.5 and 1 for an assay to be considered appropriated for HTS, as
assays with a Z’ factor in this range exhibit a large dynamic ranges and wide separation
of positive and negative results. (32-33) Assays with a SW greater than 2 are also
considered appropriate for HTS assays. (32-33) Both parameters were calculated from
the mean emission and standard deviation of the spectral area from triplicate
measurements of the negative control SAStide in the in vitro assay buffer and the positive
control pSAStide in the same conditions. The Z’ factor and SW were determined to be
0.82 and 14.63, respectively, indicating that time-resolved terbium luminescence
detection of SAStide phosphorylation is an appropriate method for HTS assays.
Detection of Syk activity in vitro was accomplished using Syk-EGFP
immunoprecipitated from engineered DT40 chicken B-cells with the kinase reaction
buffer and quenching conditions described above. After pre-incubation of the enzyme
with the kinase reaction mixture, SAStide substrate was added and aliquots of the
reaction were quenched at various time points in urea (to denature the enzyme). Tb3+ was
added and time-resolved luminescence was measured (Fig. 3-4C). The areas under the
emission spectra were calculated, the percent phosphorylation was interpolated from the
calibration curve and plotted against time (Fig. 3-4D). These data show that enzymatic
phosphorylation of SAStide can be detected using time-resolved Tb3+ luminescence. As a
control to verify phosphorylation, an additional aliquot was used for detection of
phosphorylation using an ELISA-based chemifluorescent assay.
We also examined the potential of this strategy to be used for inhibitor screening.
The effect of the Syk inhibitor piceatannol (34) was assayed in a dilution series from 10 nM
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to 10 mM. Luminescence emission spectra were collected and integrated (Fig. 3-5A). The
areas were normalized to the DMSO control and reported as percent activity. The
observed IC50 for piceatannol was 178±1.4 µM (Fig. 3-5B), consistent with that found in
the literature. (35) The Z’ factor and SW were determined in the context of the doseresponse inhibition assay, calculated from the standard deviation and mean from the
normalized percent activity from triplicate measurements of the negative control (10 mM
piceatannol) and the positive controls (10 nM – 500 µM piceatannol). Over all the
positive controls the Z’ factor was greater than 0.5 and the SW was greater than 2
demonstrating that the application of pSAStide:Tb3+ maintains its appropriateness as a
HTS tool in practice.

Figure 3-5 Detection of dose-dependent Syk inhibition. A) in vitro Syk kinase assay
luminescence emission spectra. Spectra were collected from 15 µM peptide in the
presence of 100 µM Tb3+ in the presence of the quenched kinase reaction buffer (2.4 M
urea, 40 µM ATP, 4 mM MgCl2, 0.4 µM Na3VO4, leupeptin, aprotinin, 50 ng/!L BSA
and 10 mM HEPES pH 7.5), !ex=266nm, 1000ms collection time, 50 µsec delay time and
sensitivity 180. B) Dose-response inhibition of Syk by the inhibitor piceatannol. The
extent of biosensor phosphorylation was interpolated from the calibration curve and
normalized to the uninhibited DMSO control. Data indicate averages ± SEM of
experiments performed in triplicate
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3.5

Discussion

In summary, we have demonstrated that time-resolved Tb3+ luminescence
measurements substantially increase signal to noise and thus dynamic range for
quantitative analysis of peptide phosphorylation. Time-resolved luminescence detection
has been employed in FRET-based assays for kinase activity (e.g. the LanthaScreen®
assay from Life Technologies), (36) however these assays rely on Tb3+ chelation by a
macrocyclic carrier conjugated to an anti-phosphosite antibody coupled with a
fluorescently labeled substrate, and Tb3+ itself is not involved in binding to the
phosphorylated product of the kinase reaction—therefore the LanthaScreen® technique
depends on antibody availability and is an indirect, “off-line” measure of substrate
phosphorylation. Exploiting the binding and sensitization of Tb3+ directly with a
phosphorylated substrate is essentially “label-free,” since neither antibodies nor
fluorophore labels are required. In our studies, time-resolved measurements significantly
improved the signal to noise of detection compared to steady-state measurements by
minimizing background signal. The ability to discriminate between the coordination
environments for Tb3+ binding to the unphosphorylated vs. phosphorylated peptides based
on luminescence lifetime facilitated the improvement we observed in distinguishing
between species. Accordingly, phosphorylation of the Syk substrate peptide SAStide
could be applied for rapid, quantitative and sensitive detection of Syk kinase activity and
inhibition by small molecule inhibitors with little to no interference from the components
of the kinase reaction.
Besides the specific application to Syk kinase described here, this strategy has
broad significance for detecting phosphorylation using lanthanide sensitization. Time-
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resolved detection should expand the possibilities for other peptide- and protein-based
lanthanide sensitization approaches to achieve better dynamic range and sensitivity. This
will enable us and others to leverage existing Tb3+-sensitizing substrates for other kinases,
as well as open a new avenue for development of novel substrates to achieve highthroughput compatibility for other kinase targets important in therapeutic development,
that otherwise may not have provided sufficient signal to noise with steady-state
measurements.
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CHAPTER 4. PIPELINE TO DEVELOP PHOSPHORYLATION-DEPENDENT
TERBIUM SENSITIZING TYROSINE KINASE BIOSENSORS

4.1

Abstract

Non-receptor protein tyrosine kinases represent a major class of enzymes essential
for cellular homeostasis, and thus are a major focus of current drug discovery efforts.
Many of these enzymes display differences in substrate specificity but are structurally
similar even between families. This makes the design of substrates that can distinguish
between tyrosine kinase families a challenge. Peptide substrates that can enhance
lanthanide ion luminescence upon tyrosine phosphorylation enable rapid, sensitive
screening of kinase activity. However, the bottleneck caused by the laborious task of
identifying and optimizing sequences has slowed the development of efficient and
selective substrates for lanthanide-based kinase assays. Streamlined strategies to identify
sequences that strike an ideal balance between phosphorylation efficiency, selectivity and
lanthanide binding are needed. Here we present a method to circumvent this bottleneck
and rapidly identify kinase specific substrates that are capable of detecting tyrosine
kinase activity through phosphorylation-dependent terbium (Tb3+) sensitization. We
exploited positional scanning peptide libraries and brought in existing proteomic data
from natural substrates to identify substrate preference features that can be applied to
achieve substrate specificity while enabling Tb3+ binding via key substitutions at residues
that are unimportant for specificity. We applied this strategy to develop biosensors for
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several non-receptor tyrosine kinases, including Abl, Jak2 and Src family tyrosine
kinases. We demonstrated that these substrates are selective within kinase families and
are amenable to high throughput drug screening applications. Overall, this strategy
represents a pipeline for developing efficient and specific assays that use lanthanidebased detection for virtually any tyrosine kinase/kinase family.
4.2

Introduction

Protein kinases catalyze the reversible phosphorylation of proteins and play a
ubiquitous role in the regulation of signal transduction pathways directing cellular
processes including proliferation, survival and adhesion. Phosphorylation of a protein can
result in changes in activity, conformation, and stability as well as facilitate proteinprotein interactions through phospho-recognition domains. The human genome encodes
for more than 500 protein kinases, 32 of which are non-receptor tyrosine kinases
(NRTKs). (1) This class of kinases represents the primary mechanism for integrating
signaling events initiated at the membrane to affect gene regulation in the nucleus.
Deregulation of these kinases can occur through overexpression or constitutive
activation, which are facilitated by two mechanisms: 1. Loss of function of tumor
suppressors (e.g. tyrosine phosphatases PTEN and SHP-1) or loss of autoinhibitory
mechanisms (e.g. intramolecular binding of protein interaction domains), and 2. Gain of
function mutations (as seen in Philadelphia chromosome-positive chronic myelogenous
leukemia, CML, and the Jak2 V617F mutation in myeloproliferative disorders). (2-4) The
association of many NRTKs with a multitude of disease states has led to a large drug
discovery effort, resulting in the development of 24 FDA-approved small molecule nonreceptor tyrosine kinase inhibitors since 2001. (5) However, despite the preclinical and
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clinical success of these particular drugs, small molecule inhibitors have only been
approved for 30 kinases from 12 families (5.8% of the kinome and 9.8% of the families).
Although most of these are marketed as “specific,” many actually lack selectivity for a
single target (which is arguably a factor in their success). Therefore, the development of
tools that allow for sensitive and specific detection of the activity of many kinases,
including the dissection of multiple targets, is critically important for understanding the
full scope of on- and off-target effects in kinase inhibitor biology. This integrated
information will contribute fundamentally to the development of new therapeutics and
also enable relevant treatment monitoring strategies in the clinic.
Typical strategies for monitoring kinase activity use radioactive ATP, antibodies,
or proteomics to detect phosphorylation of native substrates. (6-8) While these methods
have successfully generated a wealth of information about kinase activity they each suffer
from several disadvantages. The dependency of many kinases on upstream activities
makes interpreting phosphorylation of endogenous substrates difficult. The ability of
kinases to compensate for each others’ loss can also confound the assignment of
endogenous phosphorylation sites as targets for a specific enzyme. Artificial peptide
substrates (as opposed to endogenous substrates) offer an attractive strategy for
examining kinase activity either in vitro or intact cells due to their diverse chemistries,
compatibility with a wide variety of detection platforms, and their ability to directly
report the function of a particular enzyme. These have been used with analytical
approaches including capillary electrophoresis, voltammetry, mass spectrometry,
antibody-based detection (e.g. ELISA), light scattering based methods using SERS and
RLS, and fluorescence-based methods e.g. chelation enhanced fluorescence (CHEF),
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FRET and fluorescence quenching. (9-19) In particular, CHEF methods that sensitize
lanthanide ions such as terbium (Tb3+) in a phosphorylation-dependent manner can enable
high sensitivity and analytical reproducibility. Previously, we described the application of
a kinase specific peptide substrate (SAStide) for the sensitive detection of spleen tyrosine
kinase (Syk) activity in vitro through phosphorylation-dependent enhanced sensitization
of Tb3+ luminescence. The peptide biosensor was comprised of kinase recognition motif
as well as an acidic motif that is appropriately arranged for Tb3+ chelation. (20) The
luminescence signal is generated when phosphorylation of the tyrosine residue results in
exclusion of water and completion of the Tb3+ coordination sphere. Phosphorylation also
alters the excitation wavelength of the aromatic side chain and increases the binding
affinity for the peptide, resulting in a large increase in luminescence (16-fold in the case
of SAStide). However, other than this example of a serendipitous case, most CHEF
substrates are designed primarily to achieve optimal metal binding, which often comes at
the expense of kinase selectivity and enzyme kinetics. Currently there is no general,
streamlined method to identify and develop novel substrates that are simultaneously
specific for an individual kinase and strong metal chelators.
To develop such an approach, both elements (specificity and binding) must be
taken into account. Kinase specificity is determined by two factors: protein-protein
interaction domains and the kinase domain interaction with the substrate sequence. (21,
22) Typically, once a kinase has been recruited to a substrate through a protein-protein
interaction (e.g. a local scaffolding protein or a domain in the kinase itself), the kinase
domain’s recognition of the substrate sequence determines the efficiency of
phosphotransfer. Therefore, while scaffolding and protein-protein interactions are very
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important, the kinase substrate recognition factor is also critical for the specificity of
signal transduction. Phage display, degenerate peptide libraries, and related techniques
have successfully identified substrate specificity profiles for many kinases. (22-25)
However, these techniques have not universally yielded motifs that can be directly
translated into efficient, selective kinase substrates. Within the sequence space defined by
a given motif (which can comprise tens of thousands of permutations), computational
prediction of preference is not 100% accurate, so not all sequences that score strongly via
prediction algorithms are efficient substrates when tested empirically. Additionally,
“positive” sequences of amino acids are selected based on the best residues for catalytic
turnover in a given assay, which usually only tests one kinase. Therefore, many motifs
look similar across non-receptor tyrosine kinases, and data from these methods seem to
imply that there are few selectivity determinants. This suggests that there would be
limited ability to discriminate between kinase specificities with an individual peptide
sequence.
Amino acid residues that prevent the interaction of a protein domain with a
particular sequence (due to e.g. steric clash or charge-based repulsion), termed “nonpermissive” residues, have recently been identified as important determinants in SH2
domain specificity. (26) Anecdotal evidence exists in the literature supporting the idea
that such a hypothesis could apply to kinase substrate interactions as well. For example,
spleen tyrosine kinase (Syk) has been shown to prefer acidic residues both up- and
downstream of the phosphorylation site. Substitution analysis of the acidic endogenous
Syk substrate BLNK Y178 via point mutations of the GST-tagged substrate peptides
demonstrated that single substitutions of basic residues at the -1 or +1 positions were

!

125
sufficient to attenuate phosphorylation of the sequence by Syk. (27) Similar results were
observed when a peptide microarray containing 1,433 known phosphorylated peptides
was screened to determine Abl substrate preference. (28) Peptides containing lysine,
arginine, proline, and aspartic acid at the -2, -1, +1 and +3 positions, respectively,
reduced Abl’s ability to phosphorylate these sequences. The determinants for nonpermissive residues have even been demonstrated through structural homology models
for the catalytic domains of Abl and Src tyrosine kinase based on the crystal structure of
insulin receptor tyrosine kinase. Site directed mutations of the kinase domains guided by
these homology models displayed dramatic changes in kinetic parameters. (29, 30) These
observations suggest that incorporating the concept of non-permissive residues into a
substrate development model could enable the fine-tuning of motifs for better selectivity.
In this report, we present a pipeline to develop peptide substrates for tyrosine
kinases (using the NRTKs as a model system) that are compatible with phosphorylation
dependent sensitization of Tb3+. Using a novel high-density microarray screening assay,
we analyzed positional scanning peptide libraries against representative members of most
of the non-receptor tyrosine kinase families and tested peptides based on the consensus
motifs that were generated out of these analyses against a panel of NRTKs. We then
refined these motifs by bringing in curated collections of known endogenous substrate
sequences and combined the concepts of motif profiling and non-permissive residue
identification in an in silico model that enabled the rapid identification of selectivity
determinants and the relative “importance” of maintaining certain residues at each
position. We used this information and Tb3+ motif alignment as sequence-space-filtering
criteria to narrow down the potential substrate library generated from the motif for a
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given kinase to a manageable handful of sequences that could be empirically tested and
thoroughly characterized. We then applied this pipeline to generate biosensors for Abl,
Jak2, and Src-Family tyrosine kinases and demonstrated HTS assays using the Abl
substrate against a small molecule library to identify novel Abl inhibitors.
4.3

Methods

Peptide synthesis and purification. Peptides were synthesized using a Protein
Technologies Prelude Parallel peptide synthesizer on Rink-amide resin. Coupling of
standard Fmoc-protected amino acids were achieved with HCTU in the presence of
NMM in DMF for two 10 min couplings. Fmoc deprotection was preformed in 20%
piperidine in DMF for two 2.5 min cycles. Split-pool libraries were synthesized as a
single reaction until the +1 position where the resin was split into equal portions and each
amino acid was coupled with 4 equiv of the Fmoc-amino acid/HCTU/NMM for the same
length of time as above. Following coupling of the -1 position the resin of all reactions
with substitutions at the -1 position were combined. The reaction was continued until all
substitutions were synthesized.
Feature extraction. Positional Scanning Peptide Library – The positional scanning
peptide library was generated and assayed using recombinant enzyme and !-P32-ATP by
Dr. Yang Deng in Prof. Benjamin Turk’s laboratory at Yale University. Data
(unpublished) were provided to the Parker laboratory in the form of tables representing
the radioactive phosphate signal intensity for the spots on the PSPL arrays. To combine
the PSPL data with the endogenous substrate information in the filtering algorithm,
peptide phosphorylation signals for each array were quantified based on the median
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intensity for each spot. The median intensity values were then background corrected and
signal intensity were then normalized by the following equation:
Z i, j = m

Si, j

#S

j,i

where Zij stands for the normalized score of amino acid j at position i having a signal
score Sij, and m stands for !the total number of amino acids. Sci is the signal score of
amino acid j at position i where i is defined in the summation of all the m amino acids.
Positional Probability (from endogenous substrates) – To characterize a sequence of nine
amino acids, four on either side of the phosphorylation site (-4 to +4) were considered in
the score. These positions were chosen based on the disorder in known substrates, which
increases substantially beyond that distance from the phosphorylation site. We computed
the biological probability matrix, BPM, as follows. It is experimentally known that kinase
k phosphorylates n substrates (n1, n2, …, nn) consisting of nine amino acids, four on each
side of the phosphorylation site. The frequency of each amino acid at each position in the
collection of substrates was computed, fj,i, where j is amino acid (A, C, …, W, Y) at
position i (-4, -3, …, 1). Due to the limitation of identified substrates for some kinases,
when j = 0 for those amino acids the value of j = 1/n, where n is the number of substrate
sequences for kinase k. The matrix values were computed by comparing the observed
frequency, fi,j, within the substrates to the expected frequency (background frequency),
bi,j, derived from the frequency of each amino acid in each protein containing a substrate
sequence as well as non-phosphorylated interacting proteins (defined using proteinprotein interaction databases (Human Protein Reference Database, String 9.0 and
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BioGRID 3.2) and curated by literature analysis). We constructed the probability matrix
20 x 9 for each amino acid and position defined as si,j = fi,j / bi,j.
Positional Scoring Matrix – The two individual matrices, BPM and PSPLM, were then
multiplied together to form the positional scoring matrix, PSM. The value for each amino
acid was then used to identify favorable and unfavorable residues at each position. Values
greater than 0.9 were considered favorable or permissive for the kinase, while values less
than 0.9 were consider unfavorable or impermissive.
For an nonapeptide of a given amino acid sequence the product of all si,j values yields the
raw probability score, SR.
8

SR = " si, j
i=1

The raw score was normalized by probability of any nonapeptide being a substrate for
! by the number of kinase substrates collected, n, plus the
kinase k, Ps. Ps was determined

number of significantly peptides from the PSPL compared to the total number tyrosine
center nonapeptides seen in substrate and interacting proteins and the 200 peptides from
the PSPL for kinase k.

Ps =

S=

!

n+ x
nT + 200
SR
SR +

1
PS

!
Positional selectivity was determined
by the ratio of the number of significantly abundant
amino acids found at the subsite, nsigi,j, to that the expected abundance from a random
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distribution, nsigaai,j, multiplied by the ratio of the number of significantly abundant amino
acids at the subsite to the total number of residues, naai,j.

"n
Si =

j

"n
j

"n

sig
i, j

sigaa
i, j

#

sig
i, j

j

"n

aa
i, j

j

An amino acid was defined as being significantly abundant if its frequency was found to

! deviations above the mean frequency observed in the total
be greater than two standard
sequence library.
Performance Evaluation. To evaluate the predictive performance of the algorithm,
receiver operator characteristic (ROC) curves were calculated and plotted based on the
specificities (Sp) and sensitivities (Sn) by taking different thresholds.
Specificity (Sp) = TN / (TN + FP)
Sensitivity (Sn) = TP / (TP + FN)
where TP is the number of true positive predictions (phosphorylation predictions that
were also present in the positive data set), TN is the number of true negative predictions
(non-phosphorylated predictions that were also present in the negative data set), FN is the
number of false negative (non-phosphorylated predictions that were also in the positive
data set), and FP is the number of false positives (phosphorylation predictions that were
also in the negative data set). Areas under ROC curves (AROC) were also calculated
based on the integration and used as the Mann-Whitney U statistic.
Additional characterization was performed by the following:
Accuracy (Ac) = (TP + TN) / (TP + FN + TN + FP)
Precision (Pr) = TP / (TP + FP)
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Equal Error Rate (EER) = (1 – Sn) * (TP + FN) + ((1 – Sp) * (1 – (TP + FN))) * 0.01

MCC =

(TP " TN) # (FP " FN)
(TP + FP)(TP + FN)(TN + FP)(TN + FN)

Generation of Kinase Focused Peptide Libraries. Kinase focused peptide libraries

!
were generated
based on the values of the PSM. All si,j > 0.9 were chosen as potential
residues at each position. Combinatorial peptide sequences were generated from these
residues and scored against each kinase. Those peptides that scored positive for the
kinase (or kinase family) of interest and negative for all other kinases (or kinase families)
were then selected and added to virtual “focused libraries” for further screening.
Terbium Binding in silico Screening. Following the generation of focused putative
kinase substrate libraries, sequences were screened for the potential to bind terbium in a
phosphorylation-dependent manner. A BLOSUM 62 matrix was used to generate a
sequence similarity score between the focused library of potential kinase substrates and
the known terbium sensitizing sequence !-syn Y125 (DPDNEAYEMPSEEG). (31, 32)
In vitro kinase assays. Recombinant kinases were incubated with the kinase reaction
buffer (15 nM kinase, 100 µM ATP, 10mM MgCl2, 125 ng/!L BSA and 25 mM HEPES
pH 7.5, total volume 180 !L) containing 12.5 µM biosensor at 30°C. Aliquots (20 !L)
were taken at designated time points (0.5, 5, 10, 15, 30, 45 and 60 min) and quenched in
6 M urea (20 !L). The quenched samples were then treated with the luminescence buffer
(500 !M Tb3+ and 500 mM NaCl, 10 !L) for a total volume of 50 !L (final
concentrations of sample components: 2.4 M urea, 40 µM ATP, 4 mM MgCl2, 50 ng/!L
BSA and 10 mM HEPES pH 7.5). Luminescence emission spectra were collected as
described above and the area under each spectrum was integrated using GraphPad Prism.
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An additional aliquot (2 !L) of the kinase reaction mixture was taken at each time point
for validation of phosphorylation using an ELISA-based chemifluorescent assay as
previously described. (33) Briefly, each aliquot was quenched with 0.5 M EDTA and
incubated in a 96-well Neutravidin coated plate (15 pmol biotin binding capacity per
well, Thermo Scientific) in Tris-buffered saline (TBS) containing 0.1% BSA and 0.05%
Tween 20 for 1h. Following incubation, each well was washed with the TBS buffer and
then incubated with mouse anti-phosphotyrosine monoclonal antibody 4G10 (Millipore,
1:10,000 dilution in TBS buffer) for 1h. Following incubation, each well was washed
with TBS buffer and incubated with horseradish peroxidase-conjugated goat anti-mouse
immunoglobulin G (IgG) secondary antibody (Abcam) (1:1000 dilution) for 1h. Wells
were then washed and treated with Amplex Red reaction buffer (Amplex Red reagent,
Invitrogen, 20 mM H2O2 and sodium phosphate buffer) for 30 min. Fluorescence was
measured using a Synergy4 multiwell plate reader (Biotek) with an excitation wavelength
of 532 nm and emission wavelength of 590 nm.
Dose-response Inhibition Assay. Kinase (15 nM) was incubated with the kinase reaction
buffer described above in the presence of DMSO (vehicle) or varying concentrations of
kinase inhibitors (nilotinib, bosutinib, ruxolitinib) at 30°C for 10 min prior to the start of
the reaction by adding the peptide substrate. The reaction was started with the addition of
biosensor (12.5 !M, total reaction volume 20 !L). Each reaction was quenched after 30
min in 6 M urea (20 !L). The samples were then treated with the luminescence buffer
(500 !M Tb3+ and 500 mM NaCl, 10 !L) for a total volume of 50 !L.
Growth inhibition curves. K562 cells were seeded into 96-well plates at 10,000 cells
per well in Iscove’s Modified Dulbecco’s Medium supplemented with 10% fetal bovine
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serum and pen/strep. The cells were dosed with the indicated inhibitor at the indicated
concentrations (n = 4), and allowed to incubate for 3 days at 37° C. Following incubation,
XTT reagent (ATCC) was added according to manufacturers protocol, and allowed to
incubate at 37° C for 3 hours. Absorbance at 475 nm was measured on a Biotek Synergy4
plate reader. Values were calculated as percent of vehicle (0.1% DMSO), plotted in
Graphpad Prism 6, and IC50 values generated by fitting a variable slope (four parameter)
curve.
High-Throughput Screening Calculations. The Z’ factor was calculated according to
Eq. 2.

$
3# pos ' $
3# neg '
& µ pos "
) " &µneg +
)
n ( %
n (
%
Z'=
[2]
µ pos " µneg

! was calculated according to Eq. 3
The signal window
$
3# pos ' $
3# neg '
&µ pos "
) " & µneg +
)
n ( %
n (
%
SW =
# pos

[3]

n

where n is the!number of replicates, !pos and !neg are the average luminescence of the
positive (phosphorylated peptide or uninhibited) and negative (unphosphorylated peptide
or control inhibitor-treated) controls respectively; !pos and !neg are the standard deviation
of the positive and negative controls.
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4.4
4.4.1

Results

Design and Development of Kinase Specific Substrates For Terbium-Based
Detection of Phosphorylation

Identifying optimal peptide substrate sequences for a kinase out of the enormous
sequence space of a completely random sequence library (e.g. 25 billion possible
combinations for a 9 amino acid peptide with a fixed phosphorylation site residue) has
traditionally been a major technical challenge, and has created a bottleneck in the
development of new specific substrates. The use of degenerative peptide and one-beadone-peptide libraries has been successfully applied for the identification of catalytically
favorable sequences for individual kinases; however, most of these sequences, even when
phosphorylated, are insufficient to sensitize Tb3+ luminescence. The birth of global
proteomics and advances in proteomic technologies including protein arrays and
positional scanning peptide libraries has resulted in an explosion of kinase substrate data
over the past two decades, and catalyzed the identification of novel phosphorylation sites
and linear motifs for individual kinases. We aimed at taking advantages of these
technologies and data to develop a pipeline to identify peptide substrates that would be
not only efficiently phosphorylated by a given kinase, but also selective to that
kinase/kinase family as well as able to enhance Tb3+ luminescence in a phosphorylationdependent manner.
Inspired by the general design rules of previous CHEF-based sensors for detection
of kinase activity (i.e. Sox-Mg2+ and EF-hand-Tb3+ sensors), we aimed at developing a
general approach to design biosensors for tyrosine kinase activity analysis using
phosphorylation-dependent enhanced Tb3+ luminescence. Sensors were designed to
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combine nonreceptor tyrosine kinase substrate specificity with the excitation and
chelation elements governing Tb3+ luminescence. To achieve this, each kinase biosensor
was developed to contain an optimized substrate sequence with an embedded Tb3+
coordination motif, similar to that previously identified from the 14-residue fragment of
!-synuclein surrounding Y125. (Figure 4-1A) Based on our previous work, we reasoned
that this design strategy was plausible due to Tb3+ being a hard acid, which gives it
preferred coordination with hard bases such as the carboxylic acids in the side chains of
glutamic and aspartic acid. (20) These amino acids are also generally preferred amino
acids in tyrosine kinase substrate motifs. (34) To further utilize the hard acid character of
Tb3+ for detection of kinase activity, the incorporation of phosphate into the sequence at
tyrosine, catalyzed by the kinase, provides an additional bidentate hard base moiety. The
expectation of phosphate addition by the kinase allows for designed control of the
number of coordinating water molecules to Tb3+, otherwise known as the hydration
number. The luminescence of Tb3+ is susceptible to quenching through nonradiative
energy transfer to O-H oscillators; therefore, water molecules coordinated to Tb3+ can
quench luminescence emission. The biosensors were designed to use phosphorylation of
the peptide to decrease the hydration number of Tb3+. This led to an increase in the
luminescence lifetime as well as increased the binding affinity of the peptide for Tb3+,
ultimately resulting in enhanced Tb3+ luminescence compared to the unphosphorylated
form. The final design consideration was excitation of Tb3+, which is Laporte forbidden,
which results in Tb3+ having an extremely low molar extinction coefficient. This requires
in a chromophore to absorb the UV-visible radiation and transfer it to Tb3+ to facilitate
excitation. Sequences containing tyrosine not only provide an appropriate chromophore

!

135
for sensitization of Tb3+, but also maintain the appropriate distance between the
chromophore and the chelated Tb3+ ion for Förster resonance energy transfer. An
additional advantage of tyrosine for Tb3+ excitation and detection of kinase activity is the
resulting shift in the excitation wavelength upon phosphorylation from 275 nm to 266
nm. This allows for the selective excitation of the phosphorylated biosensor through the
use of a monochromator. Together these phosphorylation-dependent physical changes in
the biosensor enable enhanced Tb3+ luminescence of the phosphorylated biosensor
compared to the unphosphorylated form. (Figure 4-1B)
For each kinase, a focused virtual library of peptide biosensors was designed,
optimized and selected in silico through our bioinformatic pipeline, KINATEST-ID
(Kinase Terbium Emission Sensor Identification) (Fig 4-1C). This method starts with the
generation of a positional scoring matrix (PSM) (as described below) for a given kinase,
which uses biologically validated phosphorylation sites for individual kinases as well as
empirically observed effects of amino acids from positional scanning peptide library data
(Figure 4-1C Step 1). This matrix represents the relative preference the kinase has for
each amino acid at each position within the sequence. Additionally, a positional
selectivity matrix was also generated using these data. These matrices were used to guide
the generation of a focused library of possible kinase specific peptide substrates, where
motif-based substitutions were assessed based on site selectivity. In other words,
particular sites that lack selectivity (thus having more flexibility for a given amino acid at
that position) but are required for Tb3+ binding could be substituted with the appropriate
Tb3+ binding residue as opposed to a residue suggested by the catalytic preference motif
(Figure 4-1C Step 2). Each sequence in the focused library was given a score based on
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the PSM for the given kinase, as well as a score for all other kinases included in the
analysis using their respective PSMs. (Figure 4-1C Step 2) The focused library was then
filtered based on classifying the sequences as predicted “substrates” or “nonsubstrates”
for each kinase as well as “specific” or “nonspecific” for the given kinase. All
nonsubstrate and nonspecific sequences were then filtered from the library. (Figure 4-1C
Step 3) Cutoff scores for classifying the sequences as substrates or nonsubstrates for each
kinase were selected based on the algorithm training parameters to give the lowest false
discovery rate for the kinase of interest and the highest sensitivity for all off target
kinases. This ensured that all remaining sequences in the library would have a maximal
likelihood to be substrates for the desired kinase and not for the other kinases. The
remaining sequences were compared to the atypical Tb3+ sensitizing peptide derived from
the !-synuclein Y125 center peptide using BLOSUM sequence alignment scoring.
(Figure 4-1C Step 4) Sequences with a BLOSUM score below the threshold of 25%
similarity were removed from the library. This ultimately yielded a compressed library of
potential kinase-specific peptide substrate sequences that were also likely to sensitize
Tb3+ luminescence, which were then used in further studies examining kinase specificity
and Tb3+ sensitization. (Figure 4-1C Step 5).
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Figure 4-1 Design and development of phosphorylation-dependent enhanced Tb3+
luminescence tyrosine kinase peptide biosensors. A) General biosensor design strategy
for kinase biosensors capable of phosphorylation induced enhanced Tb3+ luminescence.
B) The detection strategy using the phosphorylation-dependent physical changes in the
biosensors that result in enhanced Tb3+ luminescence. C) To develop a kinase specific
peptide based biosensor, we first obtain all known phosphorylated substrates for a given
kinase as the foreground as well as all unphosphorylated tyrosine centered sequences that
interact with the kinase as the background. In addition position scanning peptide libraries
screens were perform to provide empirical values for each amino acid. (1) A library of
sequences were generated in silico based on substrate preferences at each positions along
with the Tb3+ binding motif using the positional selectivity score. The library is scored
against the kinase of interest as well as all other tyrosine kinases. (2) The library is
filtered to remove any nonspecific or nonsubstrate sequences for the kinases based on the
PSM scores. (3) The remaining sequences are scored using BLOSUM matrix to access
the similarity to the phosphorylation-dependent Tb3+ sequence !-syn Y125. (4) The
remaining sequence are validated for kinase specificity and photophysical properties
associated with Tb3+ luminescence. (5)
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4.4.2

Identification and validation of kinase specific residues

Endogenous substrate analysis. For the endogenous substrate information, an individual
prediction model was trained from our collection of non-redundant phosphorylated
sequences. “Positive” substrates for each kinase were gathered from phosphorylation site
repositories including Phosphosite Plus, Phospho.ELM and the Human Protein Reference
Database or the literature. “Negative” sequences were derived from the proteins
containing substrate sequences and any validated interacting proteins identified from
HPRD, BioGRID 3.2, String 9.0 and the literature that contained no currently known
substrate sequences for the kinase of interest—in other words, proteins that are known to
exist in the proximity of the kinase but which it has not been observed to phosphorylate.
We reasoned that this would best represent the tyrosine-containing sequences that had the
highest chance of being phosphorylated by the kinase due to the potential for high local
concentration, therefore if they are not reported to be phosphorylated, they are more
likely to represent true negatives. To characterize a sequence of nine amino acids, four
residues on either side of the phosphorylation site were considered. This range of
positions was chosen based on the previously characterized disorder in positions beyond 4 and +4 in substrates. (35) Both the identity and the physiochemical properties of the
residues at each position were taken into account. Substrate sequences were aligned
based on the tyrosine phosphorylation site, and the frequency of each amino acid at a
given position was calculated and compared to the frequency of that amino acids at the
equivalent position in the entire dataset (negative and positive). To identify propertybased features in a substrate motif, the sequence alignment was analyzed to identify
redundant properties of the various amino acid side chains (i.e. acidic or basic residues,
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hydrophobic or hydrophilic residues, etc.). We computed a biological probability matrix,
BPM, based on the frequency of each amino acid in the substrate sequences compared to
a background corrected frequency. These BPMs were used to generate a score for a given
kinase and a given substrate. The higher the score, the more closely the sequence
matched the pattern represented in the substrate preference motif.
Combined model. One limitation of using biological data to derive a prediction matrix is
that the biological sequence space does not cover all possible sequence combinations, as
sequences have evolved to perform multiple functions in a signaling cascade. To enhance
the model, score outputs from positional scanning peptide libraries (PSPLs) and the
biological probability matrices (BPMs) were multiplied together and taken as features to
generate a positional scoring matrix (PSM) for each kinase, using the product of the
scores as the classifier for each sequence. Combining the positional scanning peptide
library analysis with these endogenous matrices compensated for the information missing
from the endogenous substrate dataset. The prediction model was then trained using the
collection of endogenous positive “substrate” and negative “non-substrate” sequences
through 4-fold cross validation. Comparing to literature motifs as well as several machine
learning quality control parameters confirmed the relative quality of the model. An
additional feature determined for each kinase was the selectivity of each position (defined
as positional selectivity) within the substrate sequence. The positional selectivity was
used to describe and determine which positions within the substrate sequence for a given
kinase were the most influential in determining kinase substrate selectivity and
specificity.
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Using the values obtained from the PSM and considering the position selectivity
values, the potential effect of each amino acid at each position in the substrate could be
predicted. Positional selectivity scores demonstrated that all kinases analyzed displayed
strongest substrate selectivity based on the residues present at the -1, +1 and +3 positions
relative to the phosphorylation site. Analysis of amino acid variation at these positions
revealed that the +3 position displayed the highest selectivity scores, and there was
limited variation in the preferred residues at this position as all kinases preferred large
hydrophobic residues (I/L/M/F/V) and/or proline. This lack of variation of residues
would not allow for manipulation of kinase substrate specificity through amino acid
selection at the +3 position. However, analysis of the favorable residues at the -1 and +1
positions demonstrated more diverse preferences at both positions across the kinases
studied, providing a promising avenue for selectivity tuning.
Amino acid preference at the -1 position classified nonreceptor tyrosine kinase
specificity into two main clusters based on preference for acidic residues (D/E), which
was observed as strong for Jak2 and Syk, or large hydrophobic residues (I/L/V), preferred
by all other kinases analyzed including Src-family kinases (SFK), Abl, Fer family kinases
(FFK), Pyk2, Csk and Btk. The “large hydrophobic” cluster could be further partitioned
based on additional weaker preferences. SFK, Abl and FFK demonstrated weak
preference for acidic residues, Csk displayed strong preference for glutamine while Pyk2
and Btk exclusively hydrophobic. (Figure 4.2A)
The +1 position demonstrated increased variation in amino acid preference
compared to the -1 position, enabling kinases to be classified into four groups. Srcfamily, Abl-family and Fes-family kinases displayed strong preference for acidic residues
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as well as moderate preference for small aliphatic and hydroxyl residues (A/G/S/T). Syk,
Btk and Pyk2 displayed strong preference for acidic residues with weaker favorability for
large hydrophobic residues (I/L/V). Jak2 exclusively preferred large hydrophobic
residues and Csk displayed strong preference for glutamine and weaker preference for
large hydrophobic residues. (Figure 4.2B)
Experimental evaluation of the model using mutations of known substrates. These
differences in amino acid preference at the -1 and +1 positions offer an opportunity to
control amino acid substrate specificity through selection of the appropriate residues for
that are favorable for one kinase and unfavorable for the others. To examine the ability
for our approach to control kinase substrate specificity using these preference definitions,
a focused library of peptides based on the canonical endogenous substrates often used to
monitor the cellular activity of Abl, Csk, Jak2 and Syk, with single substitutions at the -1
or +1 position, were synthesized using split and pool peptide synthesis. (36-39) The
library was then used in an in vitro kinase assay with the kinase of interest and analyzed
using liquid chromatography-mass spectrometry (LC-MS).
Large hydrophobic residues (I/L/V) were anticipated to be strongly favored at the
-1 position for Abl. A pool of peptides based on the CrkL Y207 centered sequence, with
substitutions of the alanine at -1 to arginine and glutamic acid, was analyzed to examine
the effect of changing the charge of the position. Bioinformatic analysis predicted that the
substitutions to either residue would decrease substrate phosphorylation. Both
substitutions resulted in a significant decrease in phosphorylation compared to the wildtype substrate. Glutamic acid allowed for lower levels of phosphorylation compared to
the wild-type substrate, while substitution with arginine resulted in complete abrogation
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of phosphorylation. This suggested that arginine may be a non-permissive residue in that
position. To further examine this, the optimal Abl specific substrate Abltide
(EAIYAAPF), which is robustly and rapidly phosphorylated under normal conditions,
was synthesized with arginine substituted at the -1 position. Substitution with arginine at
-1 was able to completely abrogate phosphorylation of Abltide compared to the wild-type
substrate, providing strong evidence for non-permissivity of this substitution.
At the +1 position, acidic (D/E) and small hydrophobic residues (A/G) were
predicted to be strongly preferred by Abl. For the peptide pool, substitutions at the +1
position examined the effect of changing the size as well as the charge of the side chain
through substitutions of alanine to Glu, Leu, Phe, Val and Gly. It was predicted that
alanine would be the most preferred followed by glutamic acid and glycine, while
leucine, phenylalanine and valine would be unfavorable and potentially nonpremissive. In
kinase assays on the pool, alanine and glycine substitutions resulted in similar levels of
phosphorylation; however, glutamic acid drastically reduced the level of phosphorylation.
In agreement with the prediction, Leu, Phe and Val all significantly reduced
phosphorylation of the peptide. (Figure 4.2C)
Bioinformatic analysis of Csk displayed strong preference for large hydrophobic
residues and glutamine both the -1 and +1 positions. The substition of the -1 position to
isoleucine did not result in the expected increase in the level of phosphorylation, while
arginine completely abolished phosphorylation, which was expected. At the +1 position
the substitutions of methionine and alanine resulted in a significant improvement in
phosphorylation of Src Y530 sequence, which was not expected. Another unexpected
result was the low level of phosphorylation associated with the substitution to
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phenylalanine, which was expected to be favorable and was previously shown to be the
most abundant residue at that position in oriented peptide library screening. (Figure 42D) The lack of accuracy in the prediction of Csk substrate determinant is most likely
attributed to the bias of substrates generated in the literature, which is fairly sparse for
Csk compared to several of the other kinases analyzed in the pipeline. It should also be
noted that synergy between positions was observed, as the dual substitution of isoluecine
and phenylalanine at the -1 and +1. This result suggest that a relationship exist between
the two positions, which is lost in the PSM scoring method.
Previous studies as well as our bioinformatic analysis of Syk substrate specificity
demonstrated a strong preference for acidic residues at both the -1 and +1 positions,
which was unique amongst all kinases. Substitutions of the BLNK Y178 center sequence
examined the effects of charge and hydrophobicity at both positions. It was predicted that
substitutions of acidic residues to large hydrophobic amino acids would result in a
significant decrease in substrate phosphorylation; this prediction was borne out in the
experimental results. The smaller decrease associated with the substitution to
phenylalanine (as opposed to leucine or isoleucine) can most likely be attributed to its
similarity to tyrosine, which is a favorable residue in those positions. (Figure 4-2E)
Jak2 substrate preference also showed a strong preference for acidic residues at
the -1 position, and large hydrophobic residues at the +1 position. The substrate peptide
used was derived from the sequence surrounding STAT5 Y694. Substitution from glycine
at the -1 position to an acidic aspartic acid residue significantly improved
phosphorylation of the substrate (as predicted), while arginine performed comparably to
glycine, and glutamine and isoleucine substitutions significantly reduced

!

144
phosphorylation. Substitution from valine at the +1 position to phenyalanine resulted in
comparable levels of phosphorylation, which was also as expected. Glycine, with its less
bulky side chain, resulted in a significant decrease in phosphorylation. Glutamic acid at
the +1 position was also tolerated, which was not predicted. (Figure 4.2F)
While the majority of the predictions for individual effects of the substitutions
were correct, approximately 25% were incorrect. These results suggest two possibilities:
1) the data obtained and used are insufficient to identify the appropriate value for every
amino acid at each position in the substrate for each kinase—the limitations of the data
can arise due to limited data set sizes, bias in the data due to the context and focus of
studies for the kinase and its substrates, or other mechanisms that regulate specificity
aside from substrate sequence recognition; or 2) The other possible explanation is the
computational and prediction approach is incorrect, resulting in the wrong interpretation
of the data and the incorrect calculation of the PSMs. However, based on the correct
prediction of the majority of the substitutions, it is reasonable to believe that the incorrect
predictions are a result of the former rather than the latter.
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Figure 4-2 Analysis of amino acid preference and substitution effects on substrate specificity. Analysis of amino acid selectivity at the
-1 (A) and +1 (B) positions relative to the phosphorylation site. The heat map were generated from the positional scoring matrices
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145

!

146
4.4.3

Identification and Characterization of Abl, Jak2 and Src-family kinase biosensors
To demonstrate the application of KINATEST-ID for the identification of kinase-

specific peptide biosensors, the algorithm was applied to generate Tb3+-sensitizing
biosensors predicted to be specific for Abl, Jak2, and Src-family kinases. Initial potential
substrate sequence libraries were generated by listing all possible permutations of each
kinase’s preference motif (as determined by the PSM). These virtual libraries started with
~43,000, 92,000 and 5,500 sequences for Abl, Jak2 and Src-family kinases, respectively.
These libraries were then filtered by PSM scores for each kinase in the analysis to
remove predicted nonspecific and nonsubstrate sequences, which drastically reduced the
library size by ~99% for each kinase. The Tb3+ binding alignment score filter was then
applied, which reduced the size of the libraries by a further ~50%, leaving libraries
ranging in size from 11-250 sequences. The remaining sequences for each of the kinases
contained the identified kinase substrate motifs as well as the ! -syn Y125 Tb3+ binding
motif or slight shifts in that motif.
From these libraries, several sequences were selected to evaluate empirically for
each kinase as kinase artificial substrate peptides (KAStides) for Abl (AbAStide), Jak2
(JAStide), and Src-family (SFAStide) kinases. The specificity of these sensors was
assessed by screening the peptides against a panel of kinases representing at least one
member of each family of nonreceptor tyrosine kinases. The ability of the kinases to
phosphorylate a given peptide was determined using an endpoint in vitro kinase assay.
Phosphorylation of each peptide was determined quantitatively using a chemifluorescent
ELISA-based assay previously developed in our lab. Relative fluorescence units, which
corresponded to the amount of phosphorylated peptide present, were measured and
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percent phosphorylation was interpolated from a calibration curve. (Figure 4-3B) As
predicted by KINATEST-ID all sequences were specific substrates of the intended
kinases. AbAStide did display some nonspecific phosphorylation by Csk; however this
was only observed at a concentration of Csk 83-fold greater (250 nM) than the
concentration of Abl. This result suggested that, while not explicitly measured, the kcat
and catalytic efficiency of AbAStide for Csk is significantly lower than those for Abl.
Analysis of Jak2 preference amongst the pool of substrates demonstrated that JAStide-E
was the most preferred substrate displaying significantly more phosphorylation compared
to the other substrates (P<0.0001 for JAStide-A and D and P<0.001 for JAStide-B and
C). This result is consistent with the substrate substitution analysis preference in Jak2
substrates, for which the -1 position demonstrated the greatest preference for acidic
residues (JAStide-E) and reduced favorability for arginine (JAStide-A, B, C) and
phenylalanine (JAStide-D). The Src family substrates displayed comparable levels of
phosphorylation across all Src family kinases, while maintaining selectivity against all
other families. The variation in residue properties between the sequences at the -3 and +2
positions demonstrated that SFKs tolerate substitutions at these positions with little effect
on phosphorylation (which is in accordance with the positional selectivity matrix results).
These sequences are the first demonstrated to our knowledge of Jak2 specific substrates
(JAStide-A-E), and specific substrates for all Src-family kinases (SFAStide A and B).
The sequence we term SFAStide-A has been previously identified as an optimal Lyn
kinase motif, however it has not previously been analyzed in the context of the entire Src
family.
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AbAStide, JAStide-E and SFAStide-A were selected for further characterization
based on their specificities in the non-receptor tyrosine kinase screening panel as well as
their robust phosphorylation by their designated kinases. These biosensors were
characterized using steady-state kinetics to model the kinase-substrate interaction and
subsequent phosphorylation of the substrates. In vitro kinase reactions were carried out at
various concentrations of the substrates. The initial reaction velocities for each kinasesubstrate pair were determined and fitted to the Michaelis-Menten equation. The kinetic
parameters for each substrate were determined based on the fit, including Km, Vmax,
turnover number (kcat) and catalytic efficiency (kcat/Km). (Figure 4-3C-E, Table 2) The Km
values for all the peptides were within ~50-200 µM, which is lower than the range
typically observed for kinase-substrate pairs for endogenous substrates. (40) Compared to
the previously published optimal peptide substrates for these kinases, the Km values
measured for the selected KAStides are ~2-5-fold greater than those reported in the
literature. Relatedly, the catalytic efficiencies demonstrated that the AbAStide, JAStideE, and SFAStide-A sequences are effective substrates for their respective kinases, and
these efficiencies are comparable to those reported for the “optimal” kinase substrates.
These results demonstrate that KINATEST-ID is capable of identifying sequences with a
high likelihood of being selective substrates that have comparable kinetic parameters to
the optimal substrates previously identified using traditional, fully empirical methods.
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Figure 4-3 Identification, validation, and characterization of kinase specific biosensors
using KINATEST-ID. A) The kinase substrate sequences selected for further evaluation
and their prediction scores for the panel of kinases used in the assay B) Screening of
kinase substrate against a panel of purified recombinant kinases. Color-coded values
represent the mean of experiments performed in triplicate. C-E) Recombinant, active
Abl, Jak2 and Lyn (3 nM) were used to carry out the kinase reactions with 100 !M ATP
and increasing concentrations of AbAStide, JAStide-E and SFAStide-A. Initial rates of
phosphorylation of the kinase specific biosensors (picomoles of phosphorylated product
per minute) for AbAStide (C) JAStide-E (D) and SFAStide-A using Lyn (E) were
calculated and fitted to the Michaelis-Menten equation. Values represent the mean ±
s.e.m of experiments performed in triplicate.

!

150
Table 4-1 Kinetic constants for kinase specific peptide biosensors
Vmax
Sensor
Km (µM)
kcat (min-1)
kcat/Km
(pmol/min)
AbAStide
99.2 ± 22.0
107.3 ± 7.2
1430 ± 95.5
14.4
186.4 ±
JAStide-E
672.2 ± 37.1 2689 ± 148.4
14.4
26.9
SFAStide-A
62.4 ± 10.3
269.7 ± 16.1 3596 ± 148.4
57.6
4.4.4

R2
0.92
0.96
0.96

Tb3+ luminescence characterization of KINATEST-ID identified biosensors

The biosensors that displayed appropriate specificity in the screening panel were
further evaluated for phosphorylation-dependent enhanced Tb3+ luminescence. The ability
of the biosensors to have not only appropriate kinase specificity but also to enable large
increases in Tb3+ luminescence upon phosphorylation is important for robust detection of
kinase activity. Phosphorylated and unphosphorylated forms of the peptides were
synthesized and Tb3+ luminescence emission spectra were collected. Steady-state
measurements of the biosensors revealed a modest range of enhancement (~1-2 fold) in
Tb3+ luminescence upon phosphorylation. (Table 3.2) However, as we have previously
observed for a Syk-specific peptide substrate, time-resolved measurements significantly
improved the enhancement of Tb3+ luminescence to the range of ~5-11 fold
(approximately 3-5 fold improvement compared to steady-state measurements). The
observed enhancement of Tb3+ luminescence could be attributed to the differences in
properties of the sensors including binding affinity, hydration number, luminescence
lifetime, and excitation wavelength (characterized as described in Table 4.2), which
validated the phosphorylation-dependent design of the sensors.
Biosensors were designed such that the incorporation of phosphate into the peptide
sequence would result in several physical changes leading to enhanced Tb3+
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luminescence. Starting with the excitation wavelength, phosphorylation shifted the
excitation wavelength of tyrosine from 275 nm to 266 nm. Relative to excitation at 275
nm, selective excitation of the phosphorylated biosensor at 266 nm through the use of a
monochromator significantly improved detection of the phosphorylated biosensors while
having little effect on the signal from unphosphorylated forms. The addition of the
phosphate group to the biosensors also significantly altered the Tb3+ binding affinities for
the peptides. The unphosphorylated sequences exhibited binding constants (Kd) in the
range of 9-80 µM, which were significantly weaker than the range of 1-12 µM observed
for the phosphorylated biosensors (Table 4.2). The differences in binding affinities
between the two forms of each biosensor resulted in the Tb3+ binding equilibrium
favoring the phosphorylated peptides over the unphosphorylated peptides. Finally, timeresolved measurements significantly improved the signal to noise for all the
phosphorylated biosensors by leveraging the change in luminescence lifetime between
the two forms of each peptide for favorable detection of the phosphorylated form. The
luminescence lifetimes of the all the biosensors were increased by an amount in the range
of 100-200 µsec upon phosphorylation. The time-resolved measurements allowed the
shorter-lived signal of the unphosphorylated peptide to decay prior to collection. As we
previously described, these changes in lifetime can be attributed to the change in
hydration number of the biosensor-Tb3+ complexes upon phosphorylation. As
incorporated into the design strategy, the phosphorylated tyrosine group most likely
provides an additional bidentate chelating moiety, which in turn displaces two water
molecules from the coordination sphere of Tb3+. As in our previous work, this
interpretation is supported by experiments comparing the luminescence lifetimes in water
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vs. deuterium hydroxide (which does not quench the Tb3+ luminescence). Together these
results demonstrate that this general design strategy can be applied to diverse tyrosine
kinase substrates, and that these predicted substrates exhibit robust Tb3+ luminescence
sensitization with photophysical properties consistent with the anticipated detection
mechanism.
Table 4-2 Biosensor characterization of physical and photophysical properties
SteadyTime! -1H2O
! -1D2O
Sensor
State
Resolved
Kd (µM)
q
"q
(ms)
(ms)
S:N
S:N
1.35 ± 0.17
1.35
0.51
4
SFAStide-A
2.1:1
10.6:1
2
9.76 ± 0.54
1.83
0.53
6
8.16 ± 1.01
1.73
0.71
5
SFAStide-B
2.1:1
6.2:1
2
54.12 ± 10.31
2.13
0.67
7
1.59 ± 0.21
1.26
0.81
2
JAStide-B
1.1:1
4.6:1
2
15.31 ± 0.46
1.63
0.71
4
7.89 ± 6.21
1.61
0.62
4
JAStide-E
1.9:1
6.8:1
2
67.6 ± 8.73
2.10
0.72
6
12.24 ± 2.56
1.65
0.61
4
AbAStide-A
1.3:1
7.3:1
2
25.55 ± 3.72
2.21
0.74
6
4.4.5

In vitro detection of nonreceptor tyrosine kinase activity

AbAStide, JAStide-E, and SFAStide-A all demonstrated excellent photophysical
properties and were further characterize for their performance for in vitro detection of
kinase activity. Conditions for optimal detection of the biosensors were established in the
kinase reaction conditions as well as calibration curves for each biosensor using various
ratios of phosphorylated and unphosphorylated forms of the sensors. All sensors
displayed linear increases in Tb3+ luminescence with increasing percent phosphorylation
allowing for quantitative determination of phosphorylation. High-throughput screening
parameters were also derived from the calibration curves, including the Z-factor and
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signal widow (SW), which reflect the robustness of detection. All sensors displayed
appropriate HTS parameters (Z-factor < 0.5 and SW < 2) that support their potential
application in HTS screening assays (Table 4.3)
Table 4-3 Characterization of biosensor high-throughput screening parameters.
Limit of
Limit of
Z’
Signal
Sensor
Signal:Noise
R2
Detection Quantification factor Window
SFAStide-A
7.9
21.8
0.79
13.7
9.1:1
0.95
JAStide-E
AbAStide-A

3.1
4.8

9.6
12.1

0.90
0.65

30.8
5.86

6.0:1
4.2:1

0.98
0.95

The sensors were applied for quantitative detection of kinase activity in vitro
using recombinant active kinases over a 60-minute time course. To obtain kinase activity
measurements aliquots of the reaction were quenched and Tb3+ time-resolved
luminescence emission spectra were obtained and percent phosphorylation was
extrapolated from calibration curves. These data show that enzymatic phosphorylation of
the biosensors by the kinases results in increasing Tb3+ luminescence over the time
course. The percent phosphorylation determined by the Tb3+ based read out were in
agreement with those obtain using the quantitative ELISA-based read out. (Figure 4.4 AC)
Next, the biosensors were applied to monitor dose-response inhibition of Abl,
Jak2, and Hck kinase activity by their respective inhibitors imatinib, ruxolitinib, and
dasatinib. The effects of these inhibitors were assayed in a dilution series from 10 pM to
500 µM. Luminescence emission spectra were collected and normalized to the vehicle
(DMSO) control and reported as percent control. The observed IC50 values were 3.88 ±
1.27 nM, 2.89 ± 1.44 nM, and 2.33 ± 1.57 nM for imatinib, ruxolitinib, and dasatinib,
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respectively. These values are in agreement with those reported in the literature for each
kinase. (41-43) The Z-factor and SW for these assays were assessed to determine if HTS
parameters were maintained under the assay conditions. The Z-factors were found to be
greater than 0.5 and the SW maintained values greater than 2 for all the sensors in the
assays. These results demonstrate that these sensors can be applied for both the detection
of kinase activity and inhibition while maintaining robust detection parameters.
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Figure 4-4 Quantitative time-resolved phosphorylation-enhanced Tb3+ luminescence
detection of nonreceptor tyrosine kinase activity and inhibition. Kinase reaction progress
curves for Abl (A) Hck (B) and Jak2 (C). Dose-response inhibition of Abl with imatinib,
Hck with dasatinib, and Jak2 ruxalotinb.(D-F)
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4.4.6

Application of AbAStide for High Throughput Screening of Small Molecule
Inhibitions for Chronic Myeloid Leukemia (CML)

Chronic myeloid leukemia (CML) is caused by the reciprocal translocation of
chromosomes 9 and 22, which results in the formation of the Philadelphia chromosome
or the BCR-ABL fusion gene. This gene product results in the Bcr-Abl fusion protein,
which results in constitutive Abl kinase activity and drives uncontrolled myeloid
proliferation. Treatment of CML has achieved great success in the clinic by inhibition of
Bcr-Abl tyrosine kinase activity using the Abl specific inhibitor imatinib. However,
resistance to imatinib often arises through the development of a broad range of point
mutations within the kinase domain, which impairs inhibitor binding, as well as other offtarget mechanisms. The development of the second-generation Abl and dual Abl–Src
family kinase inhibitors nilotinib, ponatinib, dasatinib, and bosutinib have allowed many
clinically important mutations to be matched to an appropriate and effective inhibitor.
However, several mutations still remain insensitive to the currently available inhibitors,
including the E255V mutation, and others are continually emerging, indicating that
further development of Abl inhibitors that can address the rapidly evolving clinical
situation is still warranted. Here we demonstrate the application of AbAStide for the
identification of novel Abl inhibitors in a high-throughput screening format.
To scale the assay to a 384-well plate format for reproducible detection of Abl
tyrosine kinase activity and inhibition using AbAStide, replicate in vitro kinase assays
were performed in the presence (N=96) or absence (N=96) of imatinib. The peptide
substrate was incubated with Abl kinase in kinase reaction buffer containing ATP and
MgCl2 for 60 min. Reactions were quenched in Tb3+ luminescence buffer (containing urea
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and Tb3+) and time-resolved luminescence measurements were taken on a Synergy4 plate
reader (Biotek). To evaluate assay quality, luminescence of positive and negative control
wells (containing the phosphorylated form and unphosphorylated form of the biosensor,
respectively, N=96 for each) was also measured. The in vitro kinase assay replicates gave
highly reproducible detection of AbAStide phosphorylation and Abl inhibition by
imatinib. (Fig. 4.5A) The Z-factor and SW for the kinase reaction replicates were 0.56
and 84 respectively, comparable to those for control well readings. These results
demonstrate that in vitro detection of Abl kinase activity and inhibition using AbAStideenhanced Tb3+ luminescence as a read-out is scalable and robust.
The robustness of AbAStide for detecting Abl kinase activity was leveraged in a
high-throughput screen using the GSK PKIS library to identify compounds that inhibit
Abl kinase activity. Imatinib was used as the positive control and DMSO (vehicle) alone
was used as the negative control for in these assays. In addition to these experimental
controls, the phosphorylated and unphosphorylated biosensors in the absence of Abl were
also used as quality controls. The GSK PKIS library screened consisted of 364
compounds arrayed in 96-well plates as single compounds at 10 mM in DMSO. The
library was screened at a constant 1:1000 dilution, with 10 µM final concentration of
compound in each well (1% DMSO). Compounds were incubated with the kinase for 30
minutes prior to start of the kinase reaction, which was initiated by the introduction of the
biosensor substrate. The kinase reaction was allowed to proceed for one hour before
being quenched with the Tb3+ luminescence buffer (containing urea and Tb3+). The timeresolved Tb3+ emission intensity was measured and the “percent inhibition” was
determined compared to the biological positive and negative controls (known inhibitor
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imatinib and no inhibitor, respectively) (Fig. 4.5B). Primary hits were identified as
compounds reducing Tb3+ luminescence by greater than 3-fold (the top 5% most potent
inhibitors, which were the top 18 compounds). The primary hits were tested in a
secondary screen using the same kinase reaction conditions, but employing a
chemifluorescent ELISA-based detection instead of Tb3+-based detection. The secondary
screen confirmed that all of the hits inhibited Abl kinase activity by at least 50%
compared to vehicle.
The three most potent inhibitors from the HTS and validation screens were
GW693917A, GW711782X and GW513184X, developed to target TIE2/VEGFR2,
ALK5 and GSK3! respectively. These were selected for further evaluation of their
potency in vitro. In addition to the validated hits, two negative compounds (SB-358518
and GW607049C) were selected as controls for the assay. Potency (IC50) of the
compounds was assessed in a dose-response kinase assay with AbAStide. All three hits
potently inhibited Abl kinase activity, with IC50 values of 0.52 nM, 1.91 nM, and 0.35 nM
for GW693917A, GW711782X and GW513184X respectively. The selected negative
compounds did not display inhibition of Abl. (Fig. 4.5C) To determine whether the
results of the in vitro inhibition studies translate to a CML model, the compounds were
tested in cellular viability assays against the human CML cell line K562. Cellular IC50 for
GW693917A was comparable to imatinib, at 81 nM compared to 147 nM. GW711782X
and GW513184X were less potent in the cell viability assay, at 20 µM and 3.24 µM
respectively. (Fig. 4.5D) Together these results indicate that AbAStide is a biosensor that
provides a robust method for the detection of Abl kinase activity, enabling the highthroughput identification and characterization of novel Abl kinase inhibitors.
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Figure 4-5 A high-throughput chemical screen using AbAStide biosensor identifies new
inhibitors of Abl tyrosine kinase. A) The AbAStide in vitro kinase assay shows highly
reproducible signal upon imatinib treatment. Green: synthetically phosphorylated peptide
(positive control); Black: kinase reaction; Red: kinase reaction + imatinib; Blue:
unphosphorylated peptide (negative control). B) Distribution of compound activities
identified in a high-throughput screen performed with the GSK PKIS library using
AbAStide-sensitized Tb luminescence. C) Dose-response inhibition of Abl kinase
activity by selected compounds from the GSK PKIS. The extent of biosensor
phosphorylation was interpolated from an externally generated calibration curve (not
shown) and normalized to vehicle (DMSO) control. D) XTT cytotoxicity assay for
selected compounds (as in 5C), showing potencies in K562 cells.
4.5

Discussion

Although other methods using synthetic peptide libraries such as oriented peptide
libraries and encoded peptide libraries including phage and mRNA displays have been
applied to identify determinants of kinase substrate specificity, these methods require
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costly, laborious and time consuming experimentation, processing and analysis resulting
in a bottleneck in the development of novel kinase specific peptide substrates.
Computational approaches offer an alternative to circumvent an empirical bottleneck in
the generation and evaluation of kinase specific peptide substrates. They are currently
used to facilitate the discovery of novel phosphorylation sites and to identify the kinases
responsible for catalyzing the phosphorylation and have yet to be explored for the
development of artificial kinase specific sequences. Furthermore, these techniques fail to
simultaneously identify sequences that are not only compatible with the various peptidebased detection methods, but will also facilitate robust, rapid, sensitive, specific detection
of kinase activity as is seen with phosphorylation-dependent enhanced Tb3+
luminescence. To address these challenges we developed an effective strategy, termed
KINATEST-ID, which combines the identification of kinase specificity determinants
with the prediction of kinase-substrate phosphorylation and peptide:Tb3+ complex
formation to generate kinase specific biosensors for phosphorylation-dependent enhanced
Tb3+ luminescence detection. A synergy of approaches are used in the development of the
algorithm, which combines positional scanning peptide library data with validated
biological phosphorylation sites to predict the individual effects of each amino acid on
kinase specificity and BLOSUM substitution matrix sequence alignment to evaluate
phosphorylation dependent Tb3+ luminescence. Together these approaches identify novel
peptide sequences that are kinase specific and produce robust phosphorylation-dependent
enhanced Tb3+ luminescence for detection of kinase activity.
Several lines of evidence suggest that KINATEST-ID is an appropriate and
effective approach for the development of kinase specific peptide biosensors. The quality
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of the prediction is demonstrated when compared with other existing phosphorylation
prediction methods. Comparing the favorable substrate features extracted from the data
using KINATEST-ID to the recently developed M3 (Motif discovery based on Microarry
and MS/MS) and NetPhorest there is significant overlap in the identified kinase substrate
motifs. This overlap in motifs is an encouraging result to confirm the reliability of the
algorithm, since all three methods use different computational approaches and data sets to
arrive at similar results. The quality of these features is further demonstrated by the
empirical validation using substrate substitution analysis of canonical endogenous kinase
substrates. Among the 35 substitutions across the four kinase-substrate pairs examined,
the effect of 71.4% (25/35) are correctly predicted based on the PSM values. The weakest
prediction is for Csk substrates (35.6%, 3/8), which is attributed to the skewed biological
substrate set due to the context of Csk function and the limited study of its kinase
activity. This result highlights the importance of obtaining a comprehensive and well
curated dataset for the development of these prediction algorithms as the model is only as
good as the data. The ability to correctly determine the individual effect of each amino
acid on substrate specificity offers the opportunity to generate artificial sequences de
novo to sever as kinase specific substrates by selecting appropriate residues for individual
kinases. In the past the exhaustive sequence space covering 2.5 billion sequences was
screened to identify the most abundant amino acids are each position to give an “optimal”
substrate. Using the same initial sequence space and KINATEST-ID for prediction of
specificity the number of sequences to be assayed was significantly reduced by seven
orders of magnitude. This is a major advantage of using computational approaches as the
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sequence space can be reduced to a size that is feasible to screen and monitor each
sequence individual rather than identifying the effect as a population.
The sequences presented here are predicted to be specific for individual kinases
and displayed specificity in agreement with this prediction. The characterization of these
substrates demonstrated that they are all effective reporters of kinase activity. Comparing
the performance of the substrates to those reported in the literature reveal that the kinetic
parameters were between those found in optimal substrate and those for endogenous
substrates. Several Src specific peptide substrates have been developed using one-beadone-peptide and oriented peptide libraries with Km values between 20-55 µM, similar to
SFAStide (Km = 62 µM). AbAStide however displayed a significant increase in Km
compared to it’s the optimal substrate (Km = 4 µM) and comparable to the endogenous
substrate CrkL Y207 (Km = 134 µM). However, AbAStide was shown to be a better
substrate compared to CrkL Y207 due to a higher Vmax and catalytic efficiency. As for
JAStide (Km = 186 µM) this is the first report of a specific substrate compared to the
commonly used endogenous phosphorylation site STAT5 Y694 (Km = 306 µM) the Km
was 2-fold lower. This drop in kinetic parameters is to be expected as catalytic
parameters are sacrificed to accommodate Tb3+ luminescence detection of
phosphorylation. Although the sequences presented here did not perform as well
kinetically as previously identified “optimal” kinase specific substrates the design of the
sensors can be modified to improvement of kinetic constants. The incorporating of
ligands targeting protein-protein interaction domains that helps govern kinase substrate
recognition and specificity can increase substrate affinity and the efficiency of
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phosphorylation. This has previously been done using the D-domain of Erk as well as the
SH2 and SH3 domains of Abl and Hck.
Aside from the development of the specific peptide substrate another challenge in
the development of peptide biosensors using sulfonamide-oxine (Sox) fluorophores,
environmentally sensitive fluorophores and genetically encoded FRET pairs is the time
required to optimize the phosphorylation responsive signal based on the placement of the
fluorophore or the molecular switch. The ability to predict the response of the sensor and
the detection parameters would increase the throughput of development are alleviate the
optimization time. The design rules applied here for phosphorylation responsive detection
attempt to facilitate predictable response of the biosensors, but do not provide a metric to
measure the potential response. The use of BLOSUM substitution matrix sequence
alignment to identify the similarities between previously identified peptides capable of
phosphorylation-dependent Tb3+ sensitization and the sequences generated using
positional scoring matrix. As predicted by the BLOSUM scores and the design rules the
sequences presented here produced robust Tb luminescence and high throughput
screening parameters demonstrating the compatibility of the sensors with HTS screening
assays. Lanthanide-based detection has several desirable properties for high throughput
screening assays including affordability, non-radioactive, provides label-free and
antibody-free detection, it is generic, and it is compatible with time-resolved
measurements. The application the sensors here for HTS presented here offers high
sensitivity and reproducibility as well as quantitative monitoring of nonreceptor tyrosine
kinase activity. The ability to generate novel sensors de novo with similar outstanding
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detection parameters is another advantage of applying computational methods for the
development of biosensors.
The rapid development of new kinase specific probes presented here will help
alleviate the bottleneck in biosensors and facilitate new substrate sequences for novel
kinases. Aside from generating kinase specific phosphorylation-dependent Tb3+
luminescence peptide biosensors the application of the algorithm can be a resource for
the research community for the development of new artificial peptide substrates for not
only tyrosine kinases, but also serine/theronine kinases. These sequences can be applied
for detection of kinase activity using previously developed methods including Sox-based
CHEF, mass spectrometry, genetically encode FRET-based biosensors and
electrochemical assays.

!

164
4.6
1.

References

Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002)
The protein kinase complement of the human genome, Science 298, 1912-1934.

2.

Conde-Perez, A., and Larue, L. (2012) PTEN and melanomagenesis, Future
Oncol 8, 1109-1120.

3.

Ren, R. (2005) Mechanisms of BCR-ABL in the pathogenesis of chronic
myelogenous leukaemia, Nature reviews. Cancer 5, 172-183.

4.

Tefferi, A., Skoda, R., and Vardiman, J. W. (2009) Myeloproliferative neoplasms:
contemporary diagnosis using histology and genetics, Nature reviews. Clinical
oncology 6, 627-637.

5.

Uitdehaag, J. C., Verkaar, F., Alwan, H., de Man, J., Buijsman, R. C., and Zaman,
G. J. (2012) A guide to picking the most selective kinase inhibitor tool
compounds for pharmacological validation of drug targets, British journal of
pharmacology 166, 858-876.

6.

Irish, J. M., Czerwinski, D. K., Nolan, G. P., and Levy, R. (2006) Kinetics of B
cell receptor signaling in human B cell subsets mapped by phosphospecific flow
cytometry, J Immunol 177, 1581-1589.

7.

Bendall, S. C., Simonds, E. F., Qiu, P., Amir el, A. D., Krutzik, P. O., Finck, R.,
Bruggner, R. V., Melamed, R., Trejo, A., Ornatsky, O. I., Balderas, R. S.,
Plevritis, S. K., Sachs, K., Pe'er, D., Tanner, S. D., and Nolan, G. P. (2011)
Single-cell mass cytometry of differential immune and drug responses across a
human hematopoietic continuum, Science 332, 687-696.

!

165
8.

Monetti, M., Nagaraj, N., Sharma, K., and Mann, M. (2011) Large-scale
phosphosite quantification in tissues by a spike-in SILAC method, Nature
methods 8, 655-658.

9.

Fernandes, N., and Allbritton, N. L. (2009) Effect of the DEF motif on
phosphorylation of peptide substrates by ERK, Biochemical and biophysical
research communications 387, 414-418.

10.

Zhang, J., Ma, Y., Taylor, S. S., and Tsien, R. Y. (2001) Genetically encoded
reporters of protein kinase A activity reveal impact of substrate tethering,
Proceedings of the National Academy of Sciences of the United States of America
98, 14997-15002.

11.

Shults, M. D., Janes, K. A., Lauffenburger, D. A., and Imperiali, B. (2005) A
multiplexed homogeneous fluorescence-based assay for protein kinase activity in
cell lysates, Nature methods 2, 277-283.

12.

Stains, C. I., Tedford, N. C., Walkup, T. C., Lukovic, E., Goguen, B. N., Griffith,
L. G., Lauffenburger, D. A., and Imperiali, B. (2012) Interrogating signaling
nodes involved in cellular transformations using kinase activity probes, Chemistry
& biology 19, 210-217.

13.

Yeh, R. H., Yan, X., Cammer, M., Bresnick, A. R., and Lawrence, D. S. (2002)
Real time visualization of protein kinase activity in living cells, The Journal of
biological chemistry 277, 11527-11532.

14.

Wang, Q., Cahill, S. M., Blumenstein, M., and Lawrence, D. S. (2006) Selfreporting fluorescent substrates of protein tyrosine kinases, Journal of the
American Chemical Society 128, 1808-1809.

!

166
15.

Kubota, K., Anjum, R., Yu, Y., Kunz, R. C., Andersen, J. N., Kraus, M.,
Keilhack, H., Nagashima, K., Krauss, S., Paweletz, C., Hendrickson, R. C.,
Feldman, A. S., Wu, C. L., Rush, J., Villen, J., and Gygi, S. P. (2009) Sensitive
multiplexed analysis of kinase activities and activity-based kinase identification,
Nature biotechnology 27, 933-940.

16.

Parker, L. L., Brueggemeier, S. B., Rhee, W. J., Wu, D., Kent, S. B., Kron, S. J.,
and Palecek, S. P. (2006) Photocleavable peptide hydrogel arrays for MALDITOF analysis of kinase activity, The Analyst 131, 1097-1104.

17.

Xu, X., Liu, X., Nie, Z., Pan, Y., Guo, M., and Yao, S. (2011) Label-free
fluorescent detection of protein kinase activity based on the aggregation behavior
of unmodified quantum dots, Analytical chemistry 83, 52-59.

18.

Yue, Z., Zhuang, F., Kumar, R., Wong, I., Cronin, S. B., and Liu, Y. H. (2009)
Cell kinase activity assay based on surface enhanced Raman spectroscopy,
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 73, 226230.

19.

Zondlo, S. C., Gao, F., and Zondlo, N. J. (2010) Design of an encodable tyrosine
kinase-inducible domain: detection of tyrosine kinase activity by terbium
luminescence, Journal of the American Chemical Society 132, 5619-5621.

20.

Lipchik, A. M., and Parker, L. L. (2013) Time-resolved luminescence detection of
spleen tyrosine kinase activity through terbium sensitization, Analytical chemistry
85, 2582-2588.

!

167
21.

Jacobs, D., Glossip, D., Xing, H., Muslin, A. J., and Kornfeld, K. (1999) Multiple
docking sites on substrate proteins form a modular system that mediates
recognition by ERK MAP kinase, Genes & development 13, 163-175.

22.

Songyang, Z., Blechner, S., Hoagland, N., Hoekstra, M. F., Piwnica-Worms, H.,
and Cantley, L. C. (1994) Use of an oriented peptide library to determine the
optimal substrates of protein kinases, Current biology : CB 4, 973-982.

23.

Schmitz, R., Baumann, G., and Gram, H. (1996) Catalytic specificity of
phosphotyrosine kinases Blk, Lyn, c-Src and Syk as assessed by phage display,
Journal of molecular biology 260, 664-677.

24.

Lam, K. S., Wu, J., and Lou, Q. (1995) Identification and characterization of a
novel synthetic peptide substrate specific for Src-family protein tyrosine kinases,
International journal of peptide and protein research 45, 587-592.

25.

Hutti, J. E., Jarrell, E. T., Chang, J. D., Abbott, D. W., Storz, P., Toker, A.,
Cantley, L. C., and Turk, B. E. (2004) A rapid method for determining protein
kinase phosphorylation specificity, Nature methods 1, 27-29.

26.

Liu, B. A., Jablonowski, K., Shah, E. E., Engelmann, B. W., Jones, R. B., and
Nash, P. D. (2010) SH2 domains recognize contextual peptide sequence
information to determine selectivity, Molecular & cellular proteomics : MCP 9,
2391-2404.

27.

Kim, J. Y., Huh, K., Jung, R., and Kim, T. J. (2011) Identification of BCAR-1 as
a new substrate of Syk tyrosine kinase through a determination of amino acid
sequence preferences surrounding the substrate tyrosine residue, Immunology
letters 135, 151-157.

!

168
28.

Rychlewski, L., Kschischo, M., Dong, L., Schutkowski, M., and Reimer, U.
(2004) Target specificity analysis of the Abl kinase using peptide microarray data,
Journal of molecular biology 336, 307-311.

29.

Till, J. H., Chan, P. M., and Miller, W. T. (1999) Engineering the substrate
specificity of the Abl tyrosine kinase, The Journal of biological chemistry 274,
4995-5003.

30.

Yokoyama, N., and Miller, W. T. (1999) Identification of residues involved in vSrc substrate recognition by site-directed mutagenesis, FEBS letters 456, 403-408.

31.

Liu, L. L., and Franz, K. J. (2005) Phosphorylation of an alpha-synuclein peptide
fragment enhances metal binding, Journal of the American Chemical Society 127,
9662-9663.

32.

Liu, L. L., and Franz, K. J. (2007) Phosphorylation-dependent metal binding by
alpha-synuclein peptide fragments, Journal of biological inorganic chemistry :
JBIC : a publication of the Society of Biological Inorganic Chemistry 12, 234247.

33.

Lipchik, A. M., Killins, R. L., Geahlen, R. L., and Parker, L. L. (2012) A PeptideBased Biosensor Assay To Detect Intracellular Syk Kinase Activation and
Inhibition, Biochemistry.

34.

Blom, N., Gammeltoft, S., and Brunak, S. (1999) Sequence and structure-based
prediction of eukaryotic protein phosphorylation sites, Journal of molecular
biology 294, 1351-1362.

!

169
35.

Iakoucheva, L. M., Radivojac, P., Brown, C. J., O'Connor, T. R., Sikes, J. G.,
Obradovic, Z., and Dunker, A. K. (2004) The importance of intrinsic disorder for
protein phosphorylation, Nucleic acids research 32, 1037-1049.

36.

de Jong, R., ten Hoeve, J., Heisterkamp, N., and Groffen, J. (1997) Tyrosine 207
in CRKL is the BCR/ABL phosphorylation site, Oncogene 14, 507-513.

37.

Murphy, S. M., Bergman, M., and Morgan, D. O. (1993) Suppression of c-Src
activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains:
analysis with Saccharomyces cerevisiae, Molecular and cellular biology 13,
5290-5300.

38.

Ihle, J. N., and Gilliland, D. G. (2007) Jak2: normal function and role in
hematopoietic disorders, Current opinion in genetics & development 17, 8-14.

39.

Chiu, C. W., Dalton, M., Ishiai, M., Kurosaki, T., and Chan, A. C. (2002) BLNK:
molecular scaffolding through 'cis'-mediated organization of signaling proteins,
The EMBO journal 21, 6461-6472.

40.

Hantschel, O., Warsch, W., Eckelhart, E., Kaupe, I., Grebien, F., Wagner, K. U.,
Superti-Furga, G., and Sexl, V. (2012) BCR-ABL uncouples canonical JAK2STAT5 signaling in chronic myeloid leukemia, Nature chemical biology 8, 285293.

!

170
41.

Quintas-Cardama, A., Vaddi, K., Liu, P., Manshouri, T., Li, J., Scherle, P. A.,
Caulder, E., Wen, X., Li, Y., Waeltz, P., Rupar, M., Burn, T., Lo, Y., Kelley, J.,
Covington, M., Shepard, S., Rodgers, J. D., Haley, P., Kantarjian, H., Fridman, J.
S., and Verstovsek, S. (2010) Preclinical characterization of the selective JAK1/2
inhibitor INCB018424: therapeutic implications for the treatment of
myeloproliferative neoplasms, Blood 115, 3109-3117.

42.

O'Hare, T., Walters, D. K., Stoffregen, E. P., Jia, T., Manley, P. W., Mestan, J.,
Cowan-Jacob, S. W., Lee, F. Y., Heinrich, M. C., Deininger, M. W., and Druker,
B. J. (2005) In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825
against clinically relevant imatinib-resistant Abl kinase domain mutants, Cancer
research 65, 4500-4505.

43.

Manley, P. W., Drueckes, P., Fendrich, G., Furet, P., Liebetanz, J., MartinyBaron, G., Mestan, J., Trappe, J., Wartmann, M., and Fabbro, D. (2010) Extended
kinase profile and properties of the protein kinase inhibitor nilotinib, Biochimica
et biophysica acta 1804, 445-453.

!

171

CHAPTER 5. SIMULTANEOUS MUTIPLEXED DETECTION OF LYN AND SYK
TYROSINE KINASE ACTIVITIES USING TIME-RESOLVED LANTHANIDEBASED RESONANCE ENERGY TRANSFER (TR-LRET)

5.1

Abstract

SAStide, a Syk specific peptide biosensor, and SFAStide, a Src-family kinase
specific peptide biosensor, combine the biochemical principles of kinase specificity and
inorganic properties of terbium coordination for simultaneous rapid, sensitive and
quantitative detection of Syk and Lyn activity through phosphorylation dependent
terbium sensitization and time-resolved lanthanide-based resonance energy transfer (TRLRET).
5.2

Introduction

Numerous leukemias and lymphomas have been characterized by the clonal
expansion of B-lymphocytes due to the deregulation of the B-cell receptor signaling
pathway. (1, 2) Tyrosine kinases Lyn, Syk and Btk are the main signal transducers in this
pathway making them ideal therapeutic targets for small molecule inhibitors. (3) Despite
the identification of this pathway as the cause of disease there are few therapeutic options
targeting the B-cell receptor pathway or these kinases. Currently there is a need for the
development of detection platforms that offer sensitive and specific detection of kinase
activity that can enhance the depth of information obtained in a single assay. Often,
kinase activities are dependent on each other and affect the efficacy of inhibitor drugs
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targeting common pathways. In order to improve upon existing techniques for
discovering and evaluating new inhibitors, multiple events need to be monitored
simultaneously.
Förster resonance energy transfer (FRET) based assays have been developed to
monitor multiple dynamic cellular processes simultaneously in a single assay. (4-8)
However, while useful in some applications, FRET based methods using organic
fluorophores and fluorescent proteins suffer from a number of disadvantages including
small dynamic ranges, the requirement for genetic expression, small Stokes shifts, and
wide emission peaks resulting in spectral bleed through. This ultimately places a limit on
the number of events that can be detected in a single assay. Lanthanides (Ln3+) have been
explored as probes in biological assays for the detection of ligand binding, enzyme
activity, and protein-protein interactions due to their unique optical properties. (9-16)
Compared to organic fluorophores and fluorescent proteins, Ln3+ have narrow emission
bands, large Stokes shifts and long photoluminescence lifetimes, which offer high
sensitivity and specificity of detection due to the reduced background interference. These
can also allow for multiplexed detection due to the multiple distinct emission bands
associated with each Ln3+. (17-19)
Previously, we have demonstrated the development of kinase specific peptide
biosensors capable of detecting kinase activity through phosphorylation-enhanced
terbium (Tb3+) luminescence. Here we present the development of a multiplexed
detection platform for the simultaneous monitoring of Lyn and Syk kinase activities
through intramolecular energy transfer from the luminescence donor phosphopeptideTb3+ complex to orthogonal fluorophores conjugated to the individual substrates.
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5.3

Methods

Peptide synthesis, fluorophore conjugation and purification. Peptides were
synthesized at 50 µmol scale using a Prelude Parallel peptide synthesizer (Protein
Technologies, Inc.) on MBHA-amide resin (Peptides International). Coupling of standard
Fmoc (9-fluorenylmethoxy-carbonyl)-protected amino acids (4 equiv) (Peptides
International) were achieved with HCTU (3.8 equiv) in the presence of NMM (8 equiv)
in dimethylformamide (DMF) for two 10 min couplings. Fmoc deprotection was
achieved in 20% piperidine in DMF for two 2.5 min cycles. Side-chain deprotection and
peptide cleavage from the resin was performed in 5 ml of a cocktail of trifluoroacetic acid
(TFA)/water/ethanedithiol(EDT)/triisopropylsilane (TIS) (94:2.5:2.5:1). Peptides were
precipitated and washed three times with cold diethyl ether. The peptides were dissolved
in acetonitrile/water/TFA (50:50:0.1), flash frozen in liquid nitrogen, and lyophilized.
The peptides were purified by preparative reverse-phase HPLC (Agilent Technologies
1200 Series) a using C18 reverse-phase column. Peptides were characterized by LC-MS
and MALDI-TOF analysis.
SAStide was labeled with AlexaFluor-488-maleimide (Invitrogen) and Cy5maleimide (Lumiprobe) in TCEP (10 mM) and phosphate buffer (100 mM) at pH 6.5.
Reaction progress was monitored by MALDI-TOF MS and was found to be complete
after 2 h. The labeled peptide was purified using a C18 cartridge (50 mg, Waters) and
lyophilized. The labeled peptides were then characterized by LC/MS analysis (see
supporting information for characterization data). Peptides were dissolved in distilled
water and diluted using Tris buffer (20 mM), pH 9.0. UV-Vis spectroscopy of 5-FAM,
AF488, or Cy5 absorbance was determined and the concentration of the peptide solution
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was calculated according to Beer’s Law using the respective fluorophore’s !max extinction
coefficients.
Luminescence Emission measurements. Emission spectra were collected on a Biotek
Synergy4 plate reader in black 384-well plates (Greiner Fluotrac 200). Spectra were
collected from 450-800 nm after excitation at 266 nm (using a monochromator) with a
delay time of 50 !sec and collection time of 1 msec. Sensitivity was adjusted to 180.
Luminescence lifetime measurements. Luminescence emission intensities were
collected on a Biotek Synergy4 plate reader at 23°C in black 384-well plates (Greiner
Fluortrac 200). Spectra were collected from for the donor peaks (495 nm for AF488 and
5-FAM and 670 nm for Cy5) after excitation at 266 nm with a delay time starting at 100
µsec, increasing in steps of 100 µsec to 5000 µsec, and a collection time of 1 ms.
Samples were prepared with 1 µM pSAStide or SAStide with 10 µM Tb3+ in 100 mM
NaCl, 10 mM HEPES pH 7.5 in 100 !L total volume. Emission intensities were
normalized to the intensity obtained at 100 !sec delay and fitted to a single exponential
decay curve using GraphPad Prism and lifetimes
Determination of LRET parameters. LRET follows the same principles as FRET and
can have the same theory applied to calculate the distance between the fluorophore
acceptor and the terbium-peptide complex donor pair. The fundamental concept of
Förster theory is that resonance energy transfer is proportional to
R = R0 [(1/ E ) 1]1/ 6

(1)

Where E is the energy transferred, R0, is the Förster distance, and R is the distance
!
between the donor and acceptor. The percentage of energy transfer, E, can be determined
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from the lifetime measurements of the donor in the absence of the acceptor, !D, (peptideterbium complex (donor) without the conjugated fluorophore (acceptor)) and the donor in
the presence of the acceptor, !DA.

E=

1" # DA
#D

(2)

R0, the Förster distance is determined for each acceptor/donor pair as the distance
!
between the acceptor and donor that results in 50% energy transfer by the following
equation.
R0 = 0.211(" 2#$4 QD J) (3)

Where "2 is the orientation
factor, QD is the quantum yield of the donor (which was
!
determined in our previous studies for both peptide-Tb3+ complexes), # is the the
refractive index, which is 1.4 for biological samples in water, and J represents the
spectral overlap of the emission spectrum of the donor and the excitation spectrum of the
acceptor. J is determined by the following equation

%[F (")#(")" $"]
J=
%[F (")$"]
4

D

(4)

D

where FD($) is the corrected fluorescence intensity of the donor, % is the extinction
coefficient of the acceptor
!
In vitro kinase assay. Purified Lyn was obtained from a commercial source (Millipore).
His-tagged Syk was stably transfected into and purified from HEK293 cells. Cells were
lysed and Syk was purified using Ni2+ magnetic beads (Promega). Syk protein
concentration was determined using quantitative BCA assay. Each individual kinase
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enzyme (15 nM) or a combination of both was pre-incubated with the kinase reaction
buffer (100 !M ATP, 10 mM MgCl2, leupeptide, aprotinin, and HEPES pH 7.5) for 10
time, followed by initiating the kinase reaction by adding either SAStide-Cy5 (12.5 !M ),
SFAStide-5-FAM (2.5 !M ) or both at 37 oC. Aliquots were removed at designated time
points and quenched in 6 M Urea pH 7.5. The quenched samples were then treated with
10 !M Tb3+ bring the sample to a volume of 100 !L.

5.4

Results

Time-resolved lanthanide-based energy transfer (TR-LRET) detection of Lyn and
Syk kinase activities was achieved by employing the phosphopeptide-Tb3+ complexes as
the energy donors and 5-carboxyfluorescein (5-FAM) and cyanine 5 (Cy5), respectively,
as the energy acceptors (Figure 5.1A.) Phosphorylation of the peptide substrates results in
several physical changes in the peptide that ultimately lead to detection of kinase activity,
including enhancing the Tb3+ binding affinity, reducing the Tb3+ chelate hydration
number, increasing the Tb3+ luminescence lifetime, and shifting the excitation
wavelength of tyrosine. (20) Sensitization through tyrosine results in excitation of the
pSFAStide-Tb3+ complex and triggers energy transfer to 5-FAM and results in emission
from 5-FAM at its characteristic wavelength (~520nm) (Figure 5.1B). 5-FAM was
selected as the energy acceptor to couple with the pSFAStide-Tb3+ complex because its
broad excitation peak at 495 nm matches well with the 5D4 ! 7F6 emission band of Tb3+
centered at 495 nm. Similarly, detection of Syk kinase activity was achieved with
SAStide-Cy5 based on the overlap of the excitation band with the 5D4 ! 7F4 and 5D4 !
7

!

F3 emission bands of Tb3+ centered at 595 nm and 620 nm (Figure 5.1C).
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Figure 5-1 Multiplexed detection using time-resolved lanthanide-based resonance energy
transfer (TR-LRET) and fluorophore conjugated peptide biosensors. (A) Emission
spectrum of phosphopeptide-Tb3+ complex (black), excitation (dashed lines) and
emission (solid lines) spectra of the two acceptor fluorophores 5-FAM (green) and Cy5
(red). Schematic illustrating TR-LRET detection of Lyn (B) and Syk (C) tyrosine kinase
activities.
Phosphorylated and unphosphorylated forms of SAStide-Cy5 and SFAStide-5FAM were synthesized as controls. Excitation of each peptide biosensor in the presence
of Tb3+ resulted in the four characteristic luminescent emission peaks from Tb3+ as well
as the fluorescence emission peak from the conjugated fluorophore label (5-FAM at 520
nm and Cy5 at 670 nm). (Figure 5.2A,B) Both sensors displayed increased Tb3+
luminescence and fluorescence of their respective organic dyes for the phosphorylated
peptides relative to the unphosphorylated peptides. Control experiments in the presence
and absence of Tb3+ showed that the sensitization and resulting emission spectra were
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Tb3+- and LRET-dependent rather than arising from direct excitation of the fluorophores
for both biosensors. Comparing the differences in Cy5 signals between the
phosphorylated and unphosphorylated SAStide displayed a 25-fold increase in Cy5 signal
for the phosphorylated peptide. (Figure 5.2A) Comparing luminescence emission spectra
of SFAStide-5-FAM to pSFAStide-5-FAM, a 3.9-fold increase in the 5-FAM emission
intensity was observed. (Figure 5.2B) These changes in the intensity of the fluorophores
upon phosphorylation of their respective peptides provide sensor-specific spectral
features that can be monitored to determine phosphorylation of the sensors and
consequently kinase activity.
In order to achieve multiplex detection in the same sample, the reaction and
detection conditions must be optimized to have limited cross-interference between
sensors. The cross-interference could be evaluated by detecting the presence of the
fluorophore signal from an unphosphorylated sensor in the presence of the other
phosphorylated biosensor. To accomplish this, the concentrations of the biosensors and
Tb3+, as well as the delay time, were varied and and TR-LRET spectra collected.
Quantification of fluorescence signal was accomplished by Gaussian fitting of the
fluorophore emission peaks and integrating the resulting curves for each peak. The
conditions were initially optimized using the phosphorylated SAStide sensor (pSAStideCy5) with the unphosphorylated SFAStide-5-FAM peptide. Reducing the concentration
of SFAStide, increasing the delay time, and varying the concentration of the Tb3+
successfully mitigated any interference from the 5-FAM signal caused by intermolecular
LRET. (Figure 5.2C) Using the same conditions, the cross-interference from SAStideCy5 was examined in the presence of pSFAStide-5-FAM. The TR-LRET spectra
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displayed minimal signal from Cy5, while displaying significantly stronger 5-FAM
signal. (Figure 5.2D)

Figure 5-2 Time-Resolved Lanthanide-based Resonance Energy Transfer (TR-LRET)
detection of phosphorylation-dependent signals and cross-interference. (A) Timeresolved luminescence emission spectra for SAStide-Cy5 and pSAStide-Cy5 and (B)
SFAStide-5-FAM and pSFAStide-5-FAM. Spectra were collected from 15 !M peptide in
the presence of 100 !M Tb3+ in 10 mM HEPES, 100 mM NaCl, pH 7.5, !ex = 266 nm, in
50 !L total volume 1 ms collection time, 50 !s delay time, and sensitivity 180. Data
represent the average of experiments performed in triplicate. (C) pSAStide crossinterference with SFAStide signal and (D) pSFAStide cross-interference with SAStide
signal. Spectra were colleted from 0.5 !M SFAStide-5-FAM and 2.5 !M SAStide-Cy5 in
the presence of 10 !M Tb3+ in 10 mM HEPES, 100 mM NaCl, pH 7.5, Urea, ATP, BSA,
MgCl2, !ex = 266 nm, in 100 !L total volume 1 ms collection time, 50 !s delay time, and
sensitivity 180. Data represent the average of experiments performed in triplicate.
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The distance between the Tb3+ ion and the fluorophore is a critical parameter for
energy transfer, and is directly proportional to the fluorescence signal displayed in the
emission spectra. By obtaining the luminescence lifetimes of the biosensors in their
fluorophore conjugated and unconjugated forms, the energy transfer and LRET
parameters for each sensor were characterized. SAStide was also conjugated with
AlexaFluor 488 (AF488) as a control for the measurements to demonstrate the agreement
in LRET parameters between using different fluorophores. TR-LRET measurements
demonstrated efficient energy transfer (in the range of 89-93%) from Tb3+ to the various
fluorophores. The radius representing the distance between Tb3+ and the fluorophores, R,
and the Förster radius, R0, were determined from these measurements as well. The R and
R0 values ranged from 50-55 Å and 35-40 Å respectively. As indicated by the efficient
energy transfer, these parameters are within the optimal range for TR-LRET
measurements. (21)

Figure 5-3 Luminescence lifetime measurement of phosphopeptide-Tb3+ complexes in
the conjugate and unconjugated forms for (A) SAStide-Alexafluor488 (B) SAStide-Cy5
(C) SFAStide-5-FAM.
To demonstrate the utility of these biosensors for quantitative detection of Lyn
and Syk tyrosine kinase activities, a calibration curve was established for each sensor in
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the presence of the unphosphorylated form of the other biosensor and the kinase reaction
buffer (to best mimic the conditions of a multiplexed kinase reaction). Quantification of
phosphorylation was calibrated by integrating the signal centered at 520 nm for 5-FAM
and 670 nm for Cy5. The high signal to noise ratio observed in the initial control
experiments was maintained in the presence of the reaction buffer with 7.6:1 for Cy5 and
5.8:1 for 5-FAM. Z’-factor and signal window (SW) values were shown to be appropriate
for HTS, with Z-factor values of 0.72 and 0.78, and SW of 13.27 and 12.65, for SAStideCy5 and SFAStide-5-FAM, respectively.

Figure 5-4 TR-LRET quantitative calibration of biosensor phosphorylation. (A)
pSAStide-Tb3+ emission spectra with increasing proportions of phosphorylated biosensor
compared to unphosphorylated. (B) Cy5 emission spectral area calibration curve based on
spectra from (A). (C) pSFAStide-Tb3+ emission spectra at increasing proportions of
phosphorylated biosensor compared to unphosphorylated. (D) 5-FAM emission spectral
area calibration curve based on (C).
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Detection of Syk and Lyn activities in vitro was accomplished and quantified
using the purified kinases with kinase reaction buffer and detection conditions described
above. After pre-incubation of the kinases with the reaction buffer (for 10 min) the kinase
reaction was initiated by the addition of the biosensor(s). Aliquots were removed from
the reaction and quenched with urea, treated with Tb3+ and brought to a volume of 100
!L. TR-LRET emission spectra for each respective biosensor displayed an increase in the
conjugated dye’s fluorescence signal (with minimal bleed through or background
interference from the other fluorophore) over the time course of the reaction in the
presence of only one of the kinases (Figure 5.5 A,B,C,D). These results confirmed the
specificity of each biosensor for its individual kinase. To demonstrate multiplex
detection, both biosensors were applied with both kinases in a single reaction. A
simultaneous increase in fluorescence of both fluorophores was seen over the time
course, indicating an increase in phosphorylation of both peptides. The negative levels of
phosphorylation observed from the nonsubstrate biosensor indicate that the cross
interference signal was reduced compared to the calibration curve. This reduction in
signal could be the result of photobleaching of the fluorophores over the time course of
the assay and the sample handling.
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Figure 5-5 Simultaneous multiplexed in vitro detection of Syk and Lyn kinase activities.
(A) In vitro Lyn assay luminescence emission spectra in the presence of both SFAStide5-FAM and SAStide-Cy5. (C) In vitro Syk assay luminescence emission spectra in the
presence of both SFAStide-5-FAM and SAStide-Cy5. (E) In vitro Lyn and Syk assay
luminescence emission spectra the presence of both SFAStide-5-FAM and SAStide-Cy5.
(B, D, F) Quantification of SFAStide-5-FAM phosphorylation and SAStide-Cy5
phosphorylation interpolated for each assay from the calibration curves in Fig. 5.4.
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5.5

Discussion

In summary, we have presented the development of a multiplexed platform for
detection of kinase activity that leverages the overlap of the multiple distinct emission
bands of Tb3+ with orthogonal fluorescently labeled peptide substrates that are capable of
phosphorylation-enhanced Tb3+ luminescence. Previously, multiplexed kinase activity
detection has been accomplished using the environmentally sensitive fluorophores
oxazine and cascade yellow conjugated to Lyn and Abl specific substrates, where
phosphorylation of the substrates results in enhanced fluorescence. LRET-based
phosphospecific antibodies conjugated with lanthanide chelates (LanthaScreen) and
fluorescently labeled peptide substrates have also been applied to simultaneously monitor
two kinases in a single sample. However, in the case of environmentally sensitive
fluorophores, they suffer from the disadvantages of the having a small dynamic range and
background fluorescence, while LanthaScreen is limited by the requirement of
phosphospecific antibodies to facilitate detection of phosphorylation. The approach
presented here allows for direct measurements of kinase activity through the
incorporation of phosphate to the biosensors—circumventing the need for antibody
labels.
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